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ABSTRACT
UNCOVERING THE IDENTITY AND METABOLISM
OF BACTERIA COA-RNA
by Joseph Rankin Spangler
May 2017
Coenzyme A is an indispensable molecule in all known life with roles in
metabolism, gene regulation, and macromolecule synthesis. As CoA is derived
from RNA itself, it’s incorporation into RNA by in vitro methods has proven useful
in research probing the origin of life based on the RNA World theory. The
discovery in contemporary bacteria of RNA modified with CoA, however,
provided an unexpected twist to previously well-characterized bacterial systems.
The identity of sequences associated with CoA-RNA has been elusive since their
discovery in 2009 based on the difficulties in isolation while maintaining RNA
quality. The aim of this study is to develop a specific CoA-RNA capture protocol
to uncover the sequence identities for the further understanding of CoA-RNA
function. While the free thiol of CoA can be used to purify the CoA-RNA from
total bacterial RNA, the success of process depends on the specific release from
the purification matrix. This work details the characterization of recombinant
Nudix CoA pyrophosphohydrolases from various organisms for their use in CoA
hydrolysis and CoA-RNA metabolism, as well as for the development and
successful implementation of a specific CoA-RNA capture protocol. The use of
this protocol for the construction of high quality NGS libraries is vital to the
elucidation of CoA-RNA function via bioinformatics analysis, for its potential
ii

ranges from a simple stabilization adduct to contemporary examples of RNA
World era coenzyme-conjugated ribozymes.
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CHAPTER I – INTRODUCTION
1.1 RNA
1.1.1 Origin of Life
The greatest question science has sought to answer is that of the origin of
life. With all of the diversity and complexity of biological systems on the Earth,
many have turned their sights backwards in contemplation of where life began.
The outright answer to this question may never be known due to the loss of direct
scientific evidence over the course of the planet’s 4.5 billion year history. We
therefore are left with the task of theorizing with the evidence that is available. As
time progresses and new evidence is uncovered, theories are amended in light of
the new perspectives given by that evidence (Joyce 1989). As a result, some
theories become stronger while others become obsolete.
An example of a strong theory regarding origin with respect to
contemporary organisms is that of a common ancestor. As evaluation and
comparison of highly conserved RNA sequences points out, there is a branching
point from which the three kingdoms of life diverged known as the Last Universal
Common Ancestor (LUCA). Regardless of the shifting timelines of organismal
divergence that change with different phylogenetic analyses, one remaining
constant is that of the LUCA. Due to the overwhelming similarities among the
kingdoms of essential biochemical processes such as DNA replication, RNA
transcription, protein translation, and basic metabolism, their emergence from a
common ancestor is a highly accepted theory. However, the LUCA itself is a
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theoretical organism that cannot be studied, and therefore conclusions regarding
this must be made with reservation and only with great supporting evidence.
RNA is an important molecule regarding evolution and the origin of life.
This fact was recognized by Carl Woese when he used comparisons of 16S
ribosomal RNA (rRNA) to construct the phylogenetic tree identifying Archaea as
a kingdom different from Eubacteria. The identification that RNA is ancient
enough to differentiate all known organisms implicates its existence at the dawn
of our contemporary biological world. This point is further supported by the
essential role of RNA in the indispensable process of protein translation. A quick
evaluation of the logic that RNA is required for protein synthesis as a template
(messenger RNA), as a carrier molecule for monomers (transfer RNA), and as
the catalytic molecule to form the peptide bond (ribosomal RNA) allows one to
hypothesize that RNA predates the evolution of protein. Similarly, as RNA is
essential to DNA synthesis both as a primer for DNA replication and as a
substrate for ribonucleotide reductase to produce deoxyribonucleotides, it can be
hypothesized that RNA also predates the evolution of DNA. The integral role in
life played by RNA, the capability for informational storage, and the catalytic
properties of RNA are all ideas that compose the theory of the RNA World
(Gilbert 1986).
The RNA World is an intriguing idea wherein RNA was the principle
molecule supporting life before the advent of DNA and protein. One intrinsic
problem with this theory however is the lack of modern day examples of RNA
molecules that would support life by a complex metabolism and self-replication.
2

These processes today are largely carried out by protein enzymes with such high
efficiency and specificity it’s hard to comprehend a chaotic existence without
them. The RNA World however is not meant to be convincing of the superiority of
RNA function over that of proteins, but rather of such functions as a vestige of a
previous era (Benner et al. 1989, White 1982). Support of the RNA World theory
relies on examples RNA-catalyzed fundamental processes that would be
required in an RNA organism, such as RNA-catalyzed formation of thioester
bonds (Coleman and Huang 2002), acyl bonds (Li and Huang 2005), peptide
bonds, phosphodiester bonds (Yarus 1999), and coenzyme synthesis (Huang et
al. 2000). While these do not paint the entire picture of an RNA-centered
existence, they provide evidence that fundamental chemistries can be carried out
by RNA alone. Consideration of these discoveries as a precursor to facilitating
more complex processes such as template-derived polymerization of nucleotide
triphosphates, energy storage via bond formation and hydrolysis, and
improvement of catalytic efficiency by coenzymes infers the importance of RNA
to the evolution of the modern organism.
Considering that the RNA World can be reasoned to predate the LUCA
(Benner et al. 1989), the discovery of RNA-catalyzed processes to support the
theory relies heavily on in vitro methods for proof-of-concept. Only time will tell
whether more evidence arises in support of or conflict with the RNA World
theory. The proven ability of RNA to carry genetic information, catalyze important
biochemical reactions, and fold in three-dimensional structures to potentially bind
any molecule certainly implicate RNA to be capable of doing everything protein
3

can, and perhaps more. Whether or not an RNA organism is the predecessor to
the complex biological systems of today, there is no denying the current
functional diversity of RNA and its impact on life as we know it.
1.1.2 Contemporary RNA Functions
RNA has been considered a central part of life since the idea of the central
dogma was introduced. The role of messenger RNA for example is integral to
survival, for it is the obligate intermediate to protein synthesis required by all
living organisms. High fidelity mRNA production is essential to protein function,
as the sequence elements of mRNA determine the rate of translation and the
amino acid composition of a protein, and therefore the abundance and primary
structure of a protein. Furthermore, mRNA sequence elements determine the
alternative splicing in higher organisms which impacts protein diversity. Although
mRNA is the recognized molecule in the central dogma, the majority of RNA in a
cell (~90%) is tRNA and rRNA (Zhuang et al. 2012). The defined structure of
tRNA in concert with the myriad nucleotide modifications it carries is responsible
for the placement of the correct amino acid encoded by the mRNA into the
ribosome during translation. The ribosome itself is a complex of protein and
rRNA, where the catalytic activity of peptide bond formation is carried out by the
rRNA component. The functions of these three major classes of RNA are well
known in the scientific community, and the removal of one of these would
certainly be deleterious to an organism. These three distinct classes of RNA with
their conserved structures and functions only comprise part of the role of RNA in
a cell.
4

New discoveries of RNA functions have added insight into the diversity
and importance of RNA in a cell. Aside from the active roles played in translation
by mRNA, tRNA, and rRNA, there are other classes that recently have been
discovered. These RNA are considered non-coding RNA (ncRNA), and comprise
a large variety of RNA involved in one way or another with regulation of gene
expression. The ncRNAs are found in both prokaryotes and eukaryotes and
serve to directly interact with mRNA, DNA, or proteins to alter gene expression.
Examples of eukaryotic ncRNA are microRNA (miRNA), small-interfering RNA
(siRNA), and piwi-interacting RNA (piRNA).
MicroRNA represents a class of small RNA involved in translation
regulation. The impact of miRNAs is astounding in eukaryotes, for their origins
are in intron sequences of DNA that previously had an unknown function and
were largely thought to be “junk”. MicroRNA regulates protein expression by
interacting with 3’ untranslated regions (3’UTRs) of mRNA. Over 60% of human
mRNA contain miRNA targeting sequences, and there are over 2500 catalogued
miRNA (miRBase.org) indicating that miRNA are a very active regulatory
mechanism (Ha and Kim 2014). Derived from introns, primary miRNA is
transcribed by RNA Polymerase II (PolII) to >1kb single-stranded RNA that
contains a stem-loop structure. That structure contains the miRNA sequence that
is released or matured by RNase III enzyme Drosha to form pre-miRNA, which is
then further matured by the enzyme DICER to 22 basepair (bp) double-stranded
RNA (dsRNA) that is an active miRNA (Ha and Kim 2014). The multiple rounds
of processing occur by different enzymes and in different portions of the cell,
5

implying this miRNA pathway to be the resulted of a concerted effort of proteins
and transport. Once the mature miRNA is produced, it associates with AGO
proteins to form the RNA-induced silencing complex (RISC) that is responsible
for cleavage of mRNA targeted by complementary base pairing of 7 nucleotides
within the guide miRNA seed sequence (Ha and Kim 2014). The small number of
base pairs required for AGO-miRNA activity gives miRNA a broad targeting
range of mRNA, and is therefore very important to its function. MicroRNA
function, if perturbed, can result in tumor formation due to deregulation of protein
expression, and therefore miRNA currently serve as biomarkers used in cancer
research (Dong et al. 2013).
Small interfering RNA (siRNA) is another small RNA in eukaryotes that
associates with AGO proteins. Similar to miRNA, siRNA association with AGO
proteins mediates the cleavage of RNA based on complementary base pairing.
While the end function is the same with the exception of siRNA acting as the
targeting guide rather than miRNA, their origins are quite different. Small
interfering RNA is derived from viral RNA and is used as an antiviral defense.
Viral infection of cells is consists of abundant transcription of viral mRNA and
reproduction of the viral genome encoding these mRNA. Long dsRNA that
results from such reproduction of viral genomic RNA then serves as a hallmark
for viral infection, and these long dsRNA serve as a substrate for processing by
the Dicer enzyme into siRNA (Wilson and Doudna 2013). The siRNA then can be
used to selectively target and degrade their viral counterparts resulting in the
ablation or knockdown of gene expression. This process of RNA interference
6

(RNAi) has been exploited since its discovery as an alternative to gene
knockouts to study gene function in eukaryotes, where knowledge of a gene-ofinterest can be used to design dsRNA of 25 nucleotides (nts) and transfected into
cell lines for the observed RNAi effect of temporary gene knockdown.
Piwi-interacting RNA (piRNA) represent another class of small RNA that
interacts with AGO proteins. More specifically, piRNA interact with the Piwi clade
of the Argonaute superfamily. Piwi-interacting RNA are 24-30nt in length and are
active in germ cell lines and during development (Aravin et al. 2007). Their
function has not completely been characterized, but some studies have shown
piRNA to protect genomes against parasitic nucleic acid such as transposons.
These RNAs are not conserved like miRNA, and therefore their conserved
functions seem to be elusive. Conceptually, however, they appear similar to their
small RNA counterparts of siRNA and miRNA in that there is an association with
nucleotide-hydrolyzing proteins and thus a function in regulation or protection of
some sort. These small regulatory RNAs are relatively new to the scientific
community, and there is still much to be discovered about them.
Prokaryotes do not specifically contain miRNA, siRNA, or piRNA, but they
are not without RNA-mediated post-transcriptional regulation. Small noncoding
RNAs (sRNA) in bacteria can be considered a prokaryotic version of posttranscriptional gene regulation akin to miRNA in eukaryotes. These bacterial
sRNA are 50-300nt in size with a 7-12 bp seed region similar to miRNA (Bandyra
et al. 2012). While miRNA form the RISC complex with Dicer, sRNA form a
complex with Hfq proteins that will associate with the RNase E degradasome to
7

facilitate the degradation of the target mRNA (Bandyra et al. 2012). Antisense
gene regulation in bacteria has been known since the 1980s, wherein RNA
binding is followed by negative regulation either by sequestration of primers for
DNA replication, or binding mRNA to block protein translation (Wagner and
Simons 1994). The more recent discovery of the RNA-protein complex mediating
degradation of target mRNA makes the system more analogous to miRNA in
eukaryotes. The association of Hfq with these sRNA also implicates the
regulatory role of sRNA in bacterial virulence.(Papenfort and Vogel 2010) The full
details of sRNA regulation, especially with Hfq association, are yet to be
determined. Recent advances in Next Generation Sequencing (NGS) technology
have allowed investigators to predict more targets for known sRNA, and have
also identified new potential sRNA.(Cahova et al. 2015, Papenfort and Vogel
2010) In addition to specific mRNA regulation, conserved Hfq-dependent sRNA
have been implicated in the activation of σs synthesis (Papenfort and Vogel
2010). Bacteria contain a single RNA polymerase responsible for all transcription,
and therefore the determining factors of transcript abundance are promoter
sequence and σ-factor participation in transcription initiation. The sRNA control of
which σ-factors are expressed exemplifies yet another level of transcriptional
control exerted by sRNA. The field of sRNA regulation in bacteria is sure to
continue to grow as the cost of NGS continues to reduce and become more
feasible for incorporation into experimental design.
The role of RNA in gene regulation was recently expanded with the
discovery of Clustered, Regularly Interspaced Short Palindromic Repeats
8

(CRISPR) in bacteria and archaea in recent years. These RNA sequences were
discovered to be analogous to an adaptive immunity in bacteria capable of
translational repression by targeted degradation of mRNA. Sequences are
acquired from a primary infection by bacteriophage or plasmid and incorporated
into the genome as repeated units separated by spacers (Marraffini and
Sontheimer 2010). Infections from different sources provide the breadth of the
repeat units, and upon secondary infection the transcription of these CRISPR
RNA (crRNA) sequences facilitates the double-strand breakage of the cognate
DNA to combat the infection. Mechanistic investigations uncovered the potential
of the Type II CRISPR-Cas9 system for genome editing (Jinek et al. 2012). The
Type II system requires trans-activating crRNA (tracrRNA) to basepair with
crRNA to induce processing by RNase III for activation (Jinek et al. 2012). While
in the cell these two RNA are transcribed separately, they can be ectopically
transcribed as a single molecule with the same structure to elicit the same
response. Therefore by designing a tracrRNA:crRNA to target a portion of the
genome, one can induce a double-strand breakage at that site. Furthermore, by
providing a homologous replacement source of that site in the genome, the
homologous recombination repair mechanisms of the bacteria can effectively add
a synthetic sequence to the targeted region of the genome resulting in point
mutation or gene deletions (Jinek et al. 2012). The process of long pre-crRNA
transcription followed by protein-mediated maturation into a shorter active form
makes CRISPR analogous to the eukaryotic miRNA pathway (Marraffini and
Sontheimer 2010). The idea of an RNA-driven adaptive immunity in prokaryotes
9

further displays the variety of RNA functions that exist. While higher diverged
organisms such as mammals display a more complex and diverse adaptive
immunity dependent on protein, the existence of the CRISPR system in simpler
prokaryotes supports the theory of RNA-stabilized processes that throughout
evolution were amended with protein to more complex and diverse processes.
Bacterial gene regulation can also occur in a cis-acting manner.
Transcribed mRNA must have an accessible promoter and RBS for translation
initiation, and these sequence elements appear upstream of the open reading
frame (ORF) in the 5’UTR. Riboswitches are mRNAs that contain an aptamer
domain in the 5’UTR that will bind a metabolite with high affinity and induce
structural changes to allow or block translation of the encoded gene (Tucker and
Breaker 2005). This action allows the tunable translation of certain genes based
on the cellular environment. In addition to metabolite-binding riboswitches,
bacterial mRNA can also possess similar mechanisms that act as
thermosensors. The thermosensor is a structural element in the 5’UTR that will
change conformation based on temperature (Papenfort and Vogel 2010). In
lower temperatures, for example, RNA secondary structure may form blocking
the RBS, and rising temperature denatures that structure to expose the RBS and
make the mRNA accessible for translation. Similar mechanisms can occur with
pH changes (Papenfort and Vogel 2010). Riboswitches are abundant in bacteria,
but are unknown in eukaryotes with the exception of one in plants (Bocobza and
Aharoni 2008, Tucker and Breaker 2005). Without representation of the
riboswitch in more organisms, the evolutionary origin of such a mechanism is
10

uncertain. Regardless, the riboswitch mechanism is interesting as it involves a
single self-regulating RNA with a structure capable of high affinity binding and a
gene-encoding portion, and itself is a great example of the diverse multifunctional nature of RNA.
The ribozyme represents a different aspect of RNA function from those
previously discussed. The roles of RNA in post-transcriptional regulation and
antiviral protection are relatively passive roles, where the targeting is carried out
by RNA but the catalytic mechanism is carried out by protein. In the case of
ribozymes, the RNA is responsible for both the targeting and the catalytic
mechanism. The activity of ribozymes, much like protein enzymes, is reliant on
the secondary structure of the RNA which is in turn depends on the sequence
itself or primary structure. Binding is made possible by taking on specific folding
patterns that specifically orient substrates and make certain chemical reactions
favorable. Naturally occurring ribozymes are quite important for survival, such as
the activity of small nuclear RNA (snRNA) to mature eukaryotic mRNA by
removing introns. The removal of these introns and joining of exons serves to
create protein isoforms in a splicing process that is carried out by the majority of
human protein-encoding genes (Dvinge et al. 2016). It is widely accepted that
splicing accounts for the abundance of diverse protein functions encoded by a
relatively small percentage of the human genome. The splicing activity of snRNA
on a conceptual level is the same as small-scale polymerization, or the formation
of a phosphodiester bond. Ribozymes derived from in vitro selection methods
catalyze a diverse set of reactions that have not yet been identified in natural
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systems. In addition to phosphodiester bond formation carried out by snRNA, in
vitro selected ribozymes have been found that carry out phosphodiester
formation to act as a 5’-3’ and a 5’-5’ ligase, as well as phosphodiester hydrolysis
and even RNA branching and polymerization to some scale (Tuschl et al. 1998,
Pan and Uhlenbeck 1992, Bartel and Szostak 1993, Chapman and Szostak
1995, Ekland and Bartel 1996). In addition to the 5’-5’ ligase activity shown by
Chapman et al. (1995), 5’-5’ self-capping ribozyme activity has also been
observed (Huang and Yarus 1997). The formation and hydrolysis of
phosphodiester bonds by RNA is certainly impressive, but investigators have
observed much more diverse ribozyme-catalyzed chemical reactions such as
RNA phosphorylation, acyl activation, aminoacylation, acyl transfer, amide bond
formation, glycosidic bond formation, RNA alkylation, thioester formation, Michael
addition, Diels-Alder reactions, and redox reactions (Lorsch and Szostak 1994,
Kumar and Yarus 2001, Illangasekare et al. 1995, Lohse and Szostak 1996,
Unrau and Bartel 1998, Wilson and Szostak 1995, Jadhav and Yarus 2002,
Coleman and Huang 2002, Sengle et al. 2001, Tarasow et al. 1997, Tsukiji et al.
2003). The list of ribozyme-catalyzed chemistries is impressive, but these
activities are evidence of the potential for RNA to support life itself. While the
majority of ribozyme chemistries that have been observed involve a phosphate or
an anhydride, the discovery of ribozymes catalyzing carbon-carbon bond
formation, glycosidic bond formation, and alcohol dehydration broadens the
potential for ribozyme activity to be capable of supporting life itself (Chen et al.
2007).
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The importance of RNA in life has been argued for many years (Gilbert
1986). It is accepted as an obligate part of every organism by the central dogma
of biology. While serving as the template for protein translation is indispensable
for cell survival, it’s clear the role of RNA extends far beyond that of an
intermediate. RNA has been shown to serve as an information carrier, regulatory,
and catalytic molecule in all forms of life. In terms of catalytic RNA, the diverse
array of ribozyme activity observed both in vitro and in nature is astounding.
Although most ribozyme discoveries are via in vitro selection, the resulting
activity is evidence of the potential within RNA, and evidence that such
ribozymes may have existed in a time when the selective pressure was present
before the emergence of protein. It seems with all that has been recently
discovered, the depth and scope of RNA function has yet to be fully uncovered.
1.2 Coenzymes
1.2.1 Origin and Functions
Coenzymes are molecules that participate in reactions with protein
enzymes, and are considered the most conserved complex molecule throughout
evolution (White 1982). In the 1970s, half of all known enzymes required
coenzymes for their function (White 1976). Today, such coenzymes are
ubiquitous throughout life and indispensable for protein function in important
pathways such as glycolysis and the Kreb’s cycle. Many coenzymes contain
modified nucleotides or derivatives such as coenzyme A (CoA), nicotinamide
adenine dinucleotide (NAD), Flavin adenine dinucleotide (FAD), S-adenosyl
methionine (SAM), thiamin pyrophosphate, and pyridoxal phosphate (Figure 1.1).
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The housing of nucleotide structures at the conserved core of coenzymes
understood to be vital to modern enzyme function suggests a time when
nucleotide-derived enzymes, or ribozymes, fulfilled such roles (White 1976,
White 1982). Interestingly, the nucleotide incorporation plays no role in the
function of these coenzymes, and therefore is considered a vestige of a previous
era when these coenzymes likely existed as the catalytic portion of ribozymes
(Benner et al. 1989). Due to the ability for coenzymes to carry out the same
reactions as those of proteins that require them, and the known capability for
proteins to bind specific substrates and stabilize reaction transition states, it’s
possible that as evolution progressed, the emergence of proteins granted
specificity to the biochemistry catalyzed by ribozymes, and the union of the two
resulted in the modern day protein-coenzyme catalytic complex (White 1976,
White 1982). Such an evolution would result in the catalytic center being trimmed
to the smallest unit still capable of catalysis, resulting in the modern coenzyme
with an RNA nucleoside or its derivative at the core.
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Figure 1.1 Common Coenzymes Derived from Adenosine.
A, Coenzyme A (CoA); B, Flavin adenine dinucleotide (FAD); C, Nicotinamide adenine dinucleotide (NAD+); D, (S)adenosyl methionine (SAM).

The coenzymes of interest here are those that contain adenosine at the
core of their structure, such as CoA, NAD, FAD, and SAM (Figure 1.1). The
functions of these coenzymes are distinct from one another, even in terms of
NAD and FAD that both function in redox. As their origin is hypothesized to be
from the LUCA or before, these coenzymes have been deeply integrated into
modern metabolism, with each coenzyme participating in a multitude of pathways
(Benner et al. 1989). For example, SAM functions as the major methyl donor in
the cell that is responsible for, among other things, DNA methylation, and
therefore has a profound impact on gene expression (Fontecave et al. 2004,
Chiang et al. 1996). SAM has also been shown to donate amino groups,
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methylene groups, ribosyl groups, and aminoalkyl groups in different pathways.
Another example of a widely used coenzyme is NAD. This coenzyme is widely
used in redox reactions by cycling between its oxidized (NAD+) and reduced
(NADH) forms. In aerobic respiration from glucose, NAD+ is reduced during
glycolysis and the Kreb’s cycle, and the accumulated NADH is then oxidized in
the electron transport chain to drive the major ATP-yielding process of the
pathway. In addition to this well-known function of NAD+/NADH in redox
chemistry, NAD can be used for adenylation, ADP-ribosylation in DNA repair and
cell signaling through G-coupled-proteins, and as a transcriptional regulator via
activation of Sir2p deacetylase activity (Lin 2007, Garten et al. 2009). FAD is
another example of a multi-use coenzyme. It also participates in redox reactions
similar to NAD, but is a more versatile redox substrate due to its ability to capture
either 1 or 2 protons (Walsh 1980). Aside from its well-characterized roles in the
Kreb’s cycle and the electron transport system, FAD participates in many other
reactions with the flavoenzyme class of proteins. Flavoproteins are involved in
the oxidation of various metabolites such as amino acids and fatty acids, as well
as with protein folding and chromatin remodeling (Joosten and van Berkel 2007,
Giancaspero et al. 2013). The nature of the coenzyme dictates its versatile
involvement throughout life, as there are many examples to support this.
1.2.2 CoA
Perhaps one of the more important and versatile coenzymes found in all
forms of life is Coenzyme A (CoA). While the importance of CoA is open for
debate, the structure of CoA is unique and there are no functional overlaps with
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other abundant coenzymes such as those with NAD/FAD in redox and
SAM/methylcobalamin in methyl transfer. While CoA is known to participate in
over 500 reactions, its main function is acyl-transfer (Kanehisa et al. 2008). This
activity is made possible by the thiol group of CoA which can react with acylphosphates to form thioesters. The thioester serves as a great intermediate for
acyl transfer due to its high energy and considerable stability (Coleman and
Huang 2002, Berg et al. 2007). Cells take advantage of the acyl-transfer
capabilities of CoA most notably in polyketide synthesis, β-oxidation in fatty acid
metabolism, and the transition between glycolysis and the Kreb’s cycle. CoA also
plays a role in protein and amino acid synthesis when considering the
intermediates of the Kreb’s cycle are required for the synthesis of 10 amino acids
(Berg et al. 2007). Recently, CoA has been shown to participate in acetylcholine
synthesis and histone acetylation (Szutowicz et al. 2013, Nakamura et al. 2012).
These examples place the direct role of CoA in metabolism, protein synthesis,
post-translational modification, and gene regulation. The importance of CoA for
survival is therefore indisputable.
Coenzyme A synthesis takes place by a conserved pathway involving 5
steps initiated from pantothenate (Figure 1.2). The first step is the
phosphorylation of pantothenate to 4’-phosphopantothenate by the enzyme
CoaA or pantothenate kinase (PanK), which is the rate-limiting step of the
pathway and the focus of feedback inhibition by CoA itself for regulation of CoA
synthesis (Leonardi et al. 2005, Jackowski and Rock 1981). After its
phosphorylation, 4’-phosphopantothenate is condensed with cysteine by CoaB to
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form 4’-phosphopantothenoylcysteine, which is then decarboxylated by CoaC to
form 4’-phosphopantetheine. Dephospho-CoA (depCoA) is made in step 4 by the
adenylation of 4’-phosphopantetheine (PhP) by CoaD, or phosphopantetheine
adenylyl transferase (PPAT), and thereafter depCoA is phosphorylated by CoaE
to functional CoA. While the pathway itself is conserved, eukaryotes contain a
single dual-function enzyme that catalyzes the same reactions as CoaD and
CoaE in plants and bacteria (Leonardi et al. 2005). The CoA pool in eukaryotes
also varies from cytoplasm to mitochondria as well as between different tissues
because of the different metabolic pathways involved, therefore transcriptional
control of PanK is employed to locally regulated CoA levels in addition to
feedback inhibition by CoA and its thioesters on PanK activity itself (Leonardi et
al. 2005). In E. coli, however, the carbon source plays a role in CoA levels,
wherein acetate and glucose levels dictate the total amount of CoA as well as the
ratio of CoA to thioester (Leonardi et al. 2005). For example, in nutrient rich
conditions marked by excess glucose, the CoA levels are high with the majority
in the form of acetyl-CoA, but in glucose minimal media lacking pantothenate, the
thioester fraction decreases greatly along with the overall CoA concentration
(Leonardi and Jackowski 2007).
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Figure 1.2 Bacterial CoA Synthesis.
Synthesis begins with pantothenate (1) being phosphorylated by CoaA to 4’-phosphopantothenate (2), condensed with
cysteine by CoaB to form 4’-phosphopantothenoylcysteine (3), decarboxylated by CoaC to form 4’-phosphopantetheine
(4), adenylated by CoaD to make dephospo CoA (5), and phosphorylated by CoaE to form the functional CoA (6).
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The source of the CoA synthesis pathway is interesting in terms of
evolution. Humans do not possess the ability to synthesize pantothenate, and
therefore it must be acquired through other means. E. coli, on the other hand, is
quite capable of pantothenate synthesis from condensation of the amino acid
derivatives pantoic acid and β-alanine (Jackowski and Rock 1981). The
interesting aspect of pantothenate synthesis is that it and its precursors can be
obtained by prebiotic chemistry. The biosynthesis of pantoate involving
methylation and subsequent reduction of α-ketoisovalerate by Methyl-THF and
NADPH, respectively, was investigated in 1993 by Miller as a possible prebiotic
route to pantoate synthesis, considering that each of the pathway’s precursors
would be present in the prebiotic ocean (Miller and Schlesinger 1993). In addition
to this known pathway, pantoate synthesis was demonstrated with HCN,
formaldehyde and the valine precursor isobutraldehyde, wherein the subsequent
lactone form of pantoic acid could react with β-alanine to form pantothenate
without a catalyst. Both pathways involving isobutraldehyde and αketoisovalerate resulted in contextually high yields considering prebiotic reaction
conditions (Miller and Schlesinger 1993). Coenzymes have been hypothesized
as molecular fossils of evolution since the 1970s, and the demonstration of
prebiotic synthesis of coenzyme precursors further supports this claim (White
1976). The existence of CoA as a ubiquitous and vital coenzyme in all of life
indicates its existence in the LUCA, and according to Benner the fact that the
function of CoA is unrelated to its RNA core implicates its existence before the
LUCA in the breakthrough organism during the time of the proposed RNA world
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(Benner et al. 1989). Studies in the past 30 years employing in vitro selection
have yielded a great number of ribozymes as previously discussed, but most
notably the Huang lab and the Yarus lab have produced ribozymes that directly
interact with CoA (Huang et al. 2000, Coleman and Huang 2002, Li and Huang
2005, Jadhav and Yarus 2002). Such CoA-related ribozyme activity is further
evidence of the ancient relationship between CoA and RNA, and supports the
theory of an RNA world where coenzymes were synthesized and functioned in a
similar way as they are in contemporary life.
The degradation pathway of CoA is peculiarly unknown considering the
importance of the molecule. Over the years, CoA synthesis has been a target for
antibacterial drug development and therefore the synthesis pathway is fairly well
characterized (Leonardi et al. 2005). The transfer of the 4’-phosphopantetheine
arm to the acyl carrier protein (ACP) for fatty acid synthesis is also well
characterized, but after use, PhP is removed from ACP and recycled to
regenerate CoA by the sequential activities of [ACP]phosphodiesterase and
PPAT (Jackowski and Rock 1984). The breakdown of depCoA is possible by
PPAT which catalyzes both forward and reverse reactions regarding depCoA
synthesis and degradation. This degradation cannot occur with CoA itself,
however, and requires the dephosphorylation of CoA to depCoA, which is
possible by general dephosphorylation with acid phosphatase, but is not
characterized by a CoA-specific pathway (Kanehisa et al. 2008, Huang et al.
2000). Alternate pathways of depCoA degradation include ectonucleotide
pyrophosphatase (ENPP) activity, but since the 1950s, the only characterized
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ENPP enzymes exist in humans (Kanehisa et al. 2008). E. coli has been shown
to secrete both PhP and pantothenate when in excess, but studies have not
uncovered the likewise secretion of CoA, therefore leaving the degradation of
CoA to PhP and 3’5’ADP a mystery for many years (Jackowski and Rock 1984,
Vallari and Jackowski 1988, Leonardi and Jackowski 2007). If the CoA is not
being degraded, then perhaps it is just constantly recycled. Surely, such an
important molecule would be maintained in some sort of salvage pathway. The
importance of CoA, however, is what makes this aspect of CoA metabolism hard
to probe. It is because CoA is such an indispensable component of survival that
coaD knockout mutants are lethal (Balibar et al. 2011). While knockout mutants
can sometimes survive as auxotrophs in supplemented growth media, CoA
cannot imported into the cell to rescue coaD mutants, therefore making it hard to
study CoA retention and recycling by knockout techniques (Balibar et al. 2011).
The area of CoA degradation would remain unstudied until the discovery of a
new superfamily of nucleotide-hydrolyzing enzymes was found to extend into
coenzyme turnover.
1.3 The Nudix Superfamily
1.3.1 Structure and Functions
The degradation of aberrant functioning molecules is a required process in
cellular maintenance. Damaging situations can occur as a result of accumulation
of such molecules. One such example is the oxidation of the deoxyribonucleotide
guanosine (dGTP) to 8-oxo-guanosine (8-oxo-dGTP) by reactive oxygen species
in the cell. The oxidized nucleotide can be incorporated into DNA during
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replication just as dGTP, but its capability to basepair with adenosine leads to
point mutations. In an environment characterized by high oxidative stress, the
pool of 8-oxo-dGTP could be large, therefore leading to a large mutation rate
during DNA replication. Such was the scenario from which the first Nudix protein,
MutT, was discovered in E. coli. (Bessman et al. 1996). The MutT protein was
found to cleave nucleotides as a pyrophosphohydrolase, catalyzing the general
reaction of dNTP  dNMP + PPi, and due to its preference for oxidized
nucleotides such as 8-oxo-dGTP it was determined to be a housecleaning
enzyme, responsible for protecting the cell against mutagenic nucleotides
(Bessman et al. 1996). Investigation of the amino acid sequence of MutT
uncovered a new class of enzymes that catalyze the hydrolysis of nucleotides
linked by diphosphate to X (Nudix).
The Nudix box motif (PS00893) appears conserved across archaea,
bacteria, eukaryotes, and some viruses (Mildvan et al. 2005). The consensus
sequence of Gx5Ex5[U/A]xREx2EExGU (where X is any amino acid, and U is any
hydrophobic amino acid) found within a loop-helix-loop motif is the basis for the
Nudix superfamily of enzymes, and characterizes the Nudix fold of an αβα
sandwich responsible for magnesium/manganese binding and the catalytic
activity of the protein (McLennan 2006). Over 250 species have been identified to
contain Nudix enzymes, and while there is a general trend of increasing number
with genome size, their occurrence is significantly higher in prokaryotes where
organisms such as E. coli and D. radiodurans have 13 and 26, respectively
(McLennan 2006, Mildvan et al. 2005). The different Nudix hydrolases found in
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bacteria and eukaryotes have been observed to prefer a variety of substrates
that satisfy the criteria of a nucleotide diphosphate linked to X, such as 8-oxodGTP, 8-OH-dADP, GDP-mannose, GDP-glucose, ADP-ribose, ADP-glucose,
ADP-mannose, 5m-dCTP, AppA, Ap3A, Ap4A, Ap5A, diphosphoinositol
polyphosphates, 5-phosphoribosyl 1-pyrophosphate (PRPP), thiamin
pyrophosphate, NADH, FAD, eukaryotic capped mRNA, and finally CoA and CoA
thioesters (McLennan 2006, Bessman et al. 1996, Song et al. 2010). Such a
variety is possible, in part, by the substrate ambiguity displayed by many of these
enzymes when studied in vitro (McLennan 2013). The catalytic activity of all
known Nudix enzymes involves hydrolysis of a phosphoanhydride bond with the
exception of molecules such as GDP-mannose where the glycosidic bond is
targeted. This conserved activity is sufficient to inactivate or prevent the
substrate from being used, therefore allowing it to be salvaged for another
purpose. The Nudix enzymes can indeed be considered housecleaning
enzymes, however their role can be extended into gene regulation which will be
discussed in a later section. Furthermore, the activity of Nudix enzymes with
coenzymes may indicate their role in the regulation of metabolism by facilitating
the turnover of these metabolism-dependent molecules.
1.3.2 Coenzyme Pyrophosphohydrolases
The Nudix enzymes have long been accepted as antimutator proteins and
housecleaning proteins in the cell (Bessman et al. 1996). The discovery of an
NADH-hydrolyzing Nudix enzyme, however, extended the role of the Nudix
superfamily to include the potential for metabolic regulation (Figure 1.4C).
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Studies on the NADH-targeting Nudix hydrolases from E. coli, S. cerevisiae, and
C. elegans demonstrated a significantly higher preference for reduced NADH
than oxidized NAD+, implicating its potential activity to be involved with regulation
of the balance between the two (Frick and Bessman 1995, Xu et al. 2000). The
importance of the NADH-targeting Nudix enzyme is only speculated, for yeast
deletion mutants seem to survive with no significant phenotypic effects (Xu et al.
2000). Some of the speculation involves the production of NMNH (reduced
nicotinamide mononucleotide, or reduced nicotinamide D-ribonucleotide), as this
is the only known pathway of obtaining such a molecule (Frick and Bessman
1995). Considering the increasing pool of non-canonical functions of
nicotinamide coenzymes that has been recently discovered, it is plausible that its
role is regulatory. NADH-hydrolyzing Nudix enzymes must maintain some
important function, regardless of what is currently known, for the enzyme has
been detected in an abundance of organisms based on conserved motif
SQPWPxPxS located downstream of the Nudix motif (Xu et al. 2000). The three
studied by Xu et al. (2000) from organisms representing prokaryotes, singlecelled eukaryotes, and multicellular eukaryotes all display some substrate
diversity to various degrees. While showing clear preference for NADH as
mentioned earlier, the investigators also observed significantly higher preference
for AppA, and ADP-Ribose than for NAD+. The C. elegans enzyme even
displayed a higher activity towards dATP than NAD+. Furthermore, the E. coli
NudC has recently been shown to cleave NADH, NAD, and CoA, and while the
observed substrate promiscuity may indeed be an in vitro bias, it could also
25

simply be an example of a multi-purpose enzyme that has a preference for
NADH (McLennan 2013, Bird et al. 2016).

Figure 1.3 Alignment of Nudix Enzymes with CoA Hydrolysis Activity.
Consensus sequences are underlined and emboldened, and all sequences have been verified to have CoAse activity with
the exception of E. coli NudL and Human NUDT7. E. coli NudC has no CoA consensus motif, yet still displays CoA
hydrolysis activity in vitro.

The CoA-hydrolyzing Nudix enzymes have a similar potential to act as
metabolic regulators in addition to their housecleaning capabilities. These
enzymes are characterized by a CoA-binding motif of
LLTxR[S/A]x2LRx3Gx[V/I]xFPGG that is directly upstream of the Nudix box
(Figure 1.3), which is in contrast to the conserved NADH-motif located
downstream of the Nudix box in previously discussed enzymes (Gasmi and
McLennan 2001). The CoAse enzymes that have been studied in eukaryotes are
mostly localized by a signal peptide to the peroxisome or the mitochondrial
membrane (McLennan 2006). The peroxisome environment in particular can
oxidize CoA to a dimer via disulfide bond, and therefore CoAses localized here
can show a preference to oxidized CoA such as with Pcd1p of S. cerevisiae
(Cartwright et al. 2000, McLennan 2006). The yeast CoAse was the first to be
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studied, and its higher activity towards oxidized CoA was considered plausible
based on the environment in which the enzyme was found. Later, the bacterial
ortholog in D. radiodurans was isolated and characterized with the same
preference, which again seemed plausible based on the extreme-living and
resilience for which D. radiodurans is known (Kang et al. 2003). Such activity
towards oxidized CoA fit the model of Nudix enzymes being involved in
housecleaning, for CoA dimers can result from oxidative stress, and therefore
lack the free thiol required for its acylation activity. With this hypothesis, a
mechanism of CoA recycling was finally realized.
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Figure 1.4 Nudix Hydrolysis of Coenzymes.
A, Hydrolysis of CoA to PhP and 3’5’-ADP known to be carried out by all specified Nudix CoAses with the exception of
Human NUDT7 and E. coli NudL; B, Hydrolysis of FAD currently not carried out by any known Nudix enzyme; C,
Hydrolysis of NAD currently carried out by E. coli NudC.

The discovery of Nudix CoAses in other organisms, however, provided
evidence of other roles. The Nudix CoAse NDX8 in C. elegans was found to also
be targeted towards the peroxisome, but did not show the same affinity for
oxidized CoA as the previously characterized CoAse from S. cerevisiae
(AbdelRaheim and McLennan 2002). While this enzyme was capable of
28

hydrolyzing the CoA dimer, the catalytic efficiency for CoA was higher. Studies
on the Nudt7α enzyme from M. musculus that is likewise targeted to the
peroxisome showed similar results that, while the affinity for oxidized CoA was
slightly higher than CoA itself, the catalytic efficiency for CoA was almost two-fold
greater for the reduced monomer than for the dimer (Gasmi and McLennan
2001). Further studies of Nudt7α showed that its catalytic efficiency increased
with the size of CoA thioesters tested, and peaked at the C12 length of lauroylCoA with over 40-fold higher kcat/Km and 7-fold higher affinity than observed with
CoA (Reilly et al. 2008). While still capable of cleaving oxidized CoA, these
CoAses seem capable of so much more. The higher activity displayed against
thioesters implicates the role of such enzymes in metabolic regulation, such as
the switching between fatty acid metabolism and glycolysis, where CoA used in
β-oxidation may be immediately required for use in respiration. The hydrolysis for
lauroyl-CoA by Nudt7α, for example, would immediately free 3’5’-ADP as a direct
substrate for CoA synthesis by PPAT and allow the cell to repurpose CoA into
another pathway. In contrast, lauroyl-CoA (C12) would require 20 enzymecatalyzed reactions to convert completely to acetyl-CoA (C2) via β-oxidation.
Indeed, each subsequent two carbon removal from lauroyl-CoA would yield an
acetyl-CoA molecule, but this would still require 4 enzymatic steps and the three
coenzymes of CoA, FAD, and NAD to accomplish.
The putative Nudix CoAses offer the opportunity to further hone the model
of CoAse function throughout evolution. The Conserved Domain Database
shows over 140 occurrences of the Nudix motif with the CoA binding motif
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throughout Bacteria, Eukarya, and Archaea (Marchler-Bauer et al. 2015). While
there have been Nudix CoAses characterized in bacteria, yeast, insects, plants,
and mammals, there are still a great number that remain putative (Kang et al.
2003, Cartwright et al. 2000, AbdelRaheim and McLennan 2002, Kupke et al.
2009, Gasmi and McLennan 2001, Reilly et al. 2008). The human proteins Nudt7
and Nudt8 are examples of such putative enzymes, for they show homology to
the murine Nudt7α, but lack the peroxisome-targeting signal sequence (Gasmi
and McLennan 2001). Therefore while it seems plausible that they both might
maintain CoAse activity based on their sequences, the subcellular localization
differs from the eukaryotic models presented by such organisms as M. musculus
or C. elegans. Another example of a putative CoAse is YeaB (NudL) in E. coli.
This protein contains both Nudix and CoA motifs similar to characterized
enzymes in D. radiodurans, M. musculus, and C. elegans (Gasmi and McLennan
2001, McLennan 2006). Interestingly, despite the widespread availability of E.
coli in laboratory settings and a transcript abundance of approximately one-sixth
that of the indispensable dNTP-targeting NudB, this protein has yet to be
characterized (McLennan 2006). Alexander McLennan and his group have done
extensive research on the Nudix superfamily, and have referenced multiple times
the possibility that this enzyme in E. coli may also target CoA, but to date there
are no such characterizations of NudL. To date, the only group that has studied
NudL has done so with focus on its promiscuous activity, wherein the enzyme
was found to support the synthetic pyridoxal 5’ phosphate pathway with low
activity (Kim et al. 2010). The authors recognize the activity is low, indicating this
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is at best a secondary pathway, and mention that the predicted activity is towards
CoA, however there is no such evaluation of NudL’s substrate range outside of
their focus on the pyridoxal 5’ phosphate synthetic pathway. The only other E.
coli Nudix enzyme that displays activity towards CoA is the aforementioned
NudC. The study revealing this activity, however, was focused elsewhere, and
only showed this NAD-targeting Nudix hydrolase to be qualitatively active against
NAD, NADH and CoA without any investigation towards substrate range or
kinetics, therefore leaving open the question of whether NudC functions as the E.
coli CoAse or if the activity is another substrate promiscuity that seems
characteristic of the Nudix enzymes (Bird et al. 2016, McLennan 2013). One
reason this recent study failed to look into the possibility of NudC as a CoAse
may be due to the fact some substrate range of NudC orthologs had already
been probed, albeit the activity specifically towards CoA was not evaluated (Xu et
al. 2000). If NudC is the principal E. coli CoAse, then it carries out this activity
without the CoA motif (UPF0035) conserved in all other characterized Nudix
CoAses throughout evolution (Figure 1.3). If there are multiple CoA-degrading
Nudix enzymes in E. coli, the major enzyme would reasonably contain this CoA
motif as is found in NudL. Nevertheless, despite the established characterization
of a bacterial CoAse from D. radiodurans and the sequence data suggesting CoA
hydrolysis activity by E. coli NudL, we still today are left without an established
CoA-degrading enzyme in the otherwise well-characterized CoA pathway of E.
coli.
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The Nudix hydrolase superfamily has a logical place in evolution due to its
antimutator functions. The importance of organismal self-preservation certainly
warrants such a variety of enzymes that target and degrade potentially harmful
nucleotide derivatives, and this is noted in early studies of the first characterized
Nudix protein MutT (NudA) wherein knockout mutants displayed mutation rates
up to 4-log higher than the wildtype (Bessman et al. 1996). This antimutator
function, however, doesn’t seem to fit when describing the coenzyme-targeting
Nudix enzymes. The targeted coenzymes mentioned above contain no known
mutation potential. In terms of NADH, the hydrolysis to produce NMNH is one
potential function, but a downstream use has yet to be discovered for such a
molecule (Frick and Bessman 1995). The preference for hydrolysis of NADH over
NAD+ can surely regulate the balance between the two, but for what reason
would the cell destroy a molecule that has evolved to be cycled between the two
states by such a variety of proteins? Destruction of NADH seems energetically
wasteful, as the molecule could release its electrons for ATP production via
electron transport in respiratory pathways. Indeed, the regeneration of NAD+ is
vital to fermentative metabolism, and the oxidation of NADH usually results in the
production of some organic compound that may be excreted. However, cutting
NADH to produce NMNH does not regenerate NAD+ directly, primarily because
there are no known biochemical reactions involving NMNH, especially those that
would oxidize it to the NAD precursor NMN (nicotinamide mononucleotide, or
nicotinamide D-ribonucleotide). The evolutionary reasoning behind the regulation
of the NAD/NADH balance by hydrolysis is therefore unclear.
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The function of CoA pyrophosphohydrolases similarly deviates from the
Nudix superfamily. CoA has no known mutation potential similar to NADH. There
is certainly a benefit to hydrolysis of dimerized CoA by enzymes such as Nudt7α,
as it is biologically useless until it is reduced back to the free thiol-containing CoA
monomer. Such Nudix activity may be especially important in organisms such as
S. aureus and multiple Bacillus species (B. cereus, B. subtilis, B. anthracis, B.
thuringiensis) that do not possess a glutathione redox system and use CoA in its
place (Leonardi et al. 2005), however these organisms contain a CoA-disulfide
reductase to regulate such oxidation. Furthermore, there are no known Nudix
CoAses found in the Firmicutes phylum according to the CDD aside from 4 in the
Clostridia family and 3 in Bacillaceae, and none of these include the previously
mentioned CoA disulfide-reductase containing bacteria (Marchler-Bauer et al.
2015). In addition, S. cerevisiae that contains the oxidized CoA-preferring Nudix
Pcdp1 enzyme does not contain a specific CoA-disulfide reductase enzyme.
Therefore it seems these two enzymes are mutually exclusive. The role of Nudix
CoAse as a recycler of oxidized CoA would be understandably reasonable in
organisms that lack the specific CoA disulfide-reductase system, for organisms
that contain glutathione do typically possess CoA-glutathione reductase enzymes
that serve a similar purpose. However, the fact that many of the studied CoAses
do not share the same preference for oxidized CoA as Pcdp1 from S. cerevisiae
complicates this functional model. The idea that Nudix CoAses prefer CoA and
even CoA thioesters above oxidized CoA while still capable of hydrolyzing them
all implies these proteins function as multipurpose enzymes. As stated above,
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the recycling of CoA by Nudix enzymes produces in a single step a direct
substrate for CoA synthesis in 3’5’ADP, and such activity could have a place in
the regulation of the energy state of the cell, especially when considering that
excess CoA has been shown incapable of crossing the bacterial cell membrane
unlike its precursor PhP (Jackowski and Rock 1984).
It’s clear that NAD- and CoA-targeting Nudix enzymes do not fit the role of
antimutators like many of the other Nudix enzymes. These coenzyme-targeting
Nudix enzymes still bear the Nudix motif and catalytic action, but they seem to be
capable of much more than substrate turnover, simply due to the widespread
impact of the substrates themselves. While CoAse activity is something never
before demonstrated in model bacterial organisms such as E. coli, NAD
degradation has been known since the 1970s by an unrelated enzyme (Grushoff
et al. 1975). Now that there are two known coenzyme-targeting
pyrophosphohydrolases from the same superfamily in organisms across multiple
phyla, there is a question of what, if any, is their shared activity? The other Nudix
hydrolases all seem to function in sub-classes of shared activity, but is this same
type of association relevant to the coenzyme-targeting Nudix proteins? This
question would remain wide open until almost 10 years after the Nudix CoAse
was discovered.
1.4 Coenzyme-RNA Conjugates
1.4.1 In Vitro Conjugates
Conserved processes throughout evolution generally maintain the core
mechanism, but gain specificity and regulation either with additional participating
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molecules or additional protein components or subunits. One example of this
idea is the RNA Polymerase (RNAP) and its catalysis of transcription. The RNAP
maintains the same catalytic mechanism throughout all known life, but from the
progression of bacteria to archaea and eukaryotes, it gains both additional
subunits and binding partners to facilitate an initiation of transcription that is more
complicated with evolution. Viruses, on the other hand, offer a simpler version of
the process with a single RNAP subunit capable of carrying out transcription
alone. This simple and efficient version of transcription makes viral RNAPs great
candidates for in vitro transcription (Milligan et al. 1987). The in vitro transcription
system can be utilized to produce RNA transcripts of any desired sequence
downstream of a specific promoter. The T7 bacteriophage RNA polymerase
became of particular interest in the early 2000s, when investigators discovered
the advantage of the previously overlooked T7 φ2.5 promoter to allow
transcription initiation with an adenosine nucleotide rather than a guanosine that
was characteristic of the more commonly used T7 φ6.5 promoter (Huang et al.
2000). The impact of such a mechanism was rooted, for one, in the superior
homogeneity of transcripts derived from the φ2.5 promoter that lacked the
variable number of nucleotides at the 5’ end (Coleman et al. 2004). Second, the
installation of adenosine as the initiating nucleotide of transcription allowed the
efficient incorporation of an endless potential of adenosine derivatives as
initiators of transcription so long as Watson-Crick base pairing was not disrupted
(Huang et al. 2003, Li et al. 2005, Huang and Shi 2010, Huang and Shi 2012)
(Figure 1.5). In addition, biologically relevant adenosine derivatives such as CoA,
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NAD, and FAD were capable of transcription initiation under the φ2.5 promoter,
and this aspect brought forth in vitro coenzyme-RNA conjugates (Huang 2003a).
The installation of nucleotide derivatives such coenzymes into RNA had been
noted previously using the E. coli RNAP, however these observations were
limited to incorporation into abortive transcripts of 2 nucleotides (Malygin and
Shemyakin 1979). The discovery by the Huang lab demonstrated a far superior
system wherein transcripts of any length and any defined sequence can be
initiated with any adenosine derivative in high yield.
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Figure 1.5 RNA Modifications.
Currently known RNA modifications that can be made in vitro and speculated in vivo. A, 7-methyl guanosine mRNA cap
from eukaryotes; B, 5’-triphosphate cap of bacterial mRNA; C, 5’-monophosphate RNA as a degradation product of
bacterial mRNA; D, 5’-hydroxyl RNA generated in vitro; E, CoA-RNA generated in bacteria; F, AppA-RNA, generated in
vitro and speculated possible in bacteria; G, NAD-RNA generated in bacteria; H, FAD-RNA generated in vitro and
speculated in bacteria.

The in vitro transcribed RNA conjugates have had many uses since their
discovery. For example, the conjugation of fluorescent dyes to adenosine allow
for fluorescent labeling of RNA is useful in localization studies in cell culture, or
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non-radioactive hybridization techniques reminiscent of the Northern blot (Huang
et al. 2003, Li et al. 2005). As RNA therapy has become an avenue for cancer
treatment, RNA modifications that enhance stability during delivery to cell culture
are vital (York et al. 2009, Huang et al. 2008). Such delivery and treatment
enhancements can be achieved by the addition of such fluorescent derivatives or
thiol derivatives, for immune responses to targeted siRNA knockdown therapy
can be avoided by replacing the 5’-triphospate of RNA produced with in vitro
transcription, (Hornung et al. 2006). In addition to altering the biological behavior
of RNA molecules with modified 5’ termini, the derivatization of adenosine with a
free thiol introduces the potential for unique chemistries otherwise unavailable
with canonical RNA. For example, 5’-thiol labeled RNA can be covalently
attached to the surface of gold nanoparticles that are commonly used for RNA
delivery in therapeutic applications (Huang and Shi 2010, Boisselier and Astruc
2009). The thiol modification can also be used for immobilization on solid
surfaces by the formation of disulfide, thioether, or thioester bonds. Such
immobilization is vital in the process of Systematic Evolution of Ligands by
Exponential Enrichment (SELEX), wherein small populations of sequences that
contain unique folding capabilities to facilitate high affinity binding (aptamers) or
catalytic activity (ribozymes) can be isolated from large pools of randomly
sequenced oligonucleotides (Tuerk and Gold 1990).
Coenzyme A can serve as an alternate source of a free thiol group on
RNA if used as a transcription initiator as opposed to thiol-modified adenosine
(Figure 1.5E). In addition to the chemistry advantages of the thiol group, CoA
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incorporation can increase the biological relevance of SELEX results. In other
words, thiol-labeled adenosine is useful in immobilization for the purposes of
selection, but the activity of the resulting ribozyme is due to the sequence
elements and not the thiol itself. On the other hand, CoA-conjugated RNA can be
used as a way to immobilize the RNA, or as an active part of the ribozyme
activity. In this regard, CoA-RNA has been used to demonstrate ribozyme activity
directly involving the coenzyme (Coleman and Huang 2002). The transcription of
CoA-conjugated RNA and subsequent discovery of RNA-catalyzed acylation
activity is evidence that strongly supports the RNA world theory and the evolution
of coenzymes (White 1976). The acylation of CoA, as described above, is a
major component of cellular fatty acid metabolism and one of the major functions
of contemporary CoA. While such activity catalyzed by RNA had been
hypothesized for over 40 years, the discovery of such a ribozyme was not
possible without the advances of RNA-conjugate synthesis.
In vitro conjugates of RNA have proven useful in the recent 20 years.
However their uses for imaging, detection, and delivery are due to unnatural
modifications. The advantages offered by such modifications supports the
potential applications of RNA, but well-planned unnatural additions could
certainly increase the scope of use for any molecule. RNA modifications that
allow for immobilization and result in discovery of new ribozymes could easily be
equated with small molecule modifications used for immobilization and discovery
of aptamers by the same process. The discoveries by SELEX alone made
possible by such RNA conjugates are indeed impressive and provide data for the
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ongoing debate of the origin of life. As such, these modifications exist as tools,
with little to no biological significance themselves. On the contrary, coenzymeRNA conjugates surpass the point of being just tools to achieve a goal. Not only
is this modification constructed by natural means as are the others, but the
modification itself is found in all organisms in high concentration. The discovery
of a CoA-linked ribozyme capable of acylation supports a 40 year old theory of
coenzyme origin as a functional remnant of a ribozyme, and demonstrates a
biological significance to coenzyme-RNA conjugates (White 1976, Coleman and
Huang 2002). While there are no current examples of NAD- or FAD-linked
ribozymes, a redox-catalyzing ribozyme was discovered over a decade ago that
was shown to interact with NAD+ for its alcohol dehydrogenase activity (Tsukiji et
al. 2003). While this ribozyme is closer related to modern redox enzymes that
interact with NAD+, undiscovered NAD-linked ribozymes are likely capable of the
same activity just as CoA-linked ribozymes are capable of acylation. Until the
discovery of an NAD-linked ribozyme is made, the biological application of this in
vitro coenzyme-RNA conjugate is still questionable. If and when such a ribozyme
is discovered, the biological relevance of this conjugate, similar to the acylating
CoA-ribozyme, will be an evolutionary one. In order to extend beyond just an
evolutionary impact, evidence of the natural existence of coenzyme-conjugated
RNAs in contemporary organisms is needed. Such a discovery would certainly
strengthen the argument for the natural existence of coenzyme-linked ribozymes,
but it also would redefine our understanding of the role of RNA in contemporary
organisms. Fortunately, less than a decade after the discovery of CoA40

ribozymes, evidence was produced that transitioned the coenzyme-RNA
relationship from a strictly evolutionary setting to a contemporary one.
1.4.2 In Vivo Conjugates
The concept of coenzyme-linked RNA has been around for many years. It
was hypothesized by White in 1976 with his proposed origin of coenzymes, and
demonstrated by on a small scale in E. coli three years later (White 1976,
Malygin and Shemyakin 1979). The observation by Malygin that coenzymes
could be incorporated as initiators into abortive transcripts was significant, but the
impact was wanting. Does incorporation into abortive transcripts signify some
biological significance? After all, abortive transcripts result when the polymerase
is incapable of transitioning into the elongation phase of transcription. Is the
result simply from aberrant polymerase activity that is corrected by transcription
abortion? Is this any different than the simple adenylation of a coenzyme? Is this
a conserved mechanism with contemporary value or is this another vestige of an
obsolete era? Decades later when coenzyme incorporation into longer RNA was
accomplished with the T7 φ2.5 promoter, some of these questions were wiped
away, but the natural occurrence in contemporary organisms was still unknown
(Huang 2003a). Despite the impact of the T7 promoter system allowing such
incorporation into RNA, the results were still in vitro synthesized molecules used
for an in vitro technique to isolate non-naturally occurring ribozymes reminiscent
of an era long passed. However concrete the evidence was in terms of sequence
knowledge and kinetic data, the entire concept itself was still somewhat abstract
without some link to a contemporary organism.
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A set of discoveries in 2009 opened the door to areas of study and
pathways never before known to exist. In two studies from the same lab, RNA
was isolated from E. coli and S. venezuelae that was determined to be covalently
linked to the coenzymes NAD and CoA (Kowtoniuk et al. 2009, Chen et al. 2009)
(Figure 1.5E and 1.5G). Fractionation of total RNA from these bacteria indicated
the coenzymes were incorporated into smaller sized RNA 200 nucleotides or less
in length, and the identities of the conjugates were determined by LC/MS
analysis. In addition to CoA, RNA was found linked to CoA thioesters, specifically
succinyl-CoA, methylmalonyl-CoA, and acetyl-CoA (Kowtoniuk et al. 2009).
These discoveries together serve as the first demonstration of in vivo coenzymeRNA conjugates. Such a discovery strengthens the arguments for the existence
of coenzyme-containing ribozymes that previously were unanchored to any
organism existing after the LUCA. In addition, these reports generate questions
about the function, the abundance, the degree of conservation, the diversity of
different coenzymes used, the synthesis mechanisms, the biodegradation
mechanisms, and the dispersion of coenzyme-RNA across other phyla. RNA
modifications such as these have never been observed or even hypothesized
outside of an evolutionary context that predates the protein world, and therefore
these questions may constitute a new field of study in a similar manner to the
discovery of microRNA.
The diversity of the coenzyme-RNA conjugates is an interesting topic that
may be related to function and dispersion across different phyla. The discovery of
CoA thioester-linked RNA is particularly interesting because of the variety of
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thioesters known to exist. For example, the methylmalonyl-CoA RNA was only
discovered in S. venezuelae, purportedly due to the lack of methylmalonyl-CoA
synthesis in E. coli (Kowtoniuk et al. 2009). This observation implies that not only
is the process itself conserved, but the synthesis of RNA modification may be
modified to suit individual species based on their metabolic capabilities. In
addition, the discovery of such RNA in the distinct phyla of Actinobacteria and γγ-Proteobacteria implies a widespread dispersion across the entire domain, for
these phyla are two of the furthest diverged in all of Bacteria according to recent
phylogenomic analysis (Wu et al. 2009). The possibility of distinct CoA-RNA
pathways that depend on the energy state of the cell in addition to the thioester
synthesis capabilities of an organism is intriguing, and could represent an entire
area of metabolism and regulation previously unknown. Furthermore the
detection of distinct CoA-thioester modifications in this case may serve as a
biomarker. On the other hand, such CoA thioesters may be incorporated into
RNA by a single conserved enzyme with a wide substrate range, and the
different CoA thioesters identified may represent the cellular CoA/thioester ratio
reflective of growth conditions and energy state (Leonardi et al. 2005). If these
different CoA thioesters are installed as a reflection of the metabolic state, then
what purpose do they serve? Is there some selective advantage of one thioester
over another? Some basic knowledge of coenzyme-RNA function is required to
give direction to the reasoning behind specific coenzymes or even thioester
modifications.
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The function of coenzyme-RNA conjugates has a high potential to be
related to the sequence and function of the RNAs themselves. It’s hard to
imagine CoA and NAD incorporation to be by way of aberrant transcription
initiation or coincidental post-transcriptional conjugation. Given the significance of
both coenzymes in metabolism, it’s more reasonable that the coenzymes play
distinct roles tied to either the function of the RNA or the significance of that
RNA. Whether installed via transcription or post-transcriptionally, both options
would require a novel system of catalysis and regulation to complete. The
investigators unsuccessfully attempted to replicate the installation of the
coenzymes using E. coli RNA polymerase, therefore leading them to believe this
modification was a post-transcriptional modification of the RNA (Kowtoniuk et al.
2009). If this is true, then what mechanism is in place to distinguish one
sequence from another to divert to post-transcriptional modification?
Transcription and translation are understood as coupled processes in that occur
concurrently, but does the size of this RNA exclude it from being assumed as an
mRNA? Even if only half of the approximately 200 nucleotide RNA was used as
an open reading frame, it would hypothetically yield a peptide with 33 amino
acids that is roughly 7 kD. Therefore the size should not preclude the possibility
of it being mRNA.
The sequences associated with the coenzyme-RNA conjugates are of
great importance in determining the functions of these molecules, however they
were unfortunately unobtainable in the original publication. The method used to
isolate and identify the conjugates involved nuclease treatment to produce single
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nucleotides before LC/MS analysis, thereby destroying any trace of the
associated sequences (Chen et al. 2009, Kowtoniuk et al. 2009). A method was
eventually developed to capture intact NAD-RNA, and the sequence information
obtained indicated a significant portion of the RNA were regulatory sRNA
(Cahova et al. 2015). Interestingly, the most abundant NAD-RNA identified were
RNAI and CopA, which have been characterized as antisense regulators of
ColE1 and R1 plasmid regulation, respectively (Wagner and Simons 1994). In
fact, 12 of the 15 known sRNA that were identified act as antisense regulators.
Aside from RNAI and CopA, the other identified NAD-sRNAs have previously
been characterized as regulatory of stress responses, such as acid stress and
low magnesium (Cahova et al. 2015). In addition to sRNA, sequencing also
revealed NAD linked to 5’-termini of mRNA encoding metabolic enzymes such as
tagatose-1,6-bisphosphate aldolase (gatY), glycerol-3-phosphate dehydrogenase
(glpA and glpD), methylglyoxal synthase (mgsA), and threonyl-tRNA synthetase
(thrS) among others (Cahova et al. 2015). The mRNA of multiple transcription
and translation regulators were also identified, but similar to previous examples,
the sequences only mapped to the 5’-termini and not the full-length transcript.
For some of the identified genes, the existence of the 5’-termini alone can be
easier understood, such as those containing leader peptides to hisL and ilvL that
are known to attenuate the operons for amino acid synthesis. The reasoning for
this truncation of the identified mRNA is unknown and can only be speculated.
Perhaps the truncation is enough to allow feedback inhibition of these genes
similar to the translation of the inhibitory leader peptides for amino acid
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synthesis. However it is unknown whether the NAD-modification inhibits or
enhances the translation of the associated mRNA.
Based on the abundance of sRNA identified that regulate stress
responses, the investigators hypothesized the NAD-conjugation to act as a cap
of sorts that offers stabilization of these RNAs in the cell. Bacterial RNA is largely
known to contain a 5’-triphosphate group that offers protection from the
degradation pathway catalyzed by both endonuclease and exonuclease
enzymes. In E. coli, this pathway is initiated by RNaseE that requires interaction
with a 5’-monophospate to initiate internal cleavage (Bandyra et al. 2012).
Therefore the presence of a 5’-triphosphate group can prevent RNaseE activity
from initiating RNA degradation. This triphosphate “cap” can be removed by the
activity of RNA 5’ Pyrophosphohydrolase (RppH) that generates 5’monophosphate-RNA and PPi, therefore enabling RNaseE-initiated degradation
to occur (Bandyra and Luisi 2013). The addition of a coenzyme to the 5’end of
RNA therefore makes resistant to RppH, adding stability to the RNA (Cahova et
al. 2015). Considering that an RNA cap other than a triphosphate was never
known before in bacteria, a decapping bacterial enzyme was also unknown.
Cahova hypothesized that the activity of NudC, an NADH-hydrolyzing Nudix
enzyme, would serve to “decap” NAD-RNA and push it to the previously
characterized degradation pathways. It is not uncommon for Nudix enzymes to
act as RNA decappers, for members of the Nudix family from various organisms
have the ability to hydrolyze the eukaryotic 7-methyl guanosine (7mG) mRNA
cap such as human NUDT20, yeast NUDT16, and viral D10 among others
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(McLennan 2006, Song et al. 2013, Parrish et al. 2007). The decapping is
notably different between NudC and others such as NUDT20 considering that the
structures of the eukaryotic 7mG cap and the bacterial NAD-RNA cap are
structurally dissimilar, but they all function to initiate RNA decay pathways.
The degradation of coenzyme-RNA in bacteria is potentially different from
mRNA decapping in eukaryotes due to the existence of multiple structurally
distinct bacterial coenzyme-RNA conjugates. Therefore the demonstration of
NudC activity in bacteria would be specific for NAD-RNA, but not CoA-RNA
(Cahova et al. 2015). While the first characterization of NudC in the 1990s
included activity across a range of substrates, activity against other coenzymes
was not addressed (Frick and Bessman 1995, Xu et al. 2000). However,
investigators recently demonstrated that NudC appears capable of releasing both
NAD-RNA and CoA-RNA in vitro (Bird et al. 2016). As discussed earlier, while
NudC and its orthologs were capable of hydrolyzing substrates such as dNTPs,
this activity was 2 orders of magnitude or more lower than that observed for
NADH (Xu et al. 2000). The difference in activity of NudC against NADH and
NAD+ was shown to be around 5-fold, and therefore the hydrolysis of a
structurally distinct coenzyme such as CoA would be expected to be comparably
low (Xu et al. 2000). Based on the differences in activity expected between CoA
and NAD hydrolysis by NudC, the lack of a conserved CoA binding motif in
NudC, the lack of characterization on CoA hydrolysis by NudC in recent
investigations, and the lack of evidence that NudC is capable of hydrolyzing CoA
thioesters, it is unclear whether the release of CoA-RNA would be catalyzed in
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vivo by this enzyme at an acceptable rate to be considered responsible for CoARNA “decapping”. On the other hand, members of the Nudix family have been
characterized in many organisms that specifically hydrolyze CoA and its
thioesters. Based on the sequence predictions of E. coli NudL and the activity of
its orthologs, it’s highly likely that this is the enzyme responsible for turnover of
CoA-RNA. Unfortunately, however, this enzyme has not yet been and
characterized for its activity against CoA, and therefore remains a only putative
CoAse (McLennan 2006).
The RNA sequences associated with CoA remain unknown. In fact, little
about CoA-RNA is known aside from its existence. With such little information,
the subject of its function, synthesis, degradation, and modification all remain
topics of speculation. While the function of such RNA is hypothesized to be
related to NAD-RNA, it seems unlikely that two distinct structures would exist for
the same purpose. Indeed, both coenzymes would offer protection against RppHinitiated degradation of the associated RNA, but the functions of the two likely
extend beyond just RNA protection. NAD and CoA are known to associate with a
variety of different proteins and enzymes, and their conjugation to RNA would
increase a transcript’s protein association potential. Such an ability to associate
with a variety of proteins would offer another means of regulation, wherein
proteins can aid in RNA transport or alter translation rates. In addition, the RNA
sequence itself could serve as a docking site to facilitate and stabilize proteinprotein interactions. One caveat to the comparison of NAD-RNA and CoA-RNA
function is the variations of known CoA-RNA. NAD-RNA has only been
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discovered in the oxidized form of the coenzyme, but CoA itself in addition to
three separate thioesters have been isolated and identified. These four different
forms of CoA represent different functional states used throughout metabolism
whose concentrations vary based on the current cellular environment. The
diversity of CoA found in RNA-conjugates could indicate not only a function
distinct from that of NAD, but a distinct use for each CoA derivative conjugated to
RNA. Such a hypothesis depends of course on the mechanism of CoA
installment on the RNA, and whether that mechanism is universal for CoA, CoA
thioesters, and NAD. Investigators have demonstrated incorporation of CoA and
NAD into RNA by both E. coli and T7 RNA polymerases, but no one has yet
demonstrated such a process with a CoA thioester (Huang 2003a, Bird et al.
2016). While it is possible CoA thioesters can be installed similarly, it is also
possible that CoA-RNA itself is capable of acylation to produce these thioester
CoA-RNA conjugates. The mechanism of CoA installation is further complicated
by the issue of depCoA. The demonstration of CoA-RNA transcription in vitro
requires depCoA. As the substrate of PPAT and the precursor to mature CoA,
depCoA is not known to be widely available in E. coli and is also not well studied
in terms of intracellular concentrations. In eukaryotes, depCoA is expected to be
even less abundant due to its production and subsequent consumption by the
dual-functioning enzyme CoA Synthase (Leonardi et al. 2005). Given that
4’phosphopantetheine is the major intracellular intermediate of CoA synthesis in
E. coli, it’s likely that CoA-RNA may be synthesized with PhP and ATP-RNA by a
similar activity to that of PPAT (Jackowski and Rock 1981). Recent studies
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identified the most abundant NAD-RNA shared promoter elements that initiated
transcription with adenosine, and were able to replicate installment of depCoA,
NAD+, and NADH in vitro with E. coli RNA polymerase and σ70 (Bird et al. 2016).
The investigators were also able to transform E. coli with a plasmid encoding a
transcript under the same promoter to demonstrate the decapping capabilities of
NudC on isolated RNA, concluding that these structures were incorporated via
transcription initiation. The promoter used would indeed install ATP as the
initiating molecule, and while the investigators argued the molar ratios of
coenzyme to NTP needed to be tuned to facilitate coenzyme initiation in vitro,
there is no such control in vivo to produce similar results. Such a disparity may
support the hypothesis that such transcripts were initiated with ATP and were
then subsequently modified with PhP by PPAT-like activity to form CoA-RNA.
The same basic reaction can be hypothesized for other coenzyme-RNAs as well
based on a previously discovered ribozyme capable of catalyzing the reaction of
R-p + ppp-A  R-ppA + PPi, wherein the reaction of ATP-initiated RNA and the
coenzyme precursor NMN could be catalyzed to form NAD-RNA as well (Huang
et al. 2000). Such a mechanism may explain why NADH-RNA was never initially
discovered and has still not been confirmed by subsequent investigators (Chen
et al. 2009).
In addition to the unknown synthesis and functions of CoA-RNA, it is
unclear whether such RNA exists anywhere else. It’s clear that Nudix enzymes
capable of similar coenzyme degradation exist in many organisms, and it’s been
demonstrated that simple RNA polymerases can install such molecules into
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transcripts, but does this RNA modification extend beyond the domain of
Bacteria? If such RNA modifications do exist in other domains, do they serve the
same purpose as those proposed in Bacteria? Furthermore, are there other
coenzyme-RNA conjugates yet to be discovered? The most likely candidate so
far overlooked as a coenzyme-RNA conjugate is FAD. This coenzyme is
structurally similar to NAD but with an isoalloxazine group instead of
nicotinamide, and is known to be capable of initiation of transcription using T7
RNA polymerase (Huang 2003a). FAD can also be synthesized by the previously
mentioned ribozyme reaction of R-p + pppA  R-ppA + PPi. While there is no
characterized Nudix enzyme whose primary substrate is FAD, the human
NUDT12 and E. coli NudE have both been demonstrated to hydrolyze this
coenzyme (McLennan 2006, O'Handley et al. 1998). Therefore if the synthesis
and degradation capabilities are in place, there is a possibility that FAD-RNA
exists and has yet to be discovered.
The length of time between the discovery of coenzyme-RNA in 2009 and
the identification of NAD-RNA sequences in 2015 is an indication of the technical
barriers associated with this area. The identification alone of the coenzymes
required destruction of the RNA itself, leaving other investigators marveling at the
potential of coenzyme-RNA conjugates while presumably stifled in their attempts
to learn more. The eventual capture of NAD-RNA required a specific chemistry
wherein the nicotinamide group was enzymatically replaced with an alkyne via
transglycosylation that could undergo copper-catalyzed azide-alkyne
cycloaddition to a biotin derivative, therefore allowing immobilization of the NAD51

RNA on streptavidin resin (Cahova et al. 2015). The drawback to such an
efficient capture protocol is that the initial enzymatic transglycosylation requires
the reactive N-glycosidic bond found in the oxidized form of NAD+, and therefore
excludes any other known or hypothesized coenzyme-RNA conjugate. The
likewise capture protocol of CoA-RNA has yet to be discovered, leaving the
sequences of such RNA a mystery and the questions of function unanswered.
The identification of CoA-RNA and the elucidation of its function and
metabolism are undertakings associated with significantly unique problems. The
capture of CoA-RNA will require a specific protocol to be developed just like what
was required for NAD-RNA identification. The analysis of sequences will require
bioinformatics studies to place the function of these sequences to hypothesize a
function for CoA-RNA. The determination of metabolic components involved in
synthesis and degradation may reveal previously unknown enzymes and
pathways that themselves have never been characterized. Despite these
potential roadblocks and other problems associated with the development of
methods for each aspect of CoA-RNA function and metabolism as discussed
earlier, the story behind CoA-RNA can still be obtained. Many fundamental
questions may be given new perspectives from which we can further tune our
hypotheses about the origin of life. Are there more functions for CoA to add to the
myriad of responsibilities CoA has in the contemporary cell? Has life evolved
divergent pathways for modifying bacteria with ancient biomolecules for selective
advantages? Does this addition to the repertoire of RNA modification extend
beyond the domain of Bacteria? Can these coenzyme-RNA molecules still
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function similar to naked coenzymes in the cell, and therefore exist as
evolutionary intermediates of RNA World ribozymes and the contemporary living
fossils of coenzymes? Do these RNA sequences bear some catalytic activity
related to the function of their coenzyme conjugates, therefore existing as
contemporary ribozymes previously accepted as supplanted by protein enzymes
in evolution? Some of these questions may never be known, but the idea of
science in general is the addition of knowledge to the collective global database
of information, so that we can better understand ourselves, our environment, our
history, and our future. Jerry Joyce shared the idea in 1989 that due to the
complexity of life’s tumultuous history on earth, we can only base our hypotheses
towards understanding the different of aspects life on what little evidence we can
gather, and as new experimental evidence is produced over time, we cannot help
but view such questions from different perspectives. The uncovering of CoA-RNA
function and metabolism is one such feat that will certainly inspire new
perspectives.
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CHAPTER II - OBJECTIVES OF RESEARCH
The recent discoveries of bacterial coenzyme-RNA and the sequences
associated with NAD-RNA have opened a new area of study that requires unique
methods to address. The existence of such in vivo RNA modifications is
reminiscent of molecules hypothesized in the RNA World theory, and therefore
their contemporary functions likely represent a snapshot of the evolutionary
transition to the contemporary protein world that, much like coenzymes
themselves, continue to bestow a selective advantage to organisms employing
them. While some work has been done to identify sequences associated with
NAD-RNA and hypothesize its function and metabolism, no such work has been
carried out on CoA-RNA. Due to the unique chemistry of which CoA is capable,
the maturation of modern cloning techniques, and the power of Next Generation
Sequencing, we have a unique opportunity to take advantage of these advances
to develop a capturing protocol and establish the function and metabolism of
CoA-RNA.
We hypothesize that CoA-RNA can be captured by thiol chemistry and
specifically released in a pure form by recombinant Nudix enzymes, wherein the
resulting RNA can be prepared for Next Generation Sequencing for identification.
We further hypothesize that recombinant expression and characterization of E.
coli NudL will establish its role as the CoA pyrophosphohydrolase responsible for
CoA-RNA turnover. The overall goal of this research is to develop a method to
capture CoA-RNA for the identification of its function, and shed light on its
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synthesis and degradation pathways in E. coli. The specific objectives of this
research are:
1. Cloning of Nudix Hydrolases with potential CoA Hydrolase activity.
The specific release of CoA-RNA from a capture protocol while preserving
the nucleotide sequence relies on the specific hydrolysis of CoA itself. The
Nudix hydrolase superfamily contains several characterized CoA
pyrophosphohydrolases that are capable of such activity from different
organisms. Candidate enzymes will be cloned for recombinant expression
in E. coli for use as the release step of CoA-RNA purification. Due to
differences in protein solubility, affinity, and specific activity of these
enzymes, multiple candidates from different organisms will be cloned and
characterized for their ability to release CoA-RNA from solid-state resin.
2. Establishment of E. coli NudL as a CoA pyrophosphohydrolase.
Characterized Nudix enzymes with CoA pyrophosphohydrolase activity
from all organisms share two amino acid sequence elements: a Nudix box
and a CoA binding motif. These two consensus sequences have allowed
such CoAse enzymes to be predicted in a variety of organisms including
E. coli. Given the recently established importance of CoA in E. coli as an
endogenous RNA conjugate, and the propensity for E. coli to be used as a
model organism due to its widespread availability and accommodating
culturing conditions, it is peculiar that such an enzyme has been predicted
for at least a decade but never characterized. The enzyme YeaB, recently
renamed NudL, will be cloned and purified as a soluble recombinant
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protein from E. coli, whereupon it can be characterized as a CoA
pyrophosphohydrolase with various activities towards CoA derivatives
such as oxidized CoA, CoA thioesters, and CoA-RNA.
3. Assessment of the coenzyme substrate ranges of Recombinant
Nudix enzymes. Members of the Nudix hydrolase superfamily are known
for maintaining a large range of substrates. As the catalytic activity is
specific for hydrolysis of a phosphoanhydride bond, many molecules
containing such a bond can be hydrolyzed by Nudix hydrolases at different
rates. In addition to the CoA-specific sequence elements of NudL, other E.
coli Nudix hydrolases with sequence elements specific for other
coenzymes related to NAD have been shown to cleave CoA. If the NudC
enzyme is capable of hydrolyzing CoA in a similar manner to NAD and
NADH, for example, then it likely can also hydrolyze FAD and FADH2.
Therefore such Nudix enzymes will be cloned and expressed as
recombinants so that their activity against other coenzymes may be
uncovered, and to establish evidence to support the assertion of NudC as
a general coenzyme hydrolase in E. coli.
4. Development of CoA-RNA capture protocol for the identification of
CoA-RNA sequences. The capture of CoA-RNA from total E. coli RNA
will require specific thiol chemistry and specific enzyme-catalyzed CoA
hydrolysis. Such an undertaking has never before been established, and
therefore a protocol must be developed that allows the purification and
enrichment of such a rare RNA modification while also allowing its
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manipulation to generate a Next Generation Sequencing (NGS) library
with minimal enzymatic steps to maintain RNA quality. The constructed
libraries can be subjected to bioinformatics analysis via NGS by
referencing the established E.coli genome and annotations to allow the
identification of the CoA-RNA sequences and their abundance. Taken
together with the data obtained by Cahova et al. (2015) on NAD-RNA,
functional overlaps and divergence of coenzyme-RNA can be established.
5. Determination of CoA-RNA metabolism in E. coli. The establishment of
NudL as a specific CoA pyrophosphohydrolase in E. coli insinuates its
participation in CoA-RNA hydrolysis in vivo. While previous investigators
have attempted to show that the activity of another Nudix enzyme, NudC,
is responsible for in vivo NAD-RNA and CoA-RNA hydrolysis, their
conclusions are empty without a specific CoA-RNA capture protocol. By
identifying suspected CoA Hydrolases in E. coli, the metabolism of CoARNA can be probed by processing total RNA with the CoA-RNA capture
protocol from E. coli overexpressing NudC and NudL individually, and
from E. coli knockout mutants deficient in these enzymes to determine the
difference in yield from controls.
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Figure 2.1 Project Overview.
The isolation of CoA-RNA requires the discriminatory activity of specific Nudix CoAses for isolation (Steps 3A and 4).
Therefore the isolation and characterization of Nudix CoAses will be completed first, followed by the specific capture of
CoA-RNA from total RNA and subsequent preparation of NGS libraries for the identification of CoA-RNA sequences and
functions.

The following chapters describe the successful completion of these
objectives. The cloning of Nudix CoA pyrophosphohydrolases, the establishment
of NudL as a CoA pyrophosphohydrolase, and the assessment of coenzyme
substrate ranges among Nudix enzymes are described in Chapter IV. The
58

development of a CoA-RNA capture protocol for the identification of CoA-RNA
sequences is described in Chapter V.
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CHAPTER III – MATERIALS AND METHODS
3.1 Instrumentation and Equipment
Name – Model (Company)
Accumet Basic pH meter – XL25 (Fisher Scientific)
Analytical Balance – HR 60 (A&D Co)
Autoclaves – LG 250 and 3031-S (Amsco Eagle)
Balance – Pioneer (Ohaus)
Centrifuge – Avanti J-26 XP (Beckman Coulter)
Centrifuge Rotors – JLA 16.250 and JA 25.50 (Beckman)
Electrophoresis Power Supply – EC 154 (E-C Apparatus Corporation)
Electrophoresis Power Supply – EC4000P (E-C Apparatus Corporation)
Electrophoresis Power Supply – PowerPac Basic (BioRad)
Freezer -20 °C (Frigidaire)
Freezer -80 °C (Forma Scientific)
Geiger Counter – Model 3 (Ludlum Measurements Inc.)
Gel Documentation System – ChemiDoc MP (Bio-Rad)
Gel Dryer – Model 853 Gel Dryer (Bio-Rad)
Heating Blocks – 12359030 (VWR)
HPLC Control - SCL-10A VP (Shimadzu)
HPLC Diode Array Detector – SPD-10A VP (Shimadzu)
High Pressure Liquid Chromatograph – LC-10AT VP (Shimadzu)
HPLC Degasser – DGU 14A (Shimadzu)
Horizontal Electrophoresis System – FB-SB-710 (Fisher)
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Horizontal Electrophoresis System – Mini-sub Cell GT (BioRad)
Incubator 37 °C – 120 (Labline Instruments Inc.)
Liquid Scintillation Counter – 425 034 (Hidex)
Microcentrifuge – 5415 C (Eppendorf)
Microplate Reader – SpectraMax M3 (Molecular Devices)
Micron Centrifugal Filter Devices – M3, M10, M30, & M50 (Millipore)
Phosphorimager/Molecular Imager FX – 729 (BioRad)
Pipettes – P-1000, P-200 (Gilson)
Pipettes – P-10, P-2 (Fisherbrand)
Pipettes – P-200, P-20 (Thermo)
Refrigerator -20 °C & +4 °C (Kenmore)
Sonicator – XL-2000 (Misonix)
Spectrophotometer – 8453 (Agilent)
Stirrers (Nuova)
Thermocycler – Mastercycler (Eppendorf)
UV Lamp – Blak-Ray B100A (UVP)
Vertical Gel Apparatus – V16 (GibcoBRL)
Vertical Gel Apparatus – 237,504-7 (Sigma)
Vertical Gel Apparatus – Mini Protean 3 (BioRad)
Vortexer – G560 (VWR)

3.2 Chemicals, Reagents, and Kits
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Name (Company)
Acylamide (40%, 19:1) (BioRad)
Acrylamide (30%, 37.5:1) (BioRad)
Adenosine triphosphate (Sigma)
Agar (DIFCO)
Agarose (Fisher)
Ammonium Persulfate (Sigma)
Ampicillin sodium salt (Sigma)
Ampliscribe T7 Flash Transcription Kit (Epicentre)
Amylose Resin (New England Biolabs)
BCA Protein Assay Kit (Pierce)
Βeta-Mercaptoethanol (Sigma)
Beta-Nicotinamide Adenine Dinucleotide Hydrate (Sigma)
Boric Acid (Sigma)
Bovine Serum Albumin (BSA) (Fisher)
Brilliant Blue G (Sigma)
Bromophenol Blue (Sigma)
Chloramphenicol (Research Products International Corp.)
Coenzyme A Trilithium salt (Sigma)
Dextrose (Fisher)
DTT (Sigma)
EDTA Disodium Salt (Fisher)
Ethanol (Decon)
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Ethidium Bromide (Sigma)
Expresso T7 Cloning & Expression System (Lucigen)
Expresso T7 SUMO Cloning & Expression System (Lucigen)
Flavin Adenine Dinucleotide Disodium Salt Hydrate (Sigma)
GelCode Blue Safe Protein Stain (Thermo)
Glacial Acetic Acid (Sigma)
Glycerin (Fisher)
Glycine (Research Products International Corp.)
Hydrochloric Acid (Fisher)
Imidazole (Sigma)
Isopropyl β-D-1-Thiogalactopyranoside (IPTG) (Fisher)
Kanamycin Sulfate (Fisher)
Kodak Storage Phosphor Screen SO230 (Bio-Rad)
Lauryl Sulfate (Research Products International Corp.)
Magnesium Chloride (Fisher)
Maltose (Sigma)
Methanol (Fisher)
Microcon M30 and M50 Centrifugal Filter Devices (Millipore)
MicroSpin G-25 Columns (Amersham Pharmacia Biotech Inc)
MMLV Reverse Transcriptase (Promega)
NiNTA HisPur Resin (Thermo)
Parafilm (Pechiney)
Phosphoric Acid (Sigma)
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Poly(A) Polymerase (New England Biolabs)
Poly-Prep Chromatography Columns (Bio-Rad)
Potassium Chloride (Fisher)
Potassium Phosphate Monobasic (Sigma)
Potassium Phosphate Dibasic (Sigma)
Q5 Hot-Start DNA Polymerase (New England Biolabs)
RNasin (New England Biolabs)
Sodium Acetate (Sigma)
Sodium Chloride (Fisher)
Sodium Hydroxide (Sigma)
Sodium Periodate (Sigma)
Sodium Phosphate Dibasic (Fisher)
Succinimidyl Iodoacetate (SIA) (Sigma)
Superscript IV Reverse Transcriptase (Invitrogen)
T4 RNA Ligase I (New England Biolabs)
T4 RNA Ligase II (New England Biolabs)
T7 RNA Polymerase (Epicentre)
Taq DNA Polymerase (Promega)
Tentagel-NH2 Resin (Chem Impex International)
Tetramethylethylenediamine (TEMED) (Fisher)
Thiol Sepaharose 6B Resin (Sigma)
Tris (Fisher)
TRI Reagent (Sigma)
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TRI Reagent (Molecular Research Center Inc.)
Tryptone (Fisher)
UltraLink Iodoacetyl Resin (Thermo)
Urea (Fisher)
Xylene Cyanol (Sigma)
Yeast Extract (Fisher)
3.3 Buffers and Commonly Used Reagents
10X Nudix Buffer, (10 ml, pH 7.5)
Components

10X Concentration

1X Concentration

5 ml 1 M Tris, pH 7.5

500 mM

50 mM

0.5 ml 1 M MgCl2

50 mM

5 mM

4.5 ml Water

5X Native Phosphate Buffer, NPB (1 L, pH 8)
Components

5X Concentration

1X (NBB)

34.5 g NaH2PO4

250 mM

50 mM

146.3 g NaCl

2.5 M

0.5 M

1 L Water, pH 8
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3 M Imidazole Buffer (50 ml, pH 7.6)
Components

Concentration

10.2 g Imidazole

3M

1.46 g NaCl

50 mM

0.15 g NaH2PO4

20 mM

50 ml water, pH 7.6

Native Wash Buffer, NWB (250 ml, pH 8)
Components

Concentration

50 ml 5X NPB

1X

1.67 ml 3 M Imidazole Buffer

20 mM

Water to 250 ml, pH 8

Native Elution Buffer, NEB (50 ml, pH 8)
Components

Concentration

10 ml 5X NPB

1X

4.16 ml 3 M Imidazole Buffer

250 mM
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Water to 50 ml, pH 8

1 M Maltose (10 ml)
Components

Concentration

3.6 g Maltose monohydrate

1M

Water to 10 ml

NBB+Maltose (50 ml, pH 8)
Components

Concentration

10 ml 5X NPB

1X

1 ml 1 M Maltose

20 mM

Water to 50 ml, pH 8

1 M MgCl2 (10 ml)
Components

Concentration

2.07 g MgCl2

1M

10 ml water
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1 M NaCl (50 ml)
Components

Concentration

2.92 g NaCl

1M

50 ml water

1 M KCl (50 ml)
Components

Concentration

3.72 g KCl

1M

50 ml water

1 M Glucose (50 ml)
Components

Concentration

9 g dextrose

1M

50 ml water,
filter sterilize

SOC Media (100 ml)
Components

Concentration
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2 g tryptone

2%

0.5 g yeast extract

0.5%

1 ml 1 M NaCl

10 mM

0.25 ml KCl

2.5 mM

Water to 100 ml; autoclave
100 μl 1 M MgCl2

1 mM

200 μl 1 M Glucose

2 mM

LB (1 L)
Components

Concentration

10 g tryptone

10%

5 g yeast extract

5%

10 g NaCl

10 %

Water to 1 L,
autoclave
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Phosphate Dialysis Buffer, PDB (1 L, pH 8)
Components

10X Concentration

1X Concentration

27.6 g NaH2PO4

200 mM

20 mM

87.63 g NaCl

1.5 M

150 mM

Water to 1 L, pH 8

Tris/Glycine Running Buffer (2 L)
Components

Concentration

6 g Tris

25 mM

30 g Glycine

200 mM

20 ml 10% SDS

0.1%

Water to 2 L

10X Tris-Borate-EDTA, TBE (1 L)
Components

10X Concentration

1X Concentration

121.1 g Tris

1M

100 mM

61.8 g Boric Acid

1M

100 mM
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7.4 g EDTA disodium salt

20 mM

2 mM

Water to 1 L

4x Laemmli buffer (10 ml)
Components

4X Concentration

1X Concentration

1.6 ml 1.5 M Tris pH 6.8

240 mM

60 mM

0.8 g SDS

8%

2%

3 ml Glycerol

30%

7.5%

0.01 g Bromophenol Blue

0.1%

0.025%

1 ml β-mercaptoethanol

10%

2.5%

Water to 10 ml

2x TBE Gel Loading Buffer (1 ml)
Components

2X Concentration

1X Concentration

0.2 ml 10x TBE

2X

1X

0.42 g Urea

7M

3.5 M

0.001 g Bromophenol Blue 0.1%

0.05%
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0.001 g Xylene Cyanol

0.1%

0.05%

0.8 ml water

0.4M KH2PO4 (1 L)
Components

Concentration

54.4 g KH2PO4

0.4 M

1 L water

3 M Sodium Acetate (50 ml, pH 5.2)
Components

Concentration

12.3 g sodium acetate

3M

50 ml water, pH 5.2
with glacial acetic acid

10% SDS (100 ml)
Components

Concentration

10 g Lauryl sulfate

10%
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Water to 100 ml

2% SDS
Components

Concentration

2 ml 10% SDS

2%

Water to 10 ml

1.5 M Tris (1 L, pH 8.8)
Components

Concentration

181.5 g Tris

1.5 M

Water to 1 L, pH 8.8

0.5 M Tris (50 ml, pH 6.8)
Components

Concentration

3 g Tris

0.5 M

Water to 50 ml, pH 6.8
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8% Denaturing PAGE Solution (1 L)
Components

Concentration

200 ml 40% acrylamide (19:1)

8%

420 g urea

7M

100 ml 10X TBE

1X

Water to 1 L

12% SDS-PAGE Gel Solution (15 ml, pH 8.8)
Components

Concentration

3.75 ml 1.5 M Tris pH 8.8

375 mM

0.75 ml 2% SDS

0.1%

6 ml 30% acrylamide (37.5:1)

12%

Water to 15 ml
20 μl TEMED
90 ul 10% ammonium persulfate
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4% SDS-PAGE Gel Solution (6 ml, pH 6.8)
Components

Concentration

1.5 ml 0.5 M Tris pH 6.8

125 mM

0.3 ml 2% SDS

0.1%

0.8 ml 30% acrylamide (37.5:1)

4%

Water to 6 ml
7 μl TEMED
37 ul 10% ammonium persulfate

16% SDS-PAGE Gel Solution (15 ml, pH 8.8)
Components

Concentration

3.75 ml 1.5 M Tris pH 8.8

375 mM

0.75 ml 2% SDS

0.1%

8 ml 30% acrylamide (37.5:1)

12%

Water to 15 ml
20 μl TEMED
90 ul 10% ammonium persulfate
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3.4 Experimental Procedures
3.4.1 Polymerase Chain Reaction
Polymerase Chain Reaction (PCR) of cDNA, genomic DNA, and
geneblock oligos was carried out in 50 μL volumes with 1X Q5 buffer, 0.25 mM
dNTPs, 0.5 μM forward and reverse primer, and 0.02 U/μL of Q5 Hot Start DNA
Polymerase following the manufacturer’s protocol. Resulting products were
analyzed by agarose gel electrophoresis and visualized using Molecular Imager
FX after staining with ethidium bromide. Plasmids were amplified in 20 μL
reactions with 1X Thermophilic DNA Polymerase buffer, 2.5 mM MgCl2, 0.25 mM
dNTPs, 0.5 μM primers, and 0.05 U/μL Taq polymerase following the
manufacturer’s protocol. Products were resolved on agarose gel and visualized
similarly.
3.4.2 Preparation of Cloning Fragments
Linearized plasmids were prepared for cloning by PCR using primers to
specifically amplify the backbone. The pET-32b vector was prepared by PCR in
50 μL volume with 1X Q5 buffer, 0.25 mM dNTPs, 0.5 μM each of primers 32bF
and 32bR, 5 ng pET-32b-GrnA from the Rangachari lab, and 0.02 U/μL Q5. The
reaction was cycled between 98 °C for 10 seconds, 60 °C for 10 seconds, and 72
°C for 4 minutes to generate the 5.7 kb linear backbone stock to be used for
cloning. The pMBP vector was prepared by PCR in 50 μL volume with 1X Q5
buffer, 0.25 mM dNTPs, 0.5 μM each of PM1 and PM2 primers, 10 ng pMBPParallel that was gifted by the Xu lab, and 0.02 U/μL Q5. The reaction was cycled
between 98 °C for 10 seconds, 60 °C for 10 seconds, and 72 °C for 3.5 minutes
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to generate the 6.7 kb linear vector. The use of the PM1 primer specifically
served to replace the embedded TEV protease cleavage site with a thrombin
cleavage site for further use.
The NDX8 gene was prepared for insertion into the pETite-nHis-SUMOKan vector by 50 μL PCR containing 1X Q5 buffer, 0.25 mM dNTPs, 0.5 μM each
of ETitR and ETitSF primers, 12.5 ng of the NDX8 geneblock (IDT), and 0.02
U/μL Q5. The reaction was cycled between 98 °C for 10 seconds, 60 °C for 10
seconds, and 72 °C for 30 seconds to generate the 747 bp NDX fragment with 18
bp overlaps to the pETite-nHis-SUMO-Kan vector that would allow insertion
directly downstream of and in frame with the SUMO fusion. The NDX8 gene was
prepared for insertion into the pET-32b vector by 50 μL PCR containing 1X Q5
buffer, 0.25 mM dNTPs, 0.5 μM each of primers 32DXF and 32DXR, 12.5 ng of
the NDX8 geneblock (IDT), and 0.02 U/μL Q5. The reaction was cycled between
98 °C for 10 seconds, 61 °C for 10 seconds, and 72 °C for 30 seconds to
generate the 741 bp NDX8 fragment with 18 bp overlaps to the linearized pET32b vector that would allow insertion of the gene directly downstream of and in
frame with the TrxA fusion.
The Nudt7 gene was prepared for insertion into the pETite-nHis-SUMOKan vector by 100 μL PCR containing 5X Q5 buffer, 0.25 mM dNTPs, 0.5 μM
each of primers ETitSF7 and ETitR7, 10 ng mouse cDNA from C3H cells from
the Guo lab, and 0.02 U/μL Q5. The reaction was cycled between 98 °C for 10
seconds, 61 °C for 10 seconds, and 72 °C for 30 seconds to generate the 747 bp
Nudt7 fragment with 18 bp overlaps to the linearized pETite-nHis-SUMO-Kan
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vector (Lucigen) that would allow insertion of the gene directly downstream of
and in frame with the SUMO fusion.
The NudL gene was prepared for insertion into the pETite-nHis-SUMOKan vector by 50 μL PCR containing 1X Q5 buffer, 0.25 mM dNTPs, 0.5 μM each
of primers ETitSF6 and ETitR6, 10 ng of E. coli genomic DNA, and 0.02 U/μL Q5.
The reaction was cycled between 98 °C for 10 seconds, 59 °C for 10 seconds,
and 72 °C for 30 seconds to generate the 615 bp NudL fragment with 18 bp
overlaps with the vector to allow insertion downstream of and in frame with the
SUMO fusion. The NudL gene was prepared for insertion into the pMBP-Parallel
vector by 50 μL PCR containing 1X Q5 buffer, 0.25 mM dNTPs, 0.5 μM each of
primers MNF1 and MNR1, 5 ng of pETS-NudL, and 0.02 U/μL Q5. The reaction
was cycled between 98 °C for 10 seconds, 60 °C for 10 seconds, and 72 °C for
30 seconds to generate the 618 bp NudL fragment with 18 bp overlaps to the
linearized vector that would allow insertion directly downstream of and in frame
with the maltose binding protein fusion. The MNF1 primer specifically was used
to insert the thrombin cleavage site in place of the TEV cleavage site embedded
in the backbone before its preparation, and therefore the addition of this thrombin
site by MNF1 upstream of NudL and the same by PM1 downstream of the
insertion site in pMBP-Parallel served as one site of recombination.
The NudC gene was prepared for insertion into the pMBP-Parallel vector
by 50 μL PCR containing 1X Q5 buffer, 0.25 mM dNTPs, 0.5 μM each of primers
MNF2 and MNR2, 10 ng of E. coli genomic DNA, and 0.02 U/μL Q5. The reaction
was cycled between 98 °C for 10 seconds, 50 °C for 10 seconds, and 72 °C for
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45 seconds to generate the 813 bp NudC fragment with 18 bp overlaps to the
linearized vector that would allow insertion directly downstream of and in frame
with the maltose binding protein fusion. The MNF2 primer specifically was used
to insert the thrombin cleavage site in place of the TEV cleavage site embedded
in the backbone before its preparation. The NudC gene was prepared for
insertion into the pETite-nHis-SUMO-Kan vector by 50 μL PCR containing 1X Q5
buffer, 0.25 mM dNTPs, 0.5 μM each of primers ETitSF8 and ETitR8, 25 pg of
PCR product used to generate the pEMS vector, and 0.02 U/μL Q5. The reaction
was cycled between 98 °C for 10 seconds, 50 °C for 10 seconds, and 72 °C for
40 seconds to generate the 810 bp NudC fragment with 18 bp overlaps with the
vector to allow insertion downstream of and in frame with the SUMO fusion.
3.4.3 Transformation
Following the protocol by Lucigen, competent subcloning cells (HighControl 10G, DH5α) were transformed by the addition of 12.5 ng prepared
linearized plasmid and 12.5 ng prepared plasmid insert. Typical transformation
protocols followed, where cells were incubated with DNA on ice for 30 minutes,
heat shock for 30 to 45 seconds, recovery on ice for 5 minutes, and then addition
of 500 μL SOC for 1 hour outgrowth at 37 °C shaking before dilution and plating
on antibiotic solid media for overnight incubation at 37 °C.
3.4.4 Colony PCR, Plasmid Analysis, and Culture Handling
All media used to grow bacteria were LB or LB agar supplemented with
the appropriate antibiotic dictated by the plasmid used. Transformants were
picked as isolated colonies from antibiotic solid media by a pipet tip, smeared
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into a 0.2 μL PCR tube, and dipped into 1 mL antibiotic media that was then
incubated at 37 °C to propagate the culture. Batch mixtures for PCR were used
that contained 1X Thermophilic DNA Polymerase buffer, 2.5 mM MgCl2, 0.25
mM dNTPs, 0.5 μM primer pairs, and 0.05 U/μL Taq polymerase. The batch
mixture was added to each 0.2 μL tube as 18 μL aliquots, and the samples were
heated at 95 °C for 10 minutes to lyse the cells before cycling between 95 °C for
45 seconds, the annealing temperature for 45 seconds, and 72 °C for 1 minute to
extend each target considering they all were under 1 kb in size. General
backbone primers for pETite-nHis-SUMO-Kan constructs were SUMOFwd and
pETiteRev with the annealing temperature of 51 °C, and PM3 and PM4 with an
annealing temperature of 50 °C for the pMBP-Parallel vector. Products were
resolved on agarose gel, and samples with positive results were removed from
37 °C at the first signs of turbidity where aliquots were frozen with 40% glycerol
at -80 °C.
The freezer stocks were used to inoculate 5 mL antibiotic media for
overnight growth at 37 °C shaking, and the following day plasmid extraction was
carried out using the Epoch Miniprep kit following the manufacturer’s protocol.
DNA quantity was measured by absorbance at 260 nm, aliquots of samples were
diluted to 1 ng/μL and used as templates for 20 μL PCR containing 1X
Thermophilic DNA Polymerase buffer, 2.5 mM MgCl2, 0.25 mM dNTPs, 0.5 μM
appropriate primers, 1 ng plasmid DNA, and 0.05 U/μL Taq polymerase. The
reactions were cycled between 95 °C for 45 seconds, annealing temperature for
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45 seconds, and 72 °C for 1 minute. Products were visualized on agarose gel to
qualify successful generation of target plasmid.
3.4.5 Small Scale Protein Expression and Solubility Assay
Transformation into expression cell lines (High-Control Bl21 DE3, Rosetta
2 DE3, NEBExpress) following the manufacturer’s protocol was carried out
following plasmid verification by PCR. Cultures were analyzed by Colony PCR in
the same way as with subcloning cell lines, where transformants producing
positive results from Colony PCR were frozen in 40% glycerol at -80 °C, while
100 μL of the 1 mL antibiotic media grown to turbidity was used to inoculate 5 mL
antibiotic media that was incubated at 37 °C. When the absorbance at 600 nm
reached 0.5, 1 mL of the culture was removed, pelleted, resuspended in 50 μL
4X Laemmli buffer and stored at -20 °C (uninduced lysate), and the remaining
culture was induced with 0.2 to 0.5 mM IPTG to express either overnight at 16 °C
or for 2 to 3 hours at 37 °C. After expression, absorbance at 600 nm was
obtained, 1 mL culture was removed to be pelleted and resuspended in 100 μL
4X Laemmli buffer and saved at -20 °C (induced lysate). Before running on SDSPAGE, small scale cell lysate samples were lysed at 95 °C for 5 minutes and
then spun at 5,000 x g for 5 minutes. The remaining culture was pelleted and
resuspended in 1 mL NBB for lysis either by heating at 95 °C for 10 minutes or
sonicating on ice for 5 cycles of 15 seconds on with 45 seconds rest using a
probe sonicator with the XL-2000 Misonix Ultra Liquid Processor on power 18.
The resulting cell lysate was pelleted by spinning 16,000 x g for 15 minutes, and
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after removing the supernatant (soluble fraction) the pellet was resuspended in another 1
mL NBB (insoluble fraction).
3.4.6 Large Scale Protein Expression and Cell Lysate Preparation
Upon determination of positive protein expression and solubility, freezer
stocks were used to inoculate 5 mL antibiotic media for overnight growth at 37 °C
shaking. The following day, the overnight culture was used to inoculate 0.5 L of
antibiotic media and was grown until absorbance at 600 nm reached 0.5, where 1
mL was then removed to be pelleted and resuspended in 50 μL 4X Laemmli
buffer (uninduced lysate as before), and the remaining culture was induced with
0.2 to 0.5 mM IPTG for expression at 16 °C overnight shaking. The following day,
1 mL culture was removed to obtain absorbance at 600 nm, and then was
pelleted and resuspended in 100 μL 4X Laemmli buffer (induced cell lysate). The
remaining culture was pelleted at 10,000 x g for 10 minutes at 4 °C in an Avanti
J-26 XP centrifuge using a JLA 16.250 rotor and frozen at -20 °C for at least 1
hour. Cells were resuspended in 8 mL NBB (pH 8) with an 18-G syringe and
sonicated on ice with the XL-2000 sonicator with probe on power 18 for 5 cycles
of 15 seconds on and 45 seconds resting. The cell lysate was clarified by
spinning at 40,000 x g for 30 minutes at 4 °C in an Avanti J-26 XP centrifuge with
a JA 25.50 rotor, and the supernatant was taken as the soluble protein fraction.
The resulting pellet was resuspended in 8 mL NBB (pH 8) and considered the
insoluble protein fraction for SDS-PAGE.
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3.4.7 Protein Purification
Proteins were purified by either amylose resin for MBP-fusions or IMAC
using NiNTA resin for His-tagged proteins. Amylose resin was prepared by
addition of 1 mL of 50% ethanol slurry to Poly-Prep Chromatography column and
allowing to settle to approximately 0.5 mL. Storage solution was removed and
column was washed with 10 column volumes (cv) of water, 10 cv 0.1% SDS, and
20 cv water before equilibrating with 10 cv NBB (pH 8). Soluble cell lysate
prepared as stated was added and passed over the resin three times while
collecting the flow-through. The column was washed with NBB until absorbance
at 280 nm was zero (approximately 30 cv), and the protein was eluted with the
addition of 4 cv NBB + 20 mM maltose. The absorbance at 280 nm of each
fraction was obtained and they were visualized by SDS-PAGE. Eluted fractions
containing purified protein were combined on an M50 spin column to reduce the
volume to approximately 300 μL, and the combined protein was desalted by the
addition of equal volumes 1X PDB. Samples were supplemented with 40%
glycerol before absorbance at 280 nm was taken and final concentration was
calculated using the extinction coefficient of individual proteins before storage at 20 °C. The final product was run on SDS-PAGE to visualize purity.
Proteins purified by NiNTA resin followed a similar protocol with some
changes. NiNTA resin was prepared by addition of 1 mL 50% ethanol slurry to a
Poly-Prep Chromatograph Column and allowed to settle to approximately 0.5 mL,
washed with 10 cv water, and equilibrated with 10 cv NBB (pH 8). Soluble cell
lysate was passed over the resin 3 times while collecting flow-through, and
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column was washed with 8 cv NBB or until absorbance at 280 nm reached zero,
followed by 8 cv NWB (containing 20 mM imidazole) or until absorbance at 260
nm reached zero. The protein was eluted with 8 cv NEB (containing 250 mM
imidazole) or until absorbance at 280 nm was zero. Samples were visualized on
SDS-PAGE, and elution fractions were combined on M30 column to reduce the
volume to approximately 300 μL where they were desalted by the addition of
equal volumes of 1X PDB. Protein was supplemented with 40% glycerol before
taking absorbance at 280 nm and calculating final concentration using the
extinction coefficient of each protein and storing at -20 °C.
3.4.8 Enzyme Activity Assays
Enzyme activities were tested by incubation of enzyme (Nudt7, NudC, or
NudL) in 1X Nudix buffer in the presence of various concentrations of either CoA,
FAD, or NAD+ at 37 °C in an Eppendorf Mastercycler. Reaction progress was
monitored by HPLC using a 250 x 4.6 mm Allspher SAX column with an isocratic
elution protocol of 1.5 mL/min with 60% KH2PO4. Products and reactants were
resolved into separate peaks which were integrated to determine the respective
areas using Origin 8.5 software, which was also used to determine Km, Vmax,
and Kcat upon plotting rate vs. substrate concentration.
Nudt7 activity against CoA thioesters were carried out by the combination
of 16 μM Nudt7 in 1X Nudix buffer with 120 pmol internally labeled CoA-RNA
samples before and after biotinylation. The biotinylation was carried out by
incubating 60 pmol labeled CoA- RNA (with and without Nudt7 treatment) with 19
nmol Biotin-AMP in the presence of 500 mmol imidazole at room temperature for
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30 minutes. The reaction was precipitated with the addition of 0.3 M NaAc (pH
5.2) and 3:1 ethanol at -20 °C for 30 minutes, and the RNA was recovered in
water for treatment with or without Nudt7 followed by another ethanol
precipitation. Reactions were combined with 2 μg streptavidin at room
temperature for 10 minutes and then run on 8% denaturing PAGE to resolve the
RNA and Streptavidin-Biotin-CoA complex, where the gels were dried in a Model
853 gel dryer and exposed to Kodak Storage Phosphor Screen and visualized
using a PhosphorImager to observe the shift in electrophoretic mobility.
3.4.9 RNA and CoA-RNA Preparation
RNA was prepared by In Vitro Transcription of dsDNA templates bearing
the φ2.5 promoter with the Ampliscribe T7 Flash kit from Epicentre following the
manufacturer’s protocols and previously described methods (Huang 2003b).
Briefly, reactions of 10 μL contained the manufacturer specified components (1X
Reaction buffer, 2.5 mM NTPs, 10 mM DTT, 1 U RNasIn, 1X dsDNA template,
and 1 μL of T7 RNA polymerase) and were incubated at 37 °C for 1 to 3 hours.
Short RNA under 100 nt was desalted by gel filtration with MicroSpin G-25
Columns, precipitated with 0.3 M NaAc (pH 5.2) and 3:1 ethanol at -20 °C for 30
minutes, and then purified by 8% denaturing PAGE. Isolated bands on PAGE
were visualized by UV shadowing over a TLC plate and excised. RNA was
extracted from gel in the presence of 0.3 M NaAc under heat and precipitated
with the addition of 3:1 ethanol at -20 °C for 30 minutes. RNA was recovered in
water and quantified by absorbance at 260 nm. RNA longer than 100 nt were
desalted and purified by M30 centifugal filter, followed by ethanol precipitation
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and quantification similarly. CoA-RNA was prepared similarly by IVT except with
the addition of 10 mM depCoA reaction mixture, and purification and desalting
was carried out by M30 centrifugal filter followed by precipitation. CoA-RNA was
purified from pppRNA by Thiol Sepharose 6B resin (Sigma) by binding in the
presence of 50 mM Tris (pH 8) for multiple passes, extensive washing with
excess 3 M NaCl, 4 M NaAc (pH 5.2), 4 M Urea, and water, followed by three
rounds of 3 M NaCl and water, and a final round of 3 M NaCl, 4 M NaAc (pH 5.2),
4M Urea, and water. CoA-RNA was eluted with 0.5 mL 100 mM DTT in 100 mM
Tris (pH ) and 10 μg glycogen as a carrier, and the column was washed with 400
μL 0.4 M NaAc (pH 5.2) and 10 μg glycogen. The collected flow-through was
precipitated by the addition of 3:1 ethanol at -20 °C, and the RNA was recovered
in pure water.
Internally labeled CoA-RNA was prepared by IVT similar to CoA-RNA
above, except with the addition of 1:2 NTP mixture (containing half the amount of
ATP as CTP, UTP, and GTP) instead of the NTP mixture, as well as the addition
of 5 μCi α-32P-ATP. RNA was desalted and purified by M30 centrifugal filter and
precipitated as described above. CoA-RNA was alternatively internally labeled by
ligation with a 5’-labeled RNA adapter. Adapters were 5’-labeled by reacting 100
pmol RNA with 30 μCi γ-32P-ATP and T4 Polynucleotide Kinase (T4PNK) in 1X
T4PNK buffer for 30 minutes at 37 °C. The CoA-RNA was combined with labeled
adapter at various molar ratios in 1X T4Rnl1 buffer with 1 mM ATP and 0.25
U/μL T4 RNA Ligase 1 (T4Rnl1) for 1 h at 37 °C. Ligation reaction efficiency was
visualized by 8% denaturing PAGE stained with ethidium bromide for
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visualization by the Molecular Imager FX if RNA was not labeled, or dried and
exposed to a Kodak Storage Phosphor Screen for visualization by the
PhosphorImager if RNA was labeled.
3.4.10 CoA Conjugation to Resin
CoA and CoA-RNA were conjugated to resins functionalized with a
terminal iodo group (Tengtagel-NH2-SIA, UltraLink Iodoacetyl, UltraLink PCLinker Iodo, and ULPCIA) by incubation in 10-50 mM Tris (pH 8) at room
temperature while vortexing. The capacity and time of reaction for each resin was
assessed by room temperature incubation in the presence of 10 mM Tris (pH 8)
and 0.8 mM β-mercaptoethanol while quantifying the release of free iodide with
the absorbance at 226 nm and the experimentally determined extinction
coefficient of 14,000 M-1 cm-1. The total amount of iodide released was
considered the capacity of the resin. After reacting CoA or CoA-RNA with each
resin, the remaining functional groups were blocked by similar incubation upon
the addition of excess β-mercaptoethanol. The resin was subjected to extensive
washing to remove non-covalently interacting CoA or CoA-RNA with a total of 40
bed volumes alternating between water, 4 M NaCl, and 8 M urea while heating
briefly at 95 °C and vortexing.
3.4.11 CoA Release Assays
CoA release by enzyme hydrolysis was carried out in the presence of 1X
Nudix buffer with 16 μM Nudt7 at 37 °C for 30 minutes, 3 hours, or overnight
incubation. Reaction progress was determined by the absorbance at 260 nm of
the 3’5’-ADP product of CoA hydrolysis in the reaction solution. After removal of
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reaction solution, beads were washed with 10 bed volumes of water to release
any CoA stuck in the beads due to settling for similar quantification. The release
of radiolabeled CoA-RNA was carried out in a similar manner, however the
released RNA was assessed by the determination of the radioactivity in the
reaction solution as well as remaining on the resin by liquid scintillation counter.
The release of CoA-RNA by resins containing photocleavable linkers was
achieved by the exposure to 365 nm light by the 100 W Blak-Ray UV lamp for 5
minutes at a time on ice with the beads suspended in water. CoA release was
determined by absorbance of reaction solution at 260 nm of the CoA-thioester
product, as well as by electrospray ionization mass spectrometry (ESI-MS) on
negative mode.
3.4.12 RNA Ligation and Reverse Transcription
RNA Ligation was optimized by reactions containing 1X T4Rnl1 buffer, 1
mM ATP, and 0.2 U/μL T4 RNA Ligase 1 incubated at 37 °C for 30 minutes to 1
hour. RNA containing 5’ppp was generated by In Vitro Transcription as described
above. RNA containing 5’p was produced by IVT as described above with the
addition of 4 molar excess AMP, and its 3’ end was subsequently blocked from
potential ligation with oxidation by 10 mM sodium m-periodate for 40 minutes on
ice in the dark followed by ethanol precipitation. Synthetic RNA oligos containing
a 5’OH were prepared for ligation by phosphorylation with 1X T4PNK buffer, 1
mM ATP, and 0.2 U/μL T4PNK at 37 °C for 30 minutes. Adenylated DNA was
produced by the addition of 30 mM MgCl2 and 120 mM adenosine
phosphoimidazolide (ImpA) to 5’pDNA oligos at 50 °C for 3 hours, followed by
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purification with Amicon 3K spin column, ethanol precipitation, and purification by
10% denaturing PAGE. The addition of up to 15% DMSO or PEG8000 (v/v) in
ligation reactions was noted to increase the ligation efficiency in terms of amount
of product visualized by PAGE.
Reverse Transcription was initially carried out in 20 μL reactions
composed of 15 μL solutions containing 2 μL RNA, 2 μM RT primer, and 0.25
mM dNTPs that were heated for 5 minutes at 70 °C to denature RNA, cooled on
ice to allow annealing of primer, and extended at 42 °C for one hour after the
addition of 4 μL 5X MMLV buffer and 200 U MMLV RTase. Later experiments
with the more thermostable SuperScript IV enzyme were carried out in a similar
way with the exception the addition of 5 mM DTT, 1X SSIV buffer, and 1.5 μL
SSIV occurring either with or without cooling on ice. Extension of cDNA was
carried out at temperatures varying from 37 °C to 70 °C followed by the optional
denaturation of the enzyme for 5 at 95 °C.
3.4.13 CoA-RNA Capture Protocol
Total RNA from E. coli was prepared by growing High Control 10G cells
transformed with pETite-SUMO-nHis-Kan vector encoding the citrate binding
protein CitAP in 100 mL LB media with 50 μg/mL kanamycin overnight at 37 °C
shaking. Cells were pelleted at 5,000 x g and resuspended in TRI Reagent for
total RNA extraction following the manufacturer’s protocol. Total RNA was
resuspended in water, quantified by absorbance at 260 nm, and then treated with
100 mM DTT for 30 minutes at room temperature followed by ethanol
precipitation twice to isolate the RNA. The reduced RNA was resuspended in
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water and transferred to 50 μL Thiol Sepharose 6B resin where it passed over
the resin in the presence of 70 mM Tris (pH 8) ten times (Column A), and the
flow-through of Column A was kept. The column was then extensively washed to
remove nonspecifically interacting RNA by the addition of excess 3 M NaCl, 4 M
NaAc (pH 5.2), 4 M urea, and water for one round, followed by three rounds of
excess 3 M NaCl and water, and a final round of 3 M NaCl, 4 M NaAc (pH 5.2), 4
M urea, and water. The column was then treated with 0.5 mL of 100 mM DTT in
100 mM Tris (pH 8) with 10 μg glycogen to release the RNA (Sample A) from the
column, and the initial flow-through was collected by addition of 0.4 mL 0.4 M
NaAc (pH 5.2) and 10 μg glycogen so it could be precipitated with the addition of
ethanol.
Flow-through from Column A was precipitated with 0.4 M NaAc (pH 5.2)
and ethanol, and resuspended in water for treatment with 50 mM hydroxylamine
and 20 mM DTT for 15 minutes at room temperature to convert thioester-CoARNA to CoA-RNA, and after ethanol precipitation was added to a secondary
Thiol Sepharose resin (Column B) to be purified similar to above. The resulting
RNA (Sample B) was considered to be CoA-RNA not captured from Column A as
well as thioester-CoA-RNA. The initial flow-through of Column B was collected,
ethanol precipitated, and purified by a tertiary Thiol Sepharose resin (Column C)
similar to above, where the purified RNA (Sample C) was considered to be a
background control. The purified RNA from Columns A, B, and C were subjected
to secondary columns each (Columns A’, B’, and C’) following a similar protocol.
The recovered RNA was then treated with 16 μM Nudt7 in 1X T4Rnl1 buffer for 1
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hour at 37 °C to remove the CoA and leave a 5’monophosphate, where it was
subsequently ligated to the 5’ adapter GL1a in the presence of 1 mM ATP, 0.2
U/μL T4 RNA Ligase 1, 1 μL RNasIn, and 15% DMSO at 37 °C for 1 hour.
Reverse transcription was carried out by the addition of 2 μL RNA to 5 μL RT
Stock A (2 μM Adp16 and 2.5 mM dNTPs). The reaction mixture was heated for
5 minutes to 70 °C, and after the addition of 3 μL Stock B (1X SSIV buffer, 5 mM
DTT, 1.5 μL SSIV) the reaction was incubated for 10 minutes at 50 °C. After RT,
the enzyme was denatured by incubation at 95 °C for 5 minutes. The resulting
cDNA was amplified by PCR in 10 μL with 1X Q5 buffer, 0.25 mM dNTPs, 0.6 μM
Adp2, 0.6 μM PcR2 and 0.02 U/μL Q5 for 30 cycles of 98 °C for 20 seconds, 57
°C for 20 seconds, and 72 °C for 60 seconds. Results were visualized by
agarose gel.
3.5 DNA and RNA Oligos
Table 3.1
DNA and RNA Oligos
Name

5’

Sequence

3’

Adp2

OH

CGACTCTAGAGGATCCCCTTGGCTTCCATT

OH

TCTTTGA
Adp16

OH

TGGCACCCGAGAATTCCAT(28)VN

OH

Adp21

OH

CGACTCTAGAGGATCCCCGCATGGCTGAC

OH

TAGG
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Adp26

P

GTTCAGAGTTCTACAGTCCGArGrGrG

OH

Bap12

OH

ATGGTGAGCAAGGGC

OH

SP10

OH

GTGGCGGCCGCTCTATTACTTGTACAGCT
CGTCC

OH

PcR2

OH

TGGCACCCGAGAATTCCA

OH

GL1a

OH

UUGGCUUCCAUUUCUUUGAUU

OH

T7Ad

PPP AGGUACGCUCCGAAA

Ad3

P

ETitF

OH

OH

CCTAGTCAGCCATGC

NH2

CATCATCACCACCATCACATGAAGTGTGTG

OH

GTTAGCC
ETitR

OH

GTGGCGGCCGCTCTATTACTAAATTTTGGA

OH

TTTCGGTTCAAA
ETitF1

OH

ATGAAGTGTGTGGTTAGCC

OH

ETitR1

OH

CTAAATTTTGGATTTCGGTTCAAA

OH

ETitSF

OH

CGCGAACAGATTGGAGGTATGAAGTGTGT

OH

GGTTAGCC
32DXR

OH

GGTGGCAGCAGCCAATCACTAAATTTTGG
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OH

ATTTCGGTTCAAA
32DXF

OH

CTGGTGCCACGCGGTTCTATGAAGTGTGT

OH

GGTTAGCC
32bF1

OH

CATAGAACCGCGTGG

OH

32bR1

OH

TGATTGGCTGCTGCC

OH

ETitSF7

OH

CGCGAACAGATTGGAGGTATGTCGCGACC

OH

TTGTG
ETitR7

OH

GTGGCGGCCGCTCTATTATCACAACTTGC

OH

TTAAAGAATATCTC
ETitSF8

OH

CGCGAACAGATTGGAGGTATGGATCGTAT

OH

AATTGA
ETitR8

OH

GTGGCGGCCGCTCTATTATCACTCATACTC

OH

TGC
ETitSF6

OH

CGCGAACAGATTGGAGGTATGGAATACCG

OH

TAGCCTG
ETitR6

OH

GTGGCGGCCGCTCTATTATCAGGTTTCAC

OH

ACCAAT
SUMOFwd

OH

ATTCAAGCTGATCAGACCCCTGAA
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OH

pETiteRev

OH

CTCAAGACCCGTTTAGAGGC

OH

pM1

OH

AGAACCGCGTGGCACCAGGGTCGTATCGA

OH

TCCCGAGG
pM2

OH

GCCATGGATCCGGAATTC

OH

pM3

OH

CCTCGGGATCGATACG

OH

pM4

OH

GAATTCCGGATCCATGGC

OH

MNR2

OH

GAATTCCGGATCCATGGCTTATCACTCATA

OH

CTCTGC
MNF2

OH

CTGGTGCCACGCGGTTCTATGGATCGTAT

OH

AATTGA
MNF1

OH

CTGGTGCCACGCGGTTCTATGGAATACCG

OH

TAGCCTG
MNR1

OH

GAATTCCGGATCCATGGCTTATCAGGGTTT

OH

CACACCAATTTGC
All sequences listed are DNA with the exception of GL1a and T7Ad. In the event where oligos are DNA/RNA hybrids,
RNA is denoted by lower case r in front of the nucleotide. Cloning primers contain underlined sequences that represent
overlap with the gene of interest, where the remainder of the sequence represents overlap with the vector used.

3.6 Cell Lines and Genotypes
Bl21 Competent E. coli Cells (New England Biolabs) - fhuA2 [lon] ompT
gal [dcm] ΔhsdS
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Bl21 (DE3) Competent E. coli Cells (New England Biolabs) - fhuA2 [lon]
ompT gal (λ DE3) [dcm] ∆hsdS λ DE3 = λ sBamHIo ∆EcoRI-B
int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5
High-Control 10G Competent E. coli Cells (Lucigen) – mcrA Δ (mrrhsdRMS-mcrBC) endA1 recA1 φ80dlacZΔM15 ΔlacX74 araD139
Δ(ara,leu)7697 galU galK rpsL (StrR) nupG λ- tonA /Mini-F lacIq1
(GentR)
High-Control Bl21 (DE3) Competent E. coli Cells (Lucigen) – F- ompT
hsdSB (rB- mB-) gal dcm (DE3)/Mini-F lacIq1 (GentR)
NEB5-alpha Competent E. coli Cells (New England Biolabs) - Δ(ara-leu)
7697 araD139 fhuA ΔlacX74 galK16 galE15 e14ϕ80dlacZΔM15 recA1 relA1 endA1 nupG rpsL (StrR) rph
spoT1 Δ(mrr-hsdRMS-mcrBC)
NEBExpress Competent E. coli Cells (New England Biolabs) - fhuA2 [lon]
ompT gal sulA11 R(mcr-73::miniTn10--TetS)2 [dcm] R(zgb210::Tn10--TetS) endA1 Δ(mcrC-mrr)114::IS10
Rosetta 2 (DE3) Competent E. coli Cells (Novagen) - F- ompT hsdSB (rBmB-) gal dcm (DE3) pRARE2 (CamR)
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CHAPTER IV – THE CLONING AND ACTIVITY OF
NUDIX COA PYROPHOSPHOHYDROLASES
4.1 Introduction
The Nudix superfamily of enzymes is largely known for the
hydrolyzing activity of its members (McLennan 2006). With members
characterized from a variety of different species, the majority of these enzymes
target nucleotide derivatives (McLennan 2006, Kupke et al. 2009). Due to
commonalities of identified substrates, early characterizations of the Nudix
superfamily members established their antimutator potential and function in
housecleaning (Bessman et al. 1996). Further evaluation of the superfamily
resulted in the identification of members capable of hydrolyzing coenzymes,
namely Coenzyme A, and representatives of such a CoA-hydrolyzing role were
found in bacteria, yeast, worms, mammals, and plants (McLennan 2006,
Cartwright et al. 2000, Gasmi and McLennan 2001, AbdelRaheim and McLennan
2002, Kupke et al. 2009). Such a demonstration of Coenzyme A hydrolysis is
intriguing because despite being well-characterized in the 1980s, the portion of
the CoA synthetic pathway responsible for CoA degradation had never been
address in the model species of E. coli (Jackowski and Rock 1981). While most
of the enzymes in this pathway are capable of catalyzing their respective reverse
reactions, such an activity from CoaD or Phosphopantetheine Adenylyl
Transferase (PPAT) requires dephospo-CoA, which is not known to exist in any
significant concentration in the cell, and is distinctly different from mature CoA
that is so prevalent. The Nudix CoA pyprophosphohydrolases, or CoAses as they
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became known, however, are capable of degrading CoA into 3’5’-ADP and 4’phosphopantetheine.
The discovery of Nudix CoAse enzymes became particularly important
upon the realization that bacterial RNA can be capped at its 5’ end with CoA
(Kowtoniuk et al. 2009). Being the first indication of a bacterial capped RNA more
complicated than the incidental 5’-triphosphate group, the CoA cap as well as the
concurrently discovered NAD-cap have become the focus of investigation to
uncover their function and the identity of the associated sequences (Chen et al.
2009). While examples of NAD-RNA sequences have since been identified using
a specific capture chemistry for NAD+, there has been no capture protocol
comparably specific for CoA, therefore leaving these RNAs a mystery (Cahova et
al. 2015). We believe that the Nudix CoAse enzymes are the key to the
identification of CoA-RNA sequences.
The cloning and recombinant expression of such an enzyme is vital to a
specific capture protocol to be established for the isolation of CoA-RNA and the
identification of its sequences. Several Nudix CoAses have the potential for use
in a CoA-releasing protocol, such as NDX8 from C. elegans that shows the
highest enzyme efficiency of all characterized CoAses, and Nudt7 from M.
musculus that shows a high activity towards CoA thioesters (AbdelRaheim and
McLennan 2002, Gasmi and McLennan 2001). In addition to the identification of
RNA sequences, studying bacterial Nudix enzymes may shed light on the
unknown mechanism of CoA-RNA degradation. Investigators have shown the
enzyme NudC from E. coli to be active against NADH, NAD+, and CoA, however
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this enzyme has been previously uncharacterized for the latter CoA (Bird et al.
2016, Frick and Bessman 1995, Xu et al. 2000). Their demonstration that NAD
and CoA can be hydrolyzed by the same enzyme indicates a lack of substrate
specificity based on the distinct structural differences of nicotinamide and
phosphopantetheine. Indeed, the initial characterization of NudC similarly
showed its capability to hydrolyze a variety of nucleotide-derived substrates,
however if such different coenzymes can be similarly hydrolyzed, there is a high
probability that FAD can be similarly digested by NudC, and therefore NudC can
be demonstrated as a general coenzyme hydrolase in E. coli (Frick and Bessman
1995). On the other hand, previous investigators have predicted the E. coli
CoAse to be NudL (also known as YeaB) based on identification of an open
reading frame encoding a Nudix box consensus sequence common to all Nudix
enzymes that is also downstream of a CoA binding consensus sequence
common to all characterized Nudix CoAses (McLennan 2006). Therefore, the
cloning, purification, and characterization of Nudt7, NudC, and NudL are reported
here with the goal of establishing NudC as a general coenzyme hydrolase, NudL
as the E. coli CoAse, and Nudt7 as a specific Nudix CoAse capable for use in a
CoA-RNA capture protocol.
4.2 Results and Discussion
4.2.1 C. Elegans NDX8
4.2.1.1 Cloning of NDX8
The cloning of NDX8 from C. elegans was carried out with the goal of
amassing a stock of high efficiency enzyme that can be used for a specific CoA98

RNA capture protocol. As this organism had been sequenced, the most direct
route to obtaining the enzyme was determined to be ligation independent cloning
of a long DNA oligo into a linear vector following portions of a protocol obtained
from Lucigen cloning systems. Considering that DNA ligation is not required, at
least one day was removed from the timeline of typical plasmid preparation
protocols (Fig. 4.1). Plasmids are constructed in vivo by a homologous
recombination event that occurs during transformation facilitated by 18 bp
overlap regions of the vector and insert. The 18 bp overlap size was determined
through different experiments that each shortened the overlap until the resulting
number of transformants dramatically decreased. This recombination event is not
exclusive to the cells obtained from Lucigen, as this method has been shown to
be successful in the common subcloning cell line DH5α as well as expression cell
lines Bl21(DE3), Bl21, and Rosetta 2 (DE3) cells that already contain a plasmid.
By designing the primers to amplify the insert and linearize the vector, the
generation of a plasmid can be completed within 24 hours including the overnight
incubation of competent cells on selective antibiotic media.
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Figure 4.1 Ligation Independent Cloning.
Preparation of plasmids (1) and inserts (2) is carried out by PCR to linearize the vector (3) and to add 18 bp homologous
regions flanking the gene of interest (4). When combined in competent E. coli cells, the two fragments recombine to form
the desired plasmid (5).

The NDX8 gene was synthesized as a 705 bp geneblock by IDT to contain
flanking 18 bp regions homologous to the cloning site of the pETite-nHis-Kan
cloning vector from Lucigen. The synthesized geneblock and linearized vector
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were combined in in High-Control 10G E. coli cells for transformation, and the
next day colony PCR confirmed successful recombination into 90% of screened
colonies to generate the pET-NDX8 plasmid (Fig. 4.2A). One-third of the
successful colony PCR reactions showed a significantly intense band near the
766 bp marker. The amplification efficiency of the 705 bp fragment may vary
depending on a number of factors, one example of which is the amount of
bacteria used in the analysis.
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Figure 4.2 Cloning of NDX8 with pETite-nHis-Kan vector
A, Colony PCR results of transformation into High-Control 10G cells using general backbone primers to amplify the 705
bp NDX8 insert. B, Colony PCR results of transformation into Bl21 (DE3) cells using general backbone primers to amplify
the NDX8 insert. C, PCR analysis of extracted plasmids from Bl21 (DE3) cultures with failed Colony PCR. D, SDS-PAGE
of uninduced (U), soluble (S), and pellet (P) fractions of small scale expression in Bl21 (DE3) cells.

Plasmids were isolated from cultures with positive colony PCR results and
used to transform High-Control Bl21 (DE3) cells from Lucigen, whereupon
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Colony PCR analysis of transformants showed 100% negative results (Fig. 4.2B).
Considering the transformed cells grew in media supplemented with kanamycin,
a failed transformation was highly unlikely since kanamycin resistance is granted
by the successful uptake of the pETite plasmid. To confirm the problem was with
Colony PCR and not transformation, samples from which Colony PCR was
performed were grown in 5 mL cultures of antibiotic media for plasmid extraction
and verification by PCR. PCR analysis confirmed that plasmids previously used
for transformation did contain the expected insert of NDX8 (Fig, 4.2C), and
therefore there likely was a problem with Colony PCR. Bl21 (DE3) cells are
known to grow much faster than typical subcloning cells such as DH5α or, in this
case, High-Control 10G cells, and it’s possible that large colonies observed after
transformation may have had some effect on the Colony PCR protocol itself.
Assuming that majority of the colonies obtained from transformation of
pET-NDX8 into BL21 (DE3) were positive based on their grown in the presence
of kanamycin and despite the negative Colony PCR results, three cultures were
grown 5 mL antibiotic media for small scale expression analysis, grown at 37 °C
until OD600 was ~0.5, whereupon expression was induced with the addition of 1
mM IPTG and cultures were incubated overnight shaking at 16 °C. Cells were
harvested, resuspended in 250 μL NBB, and lysed at 95 °C for 10 minutes. Cell
lysates were pelleted, supernatant was separated from pellet fraction, and pellet
was resuspended in 20 μL 4X Laemmli buffer. Supernatant and pellet fractions
were analyzed by 12% SDS-PAGE as soluble and insoluble protein fractions,
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and a band in the pellet fraction was identified near the 25 kD marker to indicate
expression of the 27.2 kD NDX8 protein (Fig. 4.2D).
The insoluble expression of NDX8 was unable to be remedied by the
assessment of different cultures, different incubation temperatures and times, or
different concentrations of IPTG as an inducer. Considering that the activity of
the enzyme is dependent on its solubility, and the appropriation of large amounts
of active enzyme are dependent on soluble expression, the expression of
recombinant NDX8 would need to be carried out with a fusion partner to aid its
solubility.
4.2.1.2 Cloning and Expression of SUMO-NDX8
The addition of a SUMO fusion to NDX8 to increase its solubility during
expression was the considered the path of least resistance since a similar
recombination cloning system was provided by Lucigen with the SUMO fusion
encoded upstream of the recombination site in the linearized pETite-SUMO-nHisKan vector. PCR was carried out on the NDX8 geneblock with primers to add 18
bp flanking regions homologous to the SUMO-containing pETite vector (Fig. 4.3,
4.4A), and transformation was carried out similarly as before to produce the
pETS-NDX8 plasmid confirmed in 100% of screened colonies by Colony PCR
(Fig. 4.4B). PCR analysis of extracted plasmids confirmed insertion of the NDX8
gene after the SUMO fusion (Fig. 4.4C).
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Figure 4.3 Plasmid design of pETite-SUMO-NDX8
The primers designed for the generation of the pETite-SUMO-NDX8 plasmid (A) were intended to overlap ~18 bp of the
NDX8 gene along with the vector on each end of the insert (B, C). The inclusion of the start and stop codons as well as
the vector sequence in the plasmid insures in-frame insertion of the gene of interest through the ligation-independent
recombination method.

Transformation of the PCR-confirmed pETite-SUMO-NDX8 plasmid into
High-Control BL21 (DE3) cells successfully produced transformants on solid
antibiotic media, and small scale expression was carried out using 1 mM IPTG
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added at OD600 ~0.5 to confirm the successful expression of SUMO-NDX8 by
SDS-PAGE (Fig. 4.5A). When cells were lysed similarly as before, the SUMONDX8 band of 38.8 kD showed up in the pellet fraction by SDS-PAGE analysis.
Considering that heating is a source of denaturation, another small scale
expression was carried out where cell lysis was achieved via sonication with a
probe-tip sonicator while the sample was in ice. Similar to the heat lysis protocol,
the SUMO-NDX8 protein was found in the pellet fraction upon SDS-PAGE
analysis (Fig. 4.5B). More small scale expressions were carried out using
sonication for lysis and varying the concentration of IPTG from 5 μM to 500 μM,
however the results remained that SUMO-NDX8 was insoluble (Fig. 4.5C).
The insolubility of SUMO-NDX8 was unable to be altered by experimental
parameters such as the changing of inducer concentration, incubation
temperature, or time of expression. The possibility of purifying the protein in a
denatured protocol was an option, but the subsequent refolding of the protein
would be a potential barrier that could be insurmountable considering that the
protein itself is an enzyme that contains multiple cysteine residues. Therefore
regaining the native and active structure of the enzyme was something that could
be a problem. Based the existence of these cysteines, the addition of a
thioredoxin fusion protein was considered.
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Figure 4.4 Cloning of SUMO-NDX8
A, PCR amplification of NDX8 geneblock to generate expected 741 bp fragment with 18 bp overlaps with linear pETitenHis-SUMO vector. B, Colony PCR on High-Control 10G cells using cloning primers to amplify the 741 bp insert. C, PCR
on extracted plasmids from High-Control 10G cells with specific primers that verify insertion downstream of SUMO fusion
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Figure 4.5 SUMO-NDX8 Protein Expression
A, SDS-PAGE of small scale protein expression showing induced expression of the SUMO-NDX8 protein approximately
39 kD in size. B, SDS-PAGE of solubility analysis comparing sonication and heating as two separate methods for cell
lysis, with soluble (S) and pellet (P) fractions indicating protein is insoluble. C, SDS-PAGE of small scale expression
using lower concentrations of inducer IPTG to enhance solubility showing soluble (S) and pellet (P) samples after
sonication to lyse cells.
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4.2.1.3 Cloning and Expression of TrxA-NDX8
The previous investigators who first characterized the C. elegans NDX8
protein did so using recombinant protein expressed in E. coli with a thioredoxin
(TrxA) fusion (AbdelRaheim and McLennan 2002). Although SUMO has been
regarded as a superior fusion partner to enhance solubility of expressed
recombinant proteins, each protein behaves differently and thus responds
differently to alternate fusion partners (Malakhov et al. 2004). The thioredoxin
fusion protein, on the other hand, has been stated to aid in the formation of
cysteine disulfide bonds and additionally increase the solubility of recombinant
proteins (LaVallie et al. 1993). Therefore pET-32b was obtained from the
Rangachari lab that contained an in-frame TrxA fusion and was modified for our
purposes of inserting NDX8.

Figure 4.6 Cloning of TrxA-NDX8
A, PCR amplification of pET-32b backbone with restriction digestion (RD), gel purification (GP), or secondary PCR
(PCR2). B, PCR amplification on plasmids extracted from High-Control 10G cells with specific primers to verify the
insertion of NDX8 downstream of TrxA fusion.
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The pET-32b plasmid gifted by the Rangachari lab contained an insert for
their research interests. The backbone therefore needed to be modified to
remove that insert for the cloning of NDX8 to be successful. The linearized empty
backbone of the pET-32b plasmid generated by PCR using primers designed to
amplify away from the insertion of the previous gene (Fig. 4.1, 4.6A). The PCR
amplification will increase the amount of linearized vector orders of magnitude
above the original template, but this template can still interfere with
transformation downstream and cause a heterogeneous transformant population
to lower the efficiency of the cloning. Although attempts were made to digest the
plasmid within the previous insert before and after PCR with the restriction
enzyme SacII, PCR on the given and undigested pET-32b showed the best
results in terms of intensity and homogeneity of target (Fig. 4.6A).
The NDX8 geneblock was PCR amplified to add flanking 18 bp regions of
homology to the newly amplified backbone of pET-32b. The modified NDX8
fragment and linearized vector were combined in High-Control 10G cells for
transformation, and the next day Colony PCR confirmed the production of the
pET32-NDX8 plasmid in 95% of transformants. Plasmids were subsequently
extracted from positive cultures and used as templates for PCR to confirm the
insertion of the NDX8 gene downstream of the TrxA fusion protein (Fig. 4.6B).
The PCR-verified plasmids were used transform Rosetta 2 (DE3) cells for
protein expression. The Rosetta cell line was used in lieu of Bl21 (DE3) cells for
its chloramphenicol-selected plasmid that encodes rare tRNAs that aids in the
expression in bacteria of eukaryotic proteins without codon optimization. Colony
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PCR verified 100% of Rosetta 2 (DE3) transformants analyzed contained the
plasmid with the gene-of-interest, and subsequent small scale expression using
0.5 mM IPTG showed positive expression of the 41 kD TrxA-NDX8 fusion by
SDS-PAGE (Fig. 4.7A), however subsequent cell lysate analysis by SDS-PAGE
showed that the fusion was, yet again, insoluble.

Figure 4.7 TrxA-NDX8 Protein Expression
A, SDS-PAGE of solubility assay on small scale expression of 41 kD TrxA-NDX8 from Rosetta 2 (DE3) cells. B,
Comparison of proteins CitAPec and NDX8 expressed from the same vector in a T7 system to illustrate the low yield of
NDX8 in crude cell lysate.

The inability to produce C. elegans NDX8 in a soluble form in high yield
was a perplexing road block, especially considering that a soluble protein had
been obtained previously (AbdelRaheim and McLennan 2002). Despite altering
concentrations of inducer, induction temperatures, and fusion partners, the NDX8
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protein remained insoluble during preparation. In addition to the insolubility of the
protein, the yields observed in crude extracts were significantly lower in
comparison to other previously expressed proteins using the same T7 promoter
(Fig. 4.7B). It is unknown whether this difference in expression was due to the
protein activity itself or some other factor. NDX8 was previously described as the
most efficient Nudix CoAse characterized to date, with a Kcat of 13.8 s-1 and a
Kcat/Km of 64 mM-1 s-1 (AbdelRaheim and McLennan 2002). Because CoA is such
a vital component of cellular metabolism, the possibility exists that the activity of
this highly efficient recombinant enzyme in a soluble form was detrimental to the
cell growth, and only cultures where the protein was expressed insolubly or
sequestered into an inclusion body therefore survived to be harvested for protein
extraction. It is peculiar, however, that despite analysis showing the protein was
insoluble regardless of which expression parameter was varied, the total
recombinant protein generated was quite low considering the use of the T7
promoter. Assuming that transcription from the T7 promoter proceeded at a
comparable rate to other recombinant proteins using the same system, the
purification of soluble NDX8 protein may result from some proteolytic event
(Baneyx and Mujacic 2004). Regardless of the mechanism responsible, the
solubility issues of recombinant NDX8 expression caused the protein to be
deemed not to be a viable option for accumulating a Nudix CoAse for use in a
specific CoA-RNA capture protocol.
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4.2.2 M. musculus Nudt7
4.2.2.1 Cloning and Expression of SUMO-Nudt7
The Nudix CoAse Nudt7 from M. musculus was characterized to be less
efficient than C. elegans NDX8 with a Kcat/Km of 16 mM-1 s-1 (Gasmi and
McLennan 2001). The differences in activity from NDX8, however, may be the
key to its purification as well as its use in the CoA-RNA capture protocol. The
lower enzyme efficiency of Nudt7 may allow the survival of cells solubly
expressing the active enzyme. In addition, the activity of Nudt7 against CoAthioesters implies the distinct possibility that it may be better suited to release
CoA-RNA from our CoA-RNA capture protocol (Reilly et al. 2008)
The Nudt7 gene was obtained from a mouse embryonic fibroblast (mEF)
cDNA library from the Guo lab that was library generated by random hexamer
primers. The cDNA library is an advantageous source of cloning eukaryotic
proteins because of its generation from captured mRNA. These mRNAs have
already undergone splicing and serve as true translation substrates. PCR was
used to amplify the Nudt7 transcript from the cDNA library using primers
designed to add flanking 18 bp sequences homologous to the pETite-SUMOnHis-Kan vector (Fig. 4.8A), and the resulting fragment was added directly with
linearized vector for recombination and transformation into High-Control 10G
cells. Colony PCR with general primers to amplify any insert present confirmed
the correct incorporation into the pETite-SUMO vector in 70% of screened
transformants (Fig. 4.8B), which was similarly confirmed by the subsequent PCR
on extracted plasmids using gene-specific primers (Fig. 4.8C).
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Figure 4.8 Cloning of SUMO-Nudt7
A, PCR amplification to prepare Nudt7 for cloning with TrxA fusion (T) and SUMO fusion (S). B, Colony PCR of HighControl 10G cells with general backbone primers to confirm insertion of Nudt7 gene into pETite-SUMO vector. C, PCR
analysis of extracted plasmids from High-Control 10G cells with specific primers to confirm insertion of Nudt7 downstream
of SUMO fusion.

The newly generated pETS-Nudt7 plasmid was transformed into HighControl Bl21 (DE3) cells, whereupon Colony PCR analysis using gene-specific
primers showed 60% of transformants screened contained the correct gene.
Small scale expression of Nudt7 followed by solubility assay showed that the
protein was expressed at a higher rate than NDX8 previously was, and although
majority of the protein was present in the insoluble fraction, there was a
noticeable band below the 45 kD marker that indicated some of the 39 kD
SUMO-Nudt7 was solubly expressed (Fig. 4.9A). Large scale expression was
carried out in 1 L of antibiotic media where expression was induced at an OD 600
of 0.4 by addition of 0.5 mM IPTG and carried out overnight at 16 °C. Upon SDS114

PAGE analysis of protein extraction, the majority of the protein was observed to
be soluble (Fig. 4.9B). Purification of the N-terminal His6-tagged protein by IMAC
resin was carried out to apparent homogeneity using 250 mM imidazole as the
eluant. Samples were combined and dialyzed against 1X PDB overnight at 4 °C
to remove imidazole and salt, and afterwards quantity was determined by Beer’s
law using absorbance at 280 and the molar extinction coefficient calculated to be
20,650 M-1 cm-1, resulting in a total of 12 mg L-1 protein purified at a
concentration of 160 μM.

Figure 4.9 SUMO-Nudt7 Protein Expression
A, SDS-PAGE of small scale protein expression with uninduced (U) control, induced (I) lysate, soluble (S) extract, and
insoluble (P) extract showing 39 kD SUMO-Nudt7 to be insoluble. B, Purification of large scale SUMO-Nudt7 expression
showing uninduced control (U), induced cell lysate (I), soluble cell lysate (S), affinity column flow-through (FT), and final
eluted protein (E).

4.2.2.2 Nudt7 Activity
The activity of SUMO-Nudt7 against 1 mM CoA was carried out in 1X
Nudix buffer at pH 7.5 for 1 h at 37 °C. The reaction was visualized by HPLC
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using a strong anion exchange column with an isocratic elution protocol to
separate products from reactants based on the different number of phosphate
groups of each while monitoring the absorbance at 260 nm of the adenosine
group (Fig. 4.10A). CoA hydrolysis was observed as the appearance of a distinct
peak belonging to the product 3’5’-ADP appearing with a lower retention time
than CoA itself (Fig. 4.10B). The resolution of the two peaks varies with the
percentage of 0.4 M KH2PO4 used, but the isocratic elution at 40% phosphate
resulted in a general 2.5 minute difference in retention times between CoA and
3’5’-ADP.
To test the activity of Nudt7 against CoA-RNA, In Vitro Transcription with
α-32P-ATP was carried out in the presence of depCoA to generate a 5’ CoA-RNA
of 120 nt length following previously a described protocol (Huang 2003a). The
subsequent RNA was purified from buffer salts with an M30 column and used for
biotinylation in the presence of imidazole following a previously described
protocol (Coleman et al. 2005). The resulting Biotin-CoA-RNA was incubated for
5 minutes at room temperature with streptavidin and resolved by 8% denaturing
PAGE for analysis. Nudt7 digestion of RNA was carried out both before and after
biotinylation in separate reactions, and the successful hydrolysis was observed
as a lack of electrophoretic mobility shift on the gel (Fig. 4.10C).
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Figure 4.10 Nudt7 Activity
A, Scheme of Nudt7 hydrolysis of CoA to produce 4’-phosphopantetheine (PhP) and 3’, 5’-adenosine diphosphate (3’, 5’ADP). B, Chromatogram of Nudt7 reaction with CoA monitored by HPLC using isocratic elution on strong anion exchange
column. C, Autoradiograph of Nudt7 activity against internally labeled CoA-RNA before and after biotinylation with the
number indicates the order of treatments.

Interestingly, Nudt7 was capable of hydrolyzing all CoA after biotinylation.
The ability for Nudt7 to hydrolyze biotinylated CoA may be synonymous to the
reported increasing efficiency for cleaving CoA thioesters up to C12 in length
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where the Kcat/Km peaks at 22.26 mM-1 s-1, an approximately 40-fold higher
efficiency than for CoA itself (Reilly et al. 2008). This trait would make Nudt7 a
great candidate for the specific release of CoA-RNA in a capture protocol. While
most conceivable CoA-RNA capturing schemes would involve specific thiol
chemistry such as the formation of a covalent disulfide or a thioether bond and
would exclude the capture of other coenzymes, namely NAD+, the activity of
Nudt7 against NAD+ and FAD was assessed to confirm its substrate range to be
specifically CoA and it’s thioesters. Nudt7 was incubated at a concentration of 16
μM with 1 mM NAD+ and 1 mM FAD for 1 h at 37 °C in 1X Nudix buffer.
Reactions were analyzed by HPLC using isocratic elution from strong anion
exchange resin to separate peaks based on the difference in phosphates
contained by products and reactants, and as a result Nudt7 was determined to
have no activity against FAD or NAD (Fig. 4.11C and D).
.
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Figure 4.11 Nudt7 Activity Against NAD and FAD
A, Scheme of proposed Nudt7 activity against FAD to produce Flavin mononucleotide (FMN) and adenosine
monophosphate (AMP). B, Scheme of proposed Nudt7 activity against NAD to produce nicotinamide mononucleotide
(NMN) and adenosine monophosphate (AMP). C, Chromatogram of Nudt7 reaction with FAD showing no difference in
retention time using isocratic elution on strong anion exchange column. D, Chromatogram of Nudt7 reaction with NAD
showing no difference in retention time using isocratic elution on strong anion exchange column.
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Based on the protein solubility, quantity purified, and activity
demonstrated, Nudt7 was considered to be a viable candidate for use in specific
CoA-RNA capture protocols without the removal of the SUMO fusion. The high
activity towards CoA and thioesters such as our in vitro made biotin-CoA indicate
that CoA-RNA isolated from bacterial cells can be modified with long linkers via
thioester or thioether formation, where the free terminus contains a biotin moiety
capable of capturing on streptavidin resin. Nudt7 can thereby be used to
specifically release such CoA-RNA from the resin with a 5’-phosphate ready for
ligation and subsequent reverse transcription. The inactivity of Nudt7 against
NAD and FAD insure that, in the highly unlikely event where other coenzymeRNA conjugates are immobilized on a resin in the capture protocol, only CoARNA will be released by Nudt7. Considering that 1 h in the initial reactions was
more than enough time to hydrolyze 1 mM CoA, the Nudt7 release step of the
CoA-RNA capture protocol can likely be completed in shorter amounts of time,
especially when considering isolated amounts of CoA-RNA are estimated to be
far below 1 mM (Kowtoniuk et al. 2009).
4.2.3 E. coli NudC
4.2.3.1 Cloning and Expression of MBP-NudC
Investigators have previously shown that NudC from E. coli is capable of
hydrolyzing CoA in addition to both oxidized and reduced NAD (Bird et al. 2016).
We therefore reasoned that if this enzyme is capable of utilizing as substrates
two structurally unrelated coenzymes such as these, then it likely also can utilize
FAD as a substrate. Investigation of the enzyme kinetics of NudC with these
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various substrates may further indicate its role as a general coenzyme hydrolase
within E. coli that has a slight catalytic preference for NAD.
NudC was prepared for cloning by PCR of the E. coli genome obtained
from the discarded fraction of a mini-prep kit carried out on DH5α cells. Mini-prep
kits are fairly standard in lab protocols, where the initial steps include
resuspension of cells in a buffer, addition of a lysis buffer typically containing
SDS and NaOH, and the subsequent precipitation of SDS by the addition of a
buffer containing chaotropic salts such as guanidinium HCl. The SDS is used to
solubilize the lipid cell membrane to aid lysis, which incidentally is closely
associated with the bacterial genome. As the purpose of mini-prep kits is to
isolate cytosolic plasmid DNA, the lipid portion is selected against by precipitating
the SDS-solubilized lipids by the addition of the chaotropic agent. Following the
precipitation, the suspension is clarified by centrifugation, the soluble fraction
containing the cytosolic plasmid DNA is taken further for purification, and the
pellet fraction containing the bacterial genome is typically discarded. Here, we
took a portion of the precipitated lipid and genome fraction and resuspended
diluted it in water for use as a PCR template.
The recovered E. coli genome was used for PCR with primers to
specifically amplify NudC and add flanking 18 bp regions that are homologous to
the pMBP-Parallel vector in frame with the fusion protein (Fig. 4.12B). In addition,
pMBP-Parallel was prepared by PCR amplification of the backbone with specific
primers that were designed linearize the vector so that it could be used for the
insertion of any gene downstream of the MBP fusion (Fig. 4.12A). The successful
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recombination of the PCR amplified NudC from the E. coli genome and the
modified pMBP-Parallel backbone would result in a plasmid construct capable of
producing the maltose-binding protein fusion, followed by a thrombin cleavage
site and the inserted NudC gene. The PCR-prepared backbone and insert were
combined in DH5α cells for transformation, and subsequent Colony PCR analysis
showed a strikingly low amount of positively recombined transformants. One
single colony out of 33 tested showed evidence of successful recombination (Fig.
4.12C). Upon further inspection of the extracted plasmid by PCR amplification
using general vector primers, the recombination to generate the plasmid pEMC
was determined to be successful (Fig. 4.12D).
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Figure 4.12 Cloning of MBP-NudC
A, PCR amplification at different cycle numbers of the pMBP-Parallel backbone in preparation for cloning. B, Amplification
of the NudC gene from the E. coli genome with 30 cycles of PCR and specific primers to add 18 bp overlap regions to
pMBP-Parallel for recombination during transformation. C, Colony PCR of DH5α transformants using general primers for
pMBP-Parallel. D, Verification of extracted plasmids from DH5α transformants using PCR with general primers for pMBPParallel. E, Colony PCR of NEBExpress transformants using general pMBP-Parallel primers, where PCR was carried out
in batch along with water (-) and the pEMC plasmid used for transformation (+). F, SDS-PAGE of small scale expression
from NEBExpress transformants where the 73 kD MBP-NudC was determined not to be expressed.
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The subsequent transformation of pEMC into NEBExpress cells proved
incapable of verification by Colony PCR (Fig. 4.12E). Considering the failure of
Colony PCR had previously occurred with NDX8 constructs that upon further
inspection were perfectly fine, small scale expression of MBP-NudC was carried
out anyway only to result in a lack of observable protein expression (Fig. 4.12F).
Despite repeating the procedure from each point individually, no expression of
MBP-NudC was observed. Considering that PCR on the plasmid pEMC
generated band at the expected size, the protein was never observed on SDSPAGE. The primers used for the plasmid analysis are general primers that site
outside of the insertion site and amplify whatever is between them. Typically in
PCR, the appearance of a band at the expected size is verification of the gene
being amplified, however this method cannot substitute for conventional
sequencing techniques in the identification of mutations. It is therefore possible
that the NudC gene was inserted properly into the vector, but some mutation
arose that apparently inhibited protein expression. Such a situation could explain
positive PCR results but negative expression of the protein.
4.2.3.2 Cloning and Expression of SUMO-NudC
The expression system of NudC was switched to the pETite vector
considering the previous troubles encountered with the MBP fusion system.
Based on the previous assumption that a mutation could have been responsible
for the troubles with the previous MBP-NudC construct, the NudC gene was
prepared again by PCR from the E. coli genome with specific primers to add
flanking 18 bp regions homologous to vector pETite-SUMO-nHis-Kan (Fig.
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4.13A). The amplified product combined with linearized vector in DH5α cells for
transformation, and Colony PCR screening showed that 50% of analyzed
transformants successfully had successfully undergone recombination to
generate the pESC plasmid (Fig. 4.13B). Further analysis of extracted plasmids
by PCR confirmed the insertion of the NudC gene downstream of SUMO
encoded by the plasmid (Fig. 4.13C).

Figure 4.13 Cloning of SUMO-NudC.
A, PCR amplification of the NudC gene from the E. coli genome using primers that would add 18 bp regions of homology
to the pETite-nHis-SUMO-Kan vector for recombination. B, Colony PCR analysis of DH5α transformants using general
primers for the pETite-nHis-SUMO-Kan where a 924 bp fragment indicates incorporation of NudC downstream of the
SUMO fusion. C, PCR on plasmids extracted from DH5α cells indicating that the pESC plasmid had been generated. D,
Colony PCR analysis of High-Control Bl21 (DE3) transformants containing pESC with general backbone primers.

The verified pESC plasmid was used to transform High Control Bl21 (DE3)
cells following a typical transformation protocol. Colony PCR analysis with the
general vector primers showed that only 10% of screened transformants
contained the gene-of-interest (Fig. 4.13D), and the one positive culture was
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grown for small scale expression and solubility analysis. Expression under the T7
promoter was shown to be favorable, and the protein was observed in both the
soluble and insoluble fractions of the cell lysate (Fig. 4.14A). When expressed at
a larger scale, the protein remained soluble and was able to be purified by IMAC
resin and eluted with 250 mM imidazole to apparent homogeneity (Fig. 4.14B).
Quantity of protein was determined by Beer’s law using the calculated extinction
coefficient at 280 nm of 63,745 M-1 cm-1 and molecular weight of 41,971 Da,
resulting in a total of 29 mg L-1 protein. The eluted samples were combined on an
M30 column and washed with 1X PDB to reduce salt and imidazole
concentrations before being stored at -20 °C in 30-40% glycerol
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Figure 4.14 SUMO-NudC Protein Expression
. A, SDS-PAGE of solubility assay showing uninduced cell lysate (U), induced cell lysate (I), soluble cell lysate (S), and
insoluble cell lysate (P) indicating that SUMO-NudC was expressed in the soluble fraction. B, SDS-PAGE of SUMO-NudC
purified to apparent homogeneity.

4.2.3.3 NudC Activity
The activity of NudC was tested by incubation in 1X Nudix buffer with
different coenzymes at 37 °C for 1 h. Analysis of the reactions by HPLC showed
that 6 μM SUMO-NudC was capable of hydrolyzing 1 mM NAD+ as indicated by
previous investigators, but also 1 mM CoA and 1 mM FAD (Frick and Bessman
1995). Given the similarities in retention time between NAD+ and its hydrolysis
products of AMP and NMN, it is hard to quantify the rate the hydrolysis reaction
(Fig. 4.15B). The general progress of the reaction can still be visualized by the
splitting of the single NAD peak into its product peaks with low resolution. The
progress of the FAD hydrolysis, on the other hand, is quite easy to follow by
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HPLC because of the difference in retention times between FAD and the
products FMN and AMP (Fig. 4.16B).

Figure 4.15 NudC Activity with NAD
A, Scheme of NudC activity against NAD to produce nicotinamide mononucleotide (NMN) and adenosine monophosphate
(AMP). B, HPLC chromatogram showing appearance of AMP peak when NAD is treated with NudC, but is not well
resolved from the original NAD peak.
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Figure 4.16 Figure 2 NudC Activity with FAD
A, Scheme of NudC hydrolysis of FAD into Flavin mononucleotide (FMN) and adenosine monophosphate (AMP). B,
HPLC chromatogram showing reaction progress by the appearance of two separate peaks corresponding to AMP and
FMN.

The previously uncharacterized NudC substrate of FAD is peculiar in that
it seems, at first glance, to be hydrolyzed at a faster rate than NAD+ (Table 4.1).
As multiple reactions of NudC with FAD were carried out, it became apparent
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that the Km for FAD was below 0.05 μM, where incidentally the detection of all
three peaks of FAD, FMN, and AMP becomes problematic in terms of quantifying
rates of reaction using HPLC. The presumably lower Km for FAD in addition to
the previously reported Km for NAD of 5.1 mM is likely the reason why the FAD is
hydrolyzed at a faster rate than NAD at 1 mM each. The two coenzymes are not
at equal concentrations in the cell where NAD is estimated around 1 mM and
FAD near 100-fold lower, and therefore the enzyme may be tuned to
accommodate either substrate equally in cellular conditions (Louie et al. 2003,
Lin and Guarente 2003).
Table 4.1
Activity of NudC with FAD, NAD, and CoA
Substrate

% Activity

Km (mM)

CoA

100

0.21

FAD
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NAD

5

5.1*

NADH

0.11*

AppA

0.67*

ADP-Ribose

1.8*

Activity calculated as percentage of rate (mM/min) at 15% reaction completion as determined by HPLC. *Denotes values
obtained from Frick et al. (1995).
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Table 4.2
Kinetic Constants of Nudix Hydrolases for CoA
Enzyme

Km (mM)

Kcat (s-1)

Kcat/Km (mM -1 s-1)

NudC

0.210

0.206

0.984

NDX8*

0.22

13.8

64

Nudt7**

0.240

3.8

16

Values for NudC were calculated with standard error under 0.1 *Data taken from AbdelRaheim et al. (2002). **Data taken
from Gasmi et al. (2001)

The digestion of CoA by NudC was tested in a similar manner as Nudt7.
Solutions of varying concentrations of CoA were incubated with NudC at 37 °C in
1X Nudix buffer, and reaction progress was monitored using HPLC (Fig. 4.17B).
Kinetic studies revealed that NudC has a Km for CoA of 0.210 mM, a Kcat of 0.206
s-1, and therefore an enzyme efficiency of 0.984 mM-1 s-1 (Fig. 4.17C, Table 4.2).
The Km calculated for CoA falls between that previously calculated for NADH and
NAD+ (0.11 mM and 5 mM, respectively), and may reflect the enzymes
compatibility with each substrate at intracellular concentrations (Frick and
Bessman 1995, Lin and Guarente 2003, Miller et al. 2007). The half-saturation
constant of NudC for CoA, however, is roughly equivalent to the reported value of
murine Nudt7 (Gasmi and McLennan 2001). Despite the similarities in their halfsaturation constants, the enzyme efficiency of NudC for CoA near 1 mM-1 s-1 is
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16-fold lower than Nudt7 at 16.0 mM-1 s-1 in similar conditions, therefore
indicating NudC to be slower enzyme than Nudt7 (Gasmi and McLennan 2001).

Figure 4.17 Activity and Kinetics of NudC with CoA.
A, Scheme of NudC hydrolysis of CoA to produce 4’-phosphopantetheine (PhP) and 3’, 5’-adenosine diphosphate (3’, 5’ADP). B, Example of HPLC chromatogram used to monitor reaction progress of NudC and CoA. C, Michaelis-Menten plot
of kinetic studies on NudC with CoA, with horizontal asymptote representing Vmax and dashed line representing the halfsaturation constant Km.
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The similarities in Km between the Nudt7 and NudC are peculiar
considering that NudC lacks the CoA consensus sequence upstream of its
catalytic site that is found in all characterized Nudix CoA hydrolases. The lack of
such a motif may explain the difference in efficiency between the two enzymes,
indicating that the binding of CoA by NudC may be mediated predominantly by
the adenosine portion of the molecule. Considering the activity of NudC against
both NAD+ and FAD (Fig. 4.15 and 4.16) as well as a host of other nucleotide
derivatives, it’s likely that NudC has a high affinity for adenosine itself, but
displays compatible amino acids that specifically interact in a favorable manner
with NADH that is reflected by a lower Km (Frick and Bessman 1995). After all, a
short 7 amino acid consensus sequence has been identified in Nudix NADH
hydrolases that falls downstream of the catalytic site, and such a site may be
responsible for the preferential binding of NADH over CoA (Xu et al. 2000). Upon
its discovery, NudC was found to have a preference for NADH over NAD+
showing about 5-fold higher activity for the reduced form (Frick and Bessman
1995). This difference in activity, as well as the 50-fold difference in Km could
reflect the ratio of free NADH/NAD+ in the cell, and result from different
interactions with the protein based on the charge of the nicotinamide group (Lin
and Guarente 2003). Oxidized FAD, on the other hand, does not bear a positive
charge, but displays its oxidized state by the presence of a pair of secondary
imines in isoalloxazine ring (Fig. 4.18). This lack of a positive charge likely results
in different protein-coenzyme interactions, resulting in an assumed lower Km for
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FAD than NAD+ and leading to a higher activity of FAD hydrolysis when
compared at equal concentrations.

Figure 4.18 Redox States of NAD and FAD.
A, Redox states of NAD where the oxidized form has a negative charge on the nitrogen in the pyridine ring. B, Redox
states of FAD where the oxidized form has a pair of secondary imines in the isoalloxazine ring.

134

Figure 4.19 NudC Treatment of CoA-RNA.
Internally labeled CoA-RNA was treated with 4 μM enzyme for 30 min at 37 °C, indicating that both reduced and oxidized
CoA-RNA were capable of being degraded by NudC.

NudC was tested for its ability to hydrolyze CoA-RNA as reported by Bird
et al. (2016). Internally labeled CoA-RNA was incubated with 4 μM NudC for 30
minutes at 37 °C and run on 8% denaturing PAGE to visualize the shift in
electrophoretic mobility. The removal of PhP from CoA-RNA should result in a
shift similar to that of a 1 nt difference. While visualizing 1 nt differences is
possible by PAGE, the hydrolysis of oxidized CoA-RNA is more easily observed
based on the migration rate differences between the dimer RNA and the
uncapped monomer (Fig. 4.19). The successful hydrolysis of oxidized CoA-RNA
indicates that NudC is also capable of hydrolyzing oxidized CoA itself. This
activity therefore corroborates the conclusions of Bird et al. (2016) in terms of the
in vitro activity of NudC, and extends the previously characterized substrate
range of NudC.
The role of NudC as a general coenzyme hydrolase seems evident in its
similar activities in hydrolyzing the most common coenzymes CoA, FAD, and
NAD. Given the overlapping specificities for each coenzyme, the discrimination
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between them seems minor, and the binding of these substrates is likely due to
the adenosine of each in addition to assisting non-specific hydrophobic
interactions, therefore greatly reducing the activity against charged species such
as oxidized NAD+ (Frick and Bessman 1995). Given that intracellular CoA
concentrations can range from 30 to 400 μM, NudC could operate in nutrient rich
conditions as a CoA hydrolase near its optimum rate, which may have a large
impact on cell survival given the versatility and importance of free CoA (Miller et
al. 2007, Leonardi et al. 2005). By the same logic, NAD+ would be cleaved at far
below the optimum rate of NudC as well, given the high Km in comparison to
cellular concentrations of NAD, and even further below this rate when the ratio of
free NAD is considered (Lin and Guarente 2003). As NudC has been
demonstrated to hydrolyze CoA- and NAD-RNA, it seems logical that it would be
involved in regulating these RNAs by degradation (Bird et al. 2016). The
concentrations of CoA-RNA and NAD-RNA, however, are even farther below that
of free CoA and NAD in the cell, and therefore would not be sufficient for NudC to
operate at a rate required for immediate regulation assuming that the kinetic
parameters for CoA and NAD are the same as those for CoA-RNA and NADRNA (Kowtoniuk et al. 2009, Chen et al. 2009). As such, the activity of steadystate concentrations NudC may act as a barrier to prevent the flux of such
coenzyme-capped RNAs, maintaining their abundance below a certain point
within the cell, and upon environmental stimuli is tuned by the increased
expression of NudC itself. NudC has the third highest transcript abundance of the
Nudix enzymes in E. coli with ~1300, however it falls below NudB (3200) and
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NudH (3100) which are involved in the hydrolysis of oxidized dADP and diadenosine polyphosphates, respectively (McLennan 2006). It’s unclear whether
the transcript abundance is correlated to active enzyme concentration within the
cell, but the presence of such transcript abundance may support the hypothesis
of the induced translation of NudC upon environmental stimuli to initiate gene
regulation via coenzyme-RNA decapping.
Given the ability for NudC to act on a variety of adenosine-containing
substrates, it seems unlikely that it is the sole enzyme responsible for the
degradation of NADH, NAD+, FADH2, FAD, CoA, Acetyl-CoA, Succinyl-CoA, and
their previously observed RNA conjugates. Such a one-size-fits-all mechanism of
degradation would imply that distinct coenzyme-RNA conjugates exist as
mechanistic redundancies and do not hold specific purposes. If all coenzymeRNA conjugates hold the same function, then logically their degradation could be
regulated by the same enzyme. This seems highly unlikely given the difference in
mechanisms required for the installation of NAD and CoA as transcription
initiators. While NAD can be readily incorporated as initiators into transcripts
where A is the +1 nucleotide given an amenable promoter and yet-to-beelucidated specific σ-factor, the same cannot be said for CoA (Bird et al. 2016).
Transcription initiation is only possible with depCoA, the penultimate intermediate
of the CoA synthesis pathway. While depCoA is present in the cell between the
activities of CoaD (PPAT) and CoaE (depCoA kinase), its abundance is not
readily detectable by any known method that distinguishes it from CoA and is
therefore essentially unquantifiable. The amount of depCoA required to initiate
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transcription would need to be high enough to compete with the abundant ATP in
the cell as stated by recent work, however the intracellular concentrations of CoA
itself have only been noted to increase up to 400 μM (Bird et al. 2016, Miller et al.
2007). Assuming this estimate includes both depCoA and CoA, and assuming
depCoA only represents a small fraction of this population, it is unlikely that
depCoA exists in concentrations that would allow transcription initiation. It
therefore is unlikely that the single enzyme NudC would be responsible for
regulating two separate coenzyme-RNA conjugates that are synthesized by
presumably different pathways for presumably different reasons.
While certainly capable of hydrolyzing these RNA-conjugates in vitro, it
remains to be seen through knockout mutation studies whether or not NudC is
involved in the regulation of both in vivo. Regardless of its role as an RNAconjugate regulator, NudC has been demonstrated capable of hydrolyzing all
common diphosphate-containing coenzymes with estimated kinetic parameters
that imply some level of activity in the cellular environment. Pending further
investigations into its specific role in vivo as an RNA-conjugate decapper, NudC
should be considered a general coenzyme hydrolase.
4.2.4 E. coli NudL
4.2.4.1 Cloning and Expression of SUMO-NudL
With all of the recent interest in Nudix hydrolases that came with the
discovery of CoA- and NAD-RNA in 2009, the identification of a specific CoA
hydrolase in E. coli has remained overlooked. Despite being identified by protein
BLAST searches for both the CoA and Nudix box consensus motifs, the E. coli
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gene NudL (YeaB) had never been characterized (McLennan 2006). Given the
high likelihood that this enzyme would foster activity towards CoA and our
successful cloning protocol, NudL was cloned, purified, and characterized as a
specific CoA-hydrolyzing enzyme.
The NudL gene was amplified from the E. coli genome as previously
described using primers designed to add flanking regions of 18 bp homologous
to the pETite-nHis-SUMO-Kan vector (Fig. 4.20A). The PCR product was
combined with linear pETite-nHis-SUMO-Kan in High-Control 10G cells for
transformation and recombination, and Colony PCR analysis indicated 80% of
screened transformants had successful generated the plasmid pETS-NudL (Fig.
4.20B). Significantly more positive transformants were noted when cloning NudL
than NudC, despite their source from the same genome using the same high
fidelity Q5 polymerase. After growing cultures for plasmid extraction, PCR
confirmed a band near 729 bp that indicates the successful insertion of the NudL
gene downstream of the SUMO fusion, and therefore successful generation of
the pETite-SUMO-NudL plasmid (Fig. 4.20C).
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Figure 4.20 Cloning of SUMO-NudL.
A, Amplification of NudL gene from the E. coli genome by 30 cycles of PCR with primers to add 18 bp regions of
homology to the pETite-nHis-SUMO-kan vector for recombination during transformation. B, Colony PCR screening of
High-Control 10G transformants using general primers for the pETite vector. C, Verification of pETS-NudL plasmid
extracted from High-Control 10G transformants by PCR with general primers for the pETite vector.
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The PCR- verified plasmid was used for transformation of High-Control
Bl21 (DE3) cells used for expression. Upon successful Colony PCR analysis of
transformants, small scale expression reactions were carried out in 5 mL
antibiotic media where cultures were grown at 37 °C until OD600 ~0.5, at which
point expression was induced with the addition of 0.5 mM IPTG and allowed to
express for 3 h at 37 °C. Each culture showed high expression of the 34 kD
SUMO-NudL fusion protein (Fig. 4.21A), however solubility assays showed the
vast majority of the protein was expressed insolubly (Fig. 4.21B). Expression
conditions were repeated with induction temperature lowered to 16 °C, with
decreasing inducer concentrations down to 50 μM IPTG, and reduced induction
times, but soluble protein could not be obtained (Fig. 4.21C).
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Figure 4.21 SUMO-NudL Protein Expression.
A, SDS-PAGE of small scale expression from High-Control Bl21 (DE3) transformants containing the pETS-NudL vector
with induced (I) and uninduced (U) samples showing expression of the 34 kD SUMO-NudL fusion protein. B, SDS-PAGE
of solubility assay from small scale expression with induced (I), soluble fraction (S), and insoluble fraction (P) samples
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showing SUMO-NudL not expressed solubly. C, SDS-PAGE of larger scale expression induced at 16 °C with uninduced
(U), induced (I), soluble (S), and pellet (P) samples indicating that protein is expressed insolubly.

4.2.4.2 Cloning and Expression of MBP-NudL
After careful consideration, it was decided that the T7 promoter was too
strong and expression could not be tuned down to a level where the protein
would stay soluble. Therefore NudL was prepared for expression in a system
controlled by the Tac promoter using a maltose-binding protein fusion. Maltosebinding protein fusions have been used to increase the solubility of recombinant
proteins due in part to its high solubility and to its large size of ~40 kD (Guan et
al. 1988). In addition to increasing solubility of recombinant proteins, MBPfusions are capable of purification by amylose resins which contain fewer steps
to clean and prepare than typical IMAC resins.
The NudL gene was prepared for recombination into the pMBP-Parallel
vector by PCR amplification from the E. coli genome using primers that would
add flanking regions of 18 bp homologous to plasmid, remove the multiplecloning site, and add a thrombin recognition site for cleavage of the fusion if
necessary (Fig. 4.22A). The vector was prepared by PCR using primers
designed to amplify the backbone to generate a linear stock as described above.
The amplified products would share 18 bp of homology at the 3’ end of the ORF
near the in-frame stop codon as well as just downstream of the MBP fusion,
yielding a construct that contains the MBP fusion, thrombin cleavage site, and
NudL under the control of the Tac promoter. PCR products were combined in
DH5α cells for transformation and recombination, and Colony PCR screening
showed that 50% of transformants had successfully generated the plasmid pEML
143

(Fig. 4.22B). Further PCR analysis of extracted plasmids with general primers
confirmed that NudL had been inserted downstream of the MBP fusion (Fig.
4.22C).

Figure 4.22 Cloning of MBP-NudL.
A, Amplification of NudL gene from E. coli genome by 30 cycles of PCR using primers to add 18 bp homology to pMBPParallel vector. B, Colony PCR of DH5α transformants using general primers for pMBP-Parallel that indicate the
successful production of pEML.

PCR-verified plasmid pEML was used to transform High-Control Bl21
(DE3) cells (Fig. 4.23D). Cultures were grown for small scale expression in 5 mL
of antibiotic media at 37 °C until OD600 ~0.5 when they were induced with the
addition of 0.2 mM IPTG and allowed to express for 2 h at 37 °C. Analysis of
small scale cultures by SDS-PAGE indicated good expression of the ~64 kD
MBP-NudL fusion in all samples (Fig. 4.24A), therefore a culture was grown in
larger scale with 0.5 L antibiotic media to OD600 of ~0.5 before induction with 0.2
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mM IPTG and incubation at 16 °C overnight. The resulting protein was extracted
in the soluble fraction and purified via amylose resin where it was eluted in the
presence of 20 mM maltose (Fig. 4.23B). Eluted fractions were combined on an
M50 spin column and washed repeatedly with 1X PDB to lower the salt
concentration and remove the maltose before the addition of glycerol. Protein
quantity was determined by absorbance at 280 nm using the calculated
extinction coefficient of 93,280 M-1 cm-1 and molecular weight of 64,484 Da for a
final yield of 4 mg L-1. The relatively lower yield is expected from a non-T7
expression system, however the reduction in expression with the addition of the
MBP fusion greatly helped the solubility of the protein.
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Figure 4.23 MBP-NudL Protein Expression.
A, Verification of plasmid (P) extracted from DH5α transformants by PCR with general primers for the pMBP-Parallel
vector. B, Colony PCR of High-Control Bl21 (DE3) transformants carried out in batch with water (-) and two previously
verified versions of pEML (+). E, SDS-PAGE of solubility assay containing uninduced (U), soluble (S) and insoluble lysate
(P) samples to indicate 64 kD MBP-NudL protein is expressed in the soluble fraction. F, SDS-PAGE of MBP-NudL
purification by amylose resin showing soluble lysate (S), column flow-through (F), column wash (W), and 1 mL fractions
eluted with 20 mM maltose (E1-5).

4.2.4.3 Activity of NudL
The activity of NudL was tested in the presence of varying concentrations
of CoA in 1X Nudix Buffer at 37 °C and visualized by HPLC (Fig 4.24C). NudL
was determined to have a Km of 0.51 mM for CoA with a Kcat of 0.008 s-1 and an
enzyme efficiency of 0.015 mM-1 s-1 (Fig. 4.24D, Table 4.2). These values are all
comparatively low to previously characterized Nudix CoAses from other
organisms, in particular the Kcat/Km of NudL is 2 orders of magnitude below both
M. musculus Nudt7 and C. elegans NDX8 (AbdelRaheim and McLennan 2002,
Gasmi and McLennan 2001). While both the mouse and worm enzymes are two
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of the most efficient Nudix CoAses characterized, the turnover number of NudL is
still significantly lower in comparison (Table 4.3). The half-saturation constant of
NudL is double that of Nudt7 and NDX8, but it is still comparable to the cellular
CoA concentrations of 400 μM expected in prolific, nutrient-rich conditions
(Leonardi et al. 2005).
Table 4.3
Kinetic Constants of Nudix Hydrolases for CoA including NudL
Enzyme

Km (mM)

Kcat (s-1)

Kcat/Km (mM -1 s-1)

NudC

0.210

0.206

0.984

NudL

0.507

0.008

0.015

NDX8*

0.22

13.8

64

Nudt7**

0.240

3.8

16

*Data taken from AbdelRaheim et al. (2002). **Data taken from Gasmi et al. (2001)

Indeed, the kinetic constants for NudC were also calculated lower than the
specific CoAses from worm and mouse, but the Km values of all three are
comparable. If cellular concentrations reach to 400 μM in nutrient rich conditions,
NudC would be operating at its maximum rate and opposing the metabolic
capabilities allowed by the environment. In other words, when E. coli is in high
glucose and can achieve maximum growth rate through the use of CoA, NudC
would be active in removing this indispensable metabolic component, and
therefore NudC must be kept under some translational control or an active
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repression. NudL, on the other hand, contains the CoA consensus sequence
shared by NDX8, Nudt7 and others, and is specific for CoA with a lack of activity
towards NAD or FAD. The transcript abundance of NudL is only ~15% that of
NudB, and ~36% of NudC, indicating that significantly fewer cell resources are
devoted to maintaining the amount of mRNA present (McLennan 2006). As
previously stated, it is unclear whether the transcript abundance correlates to the
number of actual proteins present in the cell, therefore transcript abundance
should be taken lightly when concluding protein activity within the cell.
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Figure 4.24 Activity and Kinetics of NudL with CoA.
A, Scheme of NudL hydrolysis of CoA into 4’-phosphopantetheine (PhP) and 3’, 5’-adenosine diphosphate (3’, 5’-ADP). B,
HPLC chromatogram showing the separation of products (ADP) from reactant CoA due to NudL hydrolysis. C, HPLC
chromatogram showing progress of CoA hydrolysis reaction over time. D, Michaelis-Menten plot of kinetic data obtained
from HPLC monitoring of CoA hydrolysis by NudL, where solid horizontal line represents Vmax and dashed line represents
the half-saturation constant Km.

The low activity assumed from the kinetic constants of NudL may be
advantageous for the cell, as a highly active CoA hydrolase could be problematic
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due to the removal of a key metabolic coenzyme. Even in the event of high CoA
concentrations, the enzyme’s efficiency is still an order of magnitude below that
of NudC, implying that the removal of the highly important CoA is not at as high
of a risk. The stark difference in Km and Kcat values between NudL and its
eukaryotic counterparts may be explained by the evolution of the eukaryote itself.
Simply put, the E. coli enzyme must function in the cytosol in the presence of the
CoA pool that is so vital to metabolism, whereas the C. elegans, S. cerevisiae,
and M. musculus versions of the Nudix CoAse are separated from their
respective cellular CoA pools by the presence of organelles. Each of the
eukaryotic enzymes have been shown to localize to the peroxisome as a result of
a signal peptide, whereas the major pool of CoA in eukaryotes is found in the
mitochondria (Cartwright et al. 2000, Gasmi and McLennan 2001, AbdelRaheim
and McLennan 2002). Therefore the eukaryotic enzymes have no selective
disadvantage to high enzyme efficiencies, but such an enzyme in bacteria could
be detrimental to survival. While NudC has an estimated enzyme efficiency two
orders of magnitude above NudL, it is still one order of magnitude below the
eukaryotic Nudix CoAses (Table 4.3).
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Figure 4.25 NudL Treatment of CoA-RNA
Internally labeled CoA-RNA was treated with 4 μM enzyme and 100 mM DTT. NudL activity could not be observed with
oxidized or reduced CoA-RNA in the 1 h incubation time at 37 °C.

The activity of NudL against CoA-RNA was tested the same as
experiments with NudC. Internally labeled CoA-RNA was incubated with 4 μM
enzyme for 1 h at 37 °C and resolved on 8% denaturing PAGE to visualize the
removal of PhP and the resulting electrophoretic mobility shift (Fig. 4.25). The
altered migration rate is approximately equal to that resulting from a 1 nt
difference, and can easily be visualized using this method as shown by the
treatment of CoA-RNA with Nudt7. The addition of NudL to the CoA-RNA did not
appear to alter the migration rate in either the absence or presence of a
reductant, as both lanes appear similar to controls without added enzyme. The
inability to visualize CoA-RNA decapping by NudL may be caused by the lack of
NudL to process CoA-RNA, or it could be a result of NudL’s drastically lower
catalytic efficiency compared to NudC and Nudt7. Both NudC and Nudt7 were
151

capable of hydrolyzing visible amounts of CoA-RNA, however these enzymes
have 20-fold and 400-fold higher catalytic efficiencies, respectively, in addition to
Km values half that of NudL. Therefore the hydrolysis of CoA-RNA by NudL may
be occurring at a rate so slow that products are not detectable. To account for
the 20-fold difference in catalytic efficiency between NudL and NudC, CoA-RNA
would need to be incubated approximately 10 hours to achieve the same level of
decapping as observed by NudC. Experiments were therefore repeated
extending the time to 4 hours incubation, but still no detectable CoA-RNA was
hydrolyzed by NudL.
The possibility of the MBP fusion interfering with the activity of NudL
against CoA-RNA cannot be ignored. While still capable of cleaving CoA without
any observable issue with the fusion protein attached, the large nature of MBP
may sterically hinder the insertion of CoA-RNA into the active site of NudL,
causing the MBP-fusion enzyme to appear inactive against this substrate. The
MBP-NudL protein was therefore treated with thrombin overnight at both room
temperature and 37 °C to remove the MBP fusion. The resulting crude protein
was used in similar experiments with CoA-RNA without any change in activity.
Strangely, NudL was also found incapable of cleaving CoA at an equivalent rate
as its pre-processed counterpart MBP-NudL, indicating that the protease
digestion of the enzyme had resulted in either denaturation of the protein, or offtarget proteolysis to reduce the efficiency of the enzyme.
NudL was not observed to decap CoA-RNA, despite its ability to hydrolyze
CoA derivatives such as depCoA, oxidized CoA, and oxidized depCoA at
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comparatively slower rates than CoA itself. Given the size of molecules such as
oxidized CoA, it seems that NudL should be capable of hydrolyzing 15mer CoARNA as well. The issue is likely with the concentration of CoA-RNA used in the
analysis. Experiments with CoA derivatives were carried out with 1 mM substrate
which is far above the calculated Km for CoA when the enzyme would be
operating near its optimum rate, but CoA-RNA could never be used in such high
concentrations due to lack of materials. The estimated amount of 15mer CoARNA used in experiments is closer to 1 μM, therefore causing the rate of NudL to
be significantly slower. Considering these parameters in addition to the
significantly slower turnover number calculated for NudL, it seems unlikely that
CoA-RNA hydrolysis by NudL can be visualized without a significant increase in
enzyme concentration.
4.3 Conclusions
The cloning of four Nudix enzymes capable of hydrolyzing CoA in 8
different iterations was successfully carried out in this study. Solubility issues
limited the success of purification of each of these enzymes. These issues were
overcome with the latter three enzymes Nudt7, NudC, and NudL, allowing the
functional characterization of each for the assessment of their potential use in a
CoA-RNA capture protocol. NudL was determined to be less plausible of an
enzyme to use for such a protocol as NudC or Nudt7 which both bear superior
kinetic characteristics. Nudt7 and its ability to cleave CoA-thioesters and
biotinylated-CoA-RNA, in addition to its high rate of hydrolysis, appears to be the
best candidate for the task of CoA-RNA hydrolysis from resin. NudC also bears
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the capability for this task, however the specificity of its activity comes into
question. The purpose of CoA-RNA capture is selective release of CoA-RNA by
specific enzyme activity. Such specificity is displayed by Nudt7, but not NudC
(Gasmi and McLennan 2001, Reilly et al. 2008, Frick and Bessman 1995). Given
the conditions of the CoA-RNA capture protocol to be discussed in a later
section, the potential for off-target cleavage by a general hydrolysis enzyme such
as NudC is problematic. The NAD-RNA capture protocol was very specific to
capture only oxidized NAD, and yet the supplemental data the investigators
provided showed very dirty results that caused their analysis to be limited to
RNAs isolated of specific sizes (Cahova et al. 2015). The most stringent
conditions are required in order to increase the purity and depth of the CoA-RNA
capturing, and therefore the inclusion of NudC should be carefully considered
before proceeding.
This study also describes the novel characterization of two Nudix enzymes
capable of hydrolyzing CoA, one of which had never been studied at all. It is
unclear why E. coli would produce the two enzymes NudL and NudC with
overlapping functions unless each was intended for use in specific scenarios.
NudL may be strictly involved in the slow and steady metabolism of CoA itself
whereas NudC may be used for a more general purpose of coenzyme
degradation to be specifically induced for gene regulation. At the current
calculated kinetic constants, neither enzyme is capable of quickly turning over
CoA-conjugated RNA given its estimated cellular concentration (Kowtoniuk et al.
2009). The rate of CoA-RNA hydrolysis would certainly increase with protein
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concentration, leaving the possibility that NudL expression could be tuned by
environmental stimuli to induce the degradation of CoA.
Given the specificity of a motif present in NudL for CoA, CoA-RNA should
be considered its substrate as well. Experiments carried out with NudL and
internally labeled CoA-RNA, however, were unable to demonstrate this
hydrolysis. It is possible that the position and size of the MBP fusion on NudL
interferes with both the kinetics of the enzyme and its capability to hydrolyze
CoA-RNA, but several attempts to remove it by treatment with thrombin as
designed resulted in an inactive protein that was incapable of hydrolyzing CoA
itself at detectable rates. If the MBP fusion did not abrogate the ability of NudL to
hydrolyze CoA, the removal of the fusion should show a similar amount of
activity, if not better. Therefore subjecting the protein to thrombin may have
resulted in off-target degradation of the protein. The use of thrombin for fusion
removal is a popular technique, but off-target proteolysis is a known
characteristic of this protease (Jenny et al. 2003).
Considering the slow rate of CoA hydrolysis by NudL, it is possible that
CoA-RNA can still be turned over at a rate incapable of detection by the current
methods employed. The removal of PhP by NudL hydrolysis of CoA-RNA would
result in an electrophoretic mobility shift equivalent to ~1 nt. While this can easily
be visualized by PAGE, a significant fraction of the CoA-RNA needs to be
hydrolyzed in order for the shift to appear as a band and not simply a smear.
These assays can easily be used to view CoA-RNA hydrolysis by both NudC and
Nudt7 due to their increased activity in comparison to NudL. The assumption that
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hydrolysis of CoA-RNA by NudL occurs at a comparably slower rate than
observed for CoA reinforces the theory that the slow NudL gives a selective
advantage to E. coli. The high Km for CoA calculated for NudL is near the
observed upper limits of CoA flux by other investigators, implying that the
enzyme would not be active in the cell at a rate that would hinder metabolism
even in the most prolific of conditions (Leonardi et al. 2005). CoA-RNA is
estimated to be significantly lower in concentration than CoA at around 8 fmol μg1,

and therefore if the activities of CoA and CoA-RNA were assumed to be

equivalent, NudL would be comparably less active against CoA-RNA in the cell
(Kowtoniuk et al. 2009). Therefore the activity of NudL within E. coli would likely
not interfere with the function of CoA-RNA through transient degradation as
hypothesized with NudC. An enzyme such as NudL would be reasonable as a
tunable control for CoA-RNA levels, and such a situation would allow the cell to
specifically control CoA-RNA turnover without affecting NAD-RNA levels that
would result from NudC activity.
The nonspecific hydrolysis and substrate ambiguity displayed by NudC
insinuates that other enzymes could be capable of cleaving CoA-RNA without the
specificity associated with its primary sequence. Such a topic has been
discussed in recent reviews, as Nudix enzymes have been characterized with a
multitude of substrates (McLennan 2013). The fact remains that activities
discovered by in vitro methods do not necessarily reflect the native activity of the
enzyme in vivo. Surely, NudC is capable of catalyzing a vast array of nucleotidederived molecules, but does it actually exist in such abundance within the cell
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that it is capable of such activity? Reasonably the answer is no. If NudC was
actively carrying out all of its in vitro characterized hydrolyses within the cell, then
no species expressing it would be able to survive. Of the 13 identified Nudix
hydrolases in E. coli, 4 are still uncharacterized including NudL (McLennan
2006). These remaining enzymes YffH, YfaO, and YfcD likely display some
NudC-like nonspecific activity considering that no substrate specific motifs have
been identified within them aside from the NDP-sugar affinity predicted with YffH.
Other possible proteins capable of CoA-RNA hydrolysis following the
mechanisms of NudL and NudC would maintain pyrophosphohydrolase activity,
but not necessarily CoA specificity. Protein sequence analysis of related
sequences to NudL and NudC spotlights a variety of NTP
pyrophosphohydrolases that are uncharacterized in E. coli such as predicted
CTP pyrophosphohydrolase, RNA pyrophosphohydrolase, and Pyrimidine
Deoxynucleoside Triphosphate pyrophosphohydrolase. Some of these results,
especially those annotated for RNA pyrophosphohydrolase activity, seem to be
promising candidates for CoA-RNA hydrolysis activity. Unfortunately, none have
been studied to date. Furthermore, the Nudix superfamily itself is a subset of the
much larger αβ protein family that is characterized by the structural motif of
antiparallel β-sheets with segregated α and β regions. This αβ family consists of
over 376 different superfamilies according to the Superfamily v1.75 annotation
algorithm (http://www.supfam.org/), including proteinases, nucleases, RNase Alike, and DNA-binding domain containing proteins based on that characteristic
structure.
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With such an abundance of family members capable of binding nucleic
acid and hydrolyzing phosphodiester or phosphoanhydride bonds, the possibility
exists that many other enzymes could be capable of nonspecifically metabolizing
CoA-RNA. Members of the nuclease superfamily, for example, would be quite
capable of degrading CoA-RNA if they showed endonuclease or 3’-5’
exonuclease activity. Enzymes with 3’-5’ exonuclease activity would be able to
degrade the CoA-RNA and release either depCoA or CoA itself to be recycled
into metabolism or the CoA pathway. There is no reason to discount this as a
pathway for CoA-RNA degradation, and such a 3’-5’ exo pathway is certainly a
possibility for any RNA found within the cell. The problem is with the
nonspecificity of the 3’-5’ exo pathway. The CoA cap has no influence on this
pathway, but it does alter the 5’-3’ pathway initiated by RppH to decap
triphosphate RNA. It stands to reason that if there is a specific pathway to create
such a molecule, there too should be a pathway to destroy it.
The only experimentally or computationally characterized enzymes
capable of the destruction of CoA by the removal of PhP are Nudix enzymes
discussed above, the enzyme phosphopantetheine adenylyl transferase (PPAT,
CoaD) from the CoA synthetic pathway, and the acyl-carrier proteins involved in
acyl transfer. The ACPs are characterized in lipid and polyketide synthesis where
they acquire PhP to carry out acyl-transfer reactions. While this mechanism
involves the use of CoA, it is unknown whether these proteins can interact with
CoA-RNA. The enzyme CoaD is another possible candidate to carry out CoARNA hydrolysis, however it has been characterized to catalyze the reverse
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reaction of phosphopantetheine adenylation that requires depCoA as a substrate.
CoA-RNA, incidentally, does not contain a depCoA group due to the presence of
the 3’phosphate connecting it to the remaining RNA residues, and CoaD has
been shown to be incapable of this activity with CoA (Geerlof et al. 1999).
Therefore it is unlikely that CoaD is also capable of CoA-RNA hydrolysis. Just as
NudC is capable of CoA-RNA hydrolysis without specificity, it’s possible that
other proteins unearthed in the structural and sequence homology analysis could
carry out this mechanism albeit without specificity for CoA-RNA. These enzymes
will require further study and characterization to determine their roles.
Speculation in the past decade of the roles of different Nudix enzymes and
coenzyme-conjugated RNAs has led to an interesting set of conclusions. While
Nudix hydrolases are well-characterized in many organisms, it seems the field of
study shifted away from physical experiments and brought into focus the wealth
of genomic data that came with the advent of Next Generation Sequencing
technology. Even upon the discovery of CoA-RNA, the mechanism for its
generation in addition to its degradation have been argued in both logical and
illogical manners, yet no specific data has been presented as evidence that could
be used to elucidate a reasonable model.
The argument that CoA can be installed as an initiator of transcription
given the correct concentrations is simply wrong (Bird et al. 2016). Not only
would CoA not exist in the specified concentrations to outcompete ATP for
initiation in vivo, but CoA itself is incapable of extension via RNA polymerase due
to the presence of a 3’ phosphate group. Kowtoniuk et al. (2009) implied this
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point upon their initial discovery of CoA-RNA when they could not reproduce
CoA-RNA using E. coli RNA polymerase for in vitro transcription in the presence
of depCoA and promoters that encode A as the +1 nucleotide. Indeed, Bird et al.
(2016) could show this reaction to succeed in vitro using slightly different
concentrations, different promoters, and added σ-factors, however they
concluded this was the likely pathway of incorporation in vivo. In addition peculiar
conclusions about general coenzyme incorporation into RNA, Bird et al. (2016)
looked to NudC as the explanation for their idea of a sole decapping enzyme in
E. coli. While this enzyme was shown to cleave NAD and CoA in vitro, the in vivo
experiments carried out cannot be used to infer any conclusion in regards to the
process within the cell. The investigators isolated and identified RNA by Northern
blot from E. coli that had been transformed with a plasmid encoding a set
sequence from a promoter they had reasoned would yield coenzyme-capped
RNA. The isolated RNA was treated with NudC to show a gel shift, and the
conclusion was made that NudC responsible for decapping within the cell. Not
only do these experiments not provide evidence for one mechanism of coenzyme
installation over another, but they do not indicate what was actually hydrolyzed
from the 5’ end of the RNA. Looking at the original characterization of NudC from
the mid-1990s, the enzyme has long been known to be capable of hydrolyzing a
wide variety of substrates based on the presence of adenosine somewhere in the
molecule (Frick and Bessman 1995). Amidst all of these years and different
studies, CoA hydrolysis in E. coli remained uncharacterized.
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This study represents the first characterization of an E. coli enzyme
capable of CoA hydrolysis, and identifies two possible candidates to fulfill the
long uncharacterized metabolic role of CoA degradation. Given their different
efficiencies and half-saturation constants for CoA, it is likely the two enzymes
NudC and NudL fulfill different roles in the cell, for example to control the CoA
turnover in log and stationary growth phases separately. The substrate ambiguity
of NudC, however, is troubling. It’s unclear whether the variety of identified NudC
substrates would actually be hydrolyzed in the cell. If NudC is present in the cell
with 1 mM NADH, 400 μM CoA, and 10 μM FAD, it will actively hydrolyze all
three and could substantially hinder the cellular metabolism (Lin and Guarente
2003, Leonardi et al. 2005, Louie et al. 2003). In such a situation, NudC would
serve well as an inducible facilitator of the transition to stationary growth, where
metabolism slows to a steady-state. Both enzymes require more study in order to
fully understand their purposes. One thing that seems clear based on the kinetic
data presented above is that, in order for either of these enzymes to serve as the
active cellular hydrolase against such a small population of CoA-RNA, the
enzyme concentration within the cell would need to be increased, indicating a
regulatory mechanism responsible for controlling the translation of the respective
mRNAs.
In order to ascertain the true role of these enzymes within the cell, in vivo
assays will need to be carried out in the future. Knockout mutants of NudC and
NudL, in addition to other possible candidates, will need to be characterized for
differences in abundance and quality of CoA-RNA captured. In addition, these
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knockout mutants can be supplemented with plasmids expressing the knocked
out genes under the control of the arabinose operon for a tunable control of
protein level similar to those done in previous investigations (Balibar et al. 2011).
With these mutants, the changes in CoA-RNA abundance can be measured as a
function of the tunable levels of NudC or NudL during growth. Such experiments
would prove more directly the roles of these enzymes in CoA-RNA metabolism
as well as CoA turnover within cellular environments.
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CHAPTER V - DEVELOPMENT OF A SPECIFIC
COA-RNA CAPTURE PROTOCOL
5.1 Introduction
The discovery of bacterial coenzyme-RNA conjugates has sparked
new ideas regarding the bacterial transcription. The previously accepted
prokaryotic transcription system simply polymerized nucleotide triphosphates
(NTPs) to leave a 5’-triphosphate group at the terminus of all mRNA. This was as
an easily understandable system. It did not bear the complexity of the eukaryotic
system that includes 3’ modifications via polyadenylation, or 5’ modifications
such as installment of a 7-methyl-guanosine (7mG) cap, or any of the protein
interactions that go along with such modification. As such, the bacterial system
was a reflection of the bacterial domain itself: simple and stripped down in
comparison to its eukaryotic counterpart. Bacterial systems in general served as
the fundamental building blocks for metabolic and systematic cellular processes
that most complex systems in higher organisms were modeled after. As new
aspects of RNA biology in higher organisms were discovered, the discovery of
simpler versions in bacteria followed. One example is the discovery of eukaryotic
microRNA (miRNA) transcribed from intron sequences in eukaryotic genomes
that is responsible for specific post-transcriptional gene regulation that was
followed by the discovery of bacterial small noncoding RNAs (sRNAs) that carry
out the same function with fewer steps (Ha and Kim 2014, Bandyra et al. 2012).
The same could previously be said about bacterial transcription. Bacterial mRNA
are transcribed with a 5’-triphosphate at its terminus that serves to protect the
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RNA from transient degradation by RNase E, and systems have been described
that induce degradation via removal of the triphosphate group (Bandyra and Luisi
2013). Even with the addition of sRNA regulation, bacterial transcription and
translation was a process of bare essentials without any excess RNA
modification required for function. The eukaryotic system, while still maintaining
the core values displayed in prokaryotes, has additional levels of complexity
regarding both modification and RNA-protein interactions in order for the RNA to
serve its intended function.
The viewpoint of bacteria as a simple model system was cracked with the
discovery of NAD- and CoA-RNA (Kowtoniuk et al. 2009, Chen et al. 2009). For
all that can be said about the complexity of eukaryotic RNA, there is generally
one accepted cap structure of 7mG, and it is a modified form of a nucleotide that
is not known to function in any other way within the cell. The bacterial system as
of 2009 includes two separate 5’-modifiers, both of which not only are involved in
a myriad of cellular processes, but themselves are indispensable to survival.
CoA, in particular, participates in over 500 known reactions including those
involved in fatty acid metabolism, glucose metabolism, and as a source for
phosphopantetheine for carrier proteins (Leonardi et al. 2005, Kanehisa et al.
2008). NAD, on the other hand, is known for its roles in redox reactions in
metabolism, adenylation, ADP-ribosylation, and DNA repair (Lin and Guarente
2003, Lin 2007, Garten et al. 2009). The discovery of these two coenzyme-RNA
conjugates brought many questions to light. What is the function of these two
coenzyme-RNA conjugates, and both coenzymes function the same way with
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RNA? How are these coenzyme-RNA conjugates made, and are they made the
same way? Do these coenzyme-RNA conjugates act in a similar way to the
eukaryotic 7mG cap? How does the cell regulate the installation and removal of
these coenzymes? The answers to these questions all center around a common
theme that, for once, bacteria may no longer be considered a simple model
system from which all other processes in life are expanded.
A group of investigators was able to shed light on one of these questions
with the development of a specific NAD-RNA capture protocol (Cahova et al.
2015). The captured NAD-RNA were identified through Next Generation
Sequencing and determined to be mostly sRNA of approximately 300
nucleotides. Cahova et al. (2015) extended their observations that the NAD
group serves as an extra level of protection for these RNAs against RppH
processing that leads to RNase E degradation, and that they could instead be
processed by the Nudix enzyme NudC that was characterized as an NADHhydrolase (Frick and Bessman 1995). If NAD was being installed as a form of
degradation protection for sRNA, then how was this occurring? It is possible for
NAD, FAD, and depCoA all to be installed to RNA as an initiator using the T7
RNA Polymerase (Huang 2003a). However it is also possible for these
coenzymes to be generated via ribozyme activity from their respective substrates
NMN, FMN, and PhP with an ATP molecule (Huang et al. 2000). As Kowtoniuk et
al. (2009) noted, the incorporation of depCoA into RNA using the E. coli RNA
polymerase is problematic, as their attempts at recreating CoA-RNA in vitro with
such a system failed. Another group of investigators attempted to point out that
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given the right ratios of NAD and depCoA to ATP, initiation with either could be
achieved by outcompeting ATP for the +1 site of transcription (Bird et al. 2016).
These results in vitro may be promising, however the in vivo concentrations of
CoA, depCoA, and NAD are far from equivalent to each other, and in many
cases far below that of ATP such that the ratio of coenzyme to ATP to achieve
optimal transcription initiation of a coenzyme would not occur (Lin and Guarente
2003, Miller et al. 2007). While the concentrations of NAD could reach near 1 mM
to facilitate such incorporation as described by Bird et al. (2016), CoA has only
been known to increase to 400 μM in glucose-rich conditions (Leonardo et al.
1996, Miller et al. 2007). It should be understood that CoA is not capable of
transcription initiation due to the presence of a 3’-phosphate group, and only its
synthetic precursor depCoA can undergo such a reaction. DepCoA, being a
synthetic intermediate to CoA, has never previously been quantified within the
cells, and is indistinguishable from CoA in quantification methods. Regardless of
the possibility that NAD concentrations reach high enough for transcription
initiation to occur, the mechanism proposed then is that of competition, indicating
a non-specific or process of capping RNA. Such a transient mechanism is not
possible for CoA-RNA due to cellular concentrations of depCoA, so then why
would one coenzyme-RNA conjugate be coincidental, but another be more
pointed and require some specific machinery? The actual mechanisms of
installment of these coenzymes are unknown. Everything at this point is
speculation. The investigators previously published in this area all seem to
believe transcription initiation to be the answer, regardless of the points raised
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above. While certain promoters have been identified that initiate with an
adenosine at the +1 region and allow the incorporation of NAD, NADH, and CoA
as initiators in vitro, there is still no evidence of transcription initiation by
coenzymes in vivo (Bird et al. 2016).
The idea that NAD-RNA and CoA-RNA should be considered different
classes of RNA modifiers is more than simply the inability for one of them to
transiently be incorporated into RNA as an initiator. The CoA-RNA conjugates
discovered are unique. While only one type of NAD-RNA was discovered in the
form of oxidized NAD+, four different iterations of CoA-RNA were isolated (Chen
et al. 2009, Kowtoniuk et al. 2009). In addition to CoA itself, the three separate
thioesters of acetyl-CoA, succinyl-CoA, and methylmalonyl-CoA were discovered
conjugated to RNA. Methylmalonyl-CoA is particularly interesting because it is
incapable of being synthesized by E. coli, and therefore was only isolated from S.
venezuelae cultures. The appearance of each these thioesters conjugated to
RNA not only illustrates the diversity of CoA-related compounds available in
different species, but it hints at the distinction of their functions from other
coenzyme-RNA conjugates. It’s interesting to think that CoA-RNA behaves as a
contemporary version of a pre-protein enzyme, where the RNA is a stabilizing
factor or a structural scaffold that facilitates the activity of CoA in acylation
reactions (White 1976). Could the CoA conjugated to RNA therefore serve to not
only as protection from RNA degradation as the NAD adduct was proposed by
Cahova et al. (2016), but also still function in its acylation duties? Furthermore,
are there sequence elements within the RNA that specifically direct CoA to form
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these thioesters? Furthermore, do any of these sequences have similarities to
those of NAD-RNA?
None of the questions presented by the discovery of CoA- and NAD-RNA
can be completely answered without more data. The discovery of CoA-RNA will
likely bring up more questions, but it is absolutely necessary to begin uncovering
the relationships between these newly discovered coenzyme-RNA conjugates.
To further explore the functions of the CoA thioester-RNA conjugates, a specific
capturing protocol is required to distinguish between these and CoA-RNA. Here
we describe the development of a specific CoA-RNA capture protocol to
distinguish CoA-RNA from thioester-CoA-RNA, so that the RNA can be prepared
for sequencing for its identification and the subsequent elucidation of its function
(Scheme 5.1).
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Scheme 5.1 Overall Capture Protocol.
The capture of CoA-RNA via resin conjugation (1) is essential to purification, as well as the extensive washing (2) to
remove nonspecifically bound RNAs that would later show up as false positives in the sequence analysis. Removal of the
CoA from the resin can occur by enzyme (3A), UV light (3B), or reduction (3C) depending on the resin used, but ultimately
Nudix digestion (4) is required to generate the 5’-pRNA capable of ligation (5) and preparation of the NGS library (6, 7).
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5.2 Results and Discussion
5.2.1 Capture of CoA-RNA by TGSIA
The initial plan for capturing CoA-RNA was to utilize polyacrylamide resin
derivatized with a terminal iodo group. The free thiol of CoA would react with the
iodo group in a nucleophilic substitution reaction to form a stable thioether bond
(Fig. 5.1A). The commercially available resins containing iodo groups or amines
that can be functionalized with succinimidyl iodoacetate (SIA) were obtained for
this purpose. The iodo group is stable at acidic temperatures, but as the pH
increases it releases from the resin forming I-. Because the CoA would need an
ionized thiol for the nucleophilic substitution to occur, the pH would need to be
acid enough to prevent the non-specific loss of iodo from the resin, while still
being basic enough to facilitate the nucleophilic substitution to form the thioether
bond. The pH also would need to remain at or below 8 in order to maintain the
integrity of RNA samples prone to alkaline hydrolysis due to the presence of their
2’-OH group.
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Figure 5.1 CoA-Resin Conjugation.
The thiol of CoA can be used to conjugate CoA to resins functionalized with an iodoacetyl group to form a thioether bond
(A) or to form a disulfide bond if the resin is thiol functionalized (B).
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In order to estimate the capacity of the beads, the iodo groups were
reacted with β-mercaptoethanol. Twenty microliters of Tentagel amino resin
(Chem Impex) functionalized with SIA (TGSIA, Fig. 5.2A & 5.3) were washed
with excess water and then incubated at room temperature in the presence of 10
mM Tris (pH 8), and 0.006% (v/v) β-mercaptoethanol (0.8 mM) at room
temperature while vortexing to monitor the release of I- by its absorbance at 226
nm (Fig. 5.4A). Using the extinction coefficient of I- at 14 mM-1 cm-1, the beads
were considered to contain a capacity of approximately 4 mM. The calculated
capacity should be sufficient for the capture of CoA-RNA given the estimated
number of molecules by Kowtoniuk et al. (2009), but it is still lower than expected
as a result of possible resin derivatization inefficiency.
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Figure 5.2 Resins for CoA-RNA Capture.
A, Tentagel-HL-SIA (TGSIA). B, UltraLink Iodoacetyl (ULIA). C, UltraLink Iodoacetyl-PC-linker-SIA (ULLI). D, ULPCIA .

Figure 5.3 TGSIA Synthesis.
Tentagel-HL-NH2 resin combined with succinimidyl iodoacetate (SIA) to form TGSIA.

CoA-RNA was prepared by IVT in the presence of depCoA for trial capture
and release from the TGSIA beads. The RNA was radiolabeled ligation of short
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22mer RNA that itself had been phosphorylated by γ-32P-ATP using T4
Polynucleotide Kinase (Scheme 5.2). The radiolabeled adapter will only ligate to
the 3’ end of the CoA-RNA, and therefore acts as an internal label (Fig. 5.5). The
labeled CoA-RNA was combined with 20 μL TGSIA beads with 20 mM Tris at pH
8 in a 50 μL volume and vortexed for 30 minutes at room temperature. After CoARNA conjugation, the remaining iodo groups were reacted with excess βmercaptoethanol, followed by extensive washing for multiple rounds with 40 bed
volumes of water, 4 M NaCl, and 8 M urea while heating briefly at 95 °C and
vortexing. The urea and salt were removed from the beads by rinsing with excess
water, and the remaining radioactivity was determined to be 300 counts per
minute (cpm) by liquid scintillation counter. This measurement is very low and
near the detection limit of the liquid scintillation counter, indicating that only
approximately 10% of the RNA was captured on the beads. The estimated yield
of captured CoA-RNA presented a problem with the overall protocol. If only 10%
was expected to be captured, the hopes for isolating pools of CoA-RNA from
bacterial total RNA extracts may be impossible, especially when considering the
low estimated amounts of CoA- and thioester-CoA-RNA in the cell. While the
TGSIA did appear to capture some RNA, the estimated capacity of 4 mM was not
reached by the trial with labeled CoA-RNA.
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Figure 5.4 Iodo Capacity by β-Mercaptoethanol.
A, UV absorbance spectra showing increase at 226 nm indicating release of iodo from TGSIA beads over time in the
presence of B-mercaptoethanol, where each line represents 5 minutes from 0 to 25 minutes total. B, UV absorbance
spectra showing increase at 226 nm indicating the release of iodo from ULIA beads in the presence of B-mercaptoethanol
over time, where each spectra represents 5 minutes from 0 to 10 minutes total. C, UV absorbance spectra showing
increase at 226 nm indicating release of iodo from ULLI beads over time in the presence of B-mercaptoethanol, where
each line represents 5 minutes from 0 to 20 minutes total.
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5.2.2 Capture of CoA-RNA by ULIA
The commercially available UltraLink Iodoacetyl (ULIA) resin from Thermo
was acquired to replace the TGSIA with the expectation that the capture yield
would be much higher. To test for its capacity 20 μL of ULIA were washed with
water and incubated in 10 mM Tris (pH 8) and 0.8 mM β-mercaptoethanol at
room temperature while monitoring the absorbance at 226 nm. Using the same
extinction coefficient of 14 mM-1 cm-1, the ULIA beads were determined to have a
capacity of approximately 30 mM (Fig. 5.4B). In addition to the higher capacity,
the iodo was completely released within minutes of the initial contact with the
higher pH buffer and β-mercaptoethanol, therefore making ULIA a much better
candidate for CoA-RNA capture.

Scheme 5.2 Internal Labeling of CoA-RNA by γATP.
CoA-RNA is generated by IVT in the presence of depCoA (1). RNA oligo Adp is labeled by kinase reaction with γ32P-ATP
(2) and used as donor in a ligation reaction with CoA-RNA (3).
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CoA-RNA was internally labeled as previously described (Scheme 5.2)
and conjugated to 100 μL ULIA beads in 20 mM Tris (pH 8) for 7 minutes at room
temperature. After initial incubation, remaining iodo groups were blocked by the
addition of excess β-mercaptoethanol for 7 minutes at room temperature. The
beads were then washed extensively in a process similar to the TGSIA beads
and the remaining radioactivity was determined by liquid scintillation counter to
be approximately 30% of the input CoA-RNA. The amount of captured RNA is
much higher than previously observed for the TGSIA beads in one quarter the
amount of time. Considering the CoA-RNA was not purified from pppRNA
generated during IVT and tends to be optimally a 50% yield mixture (Scheme
5.2), the estimated RNA captured is a promising figure for our purposes (Huang
2003a).
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Figure 5.5 Radiolabeling of CoA-RNA by Ligation.
Autoradiograph showing the internal labeling of CoA RNA, where a short RNA adapter is labeled by T4PNK with γ-32PATP and then ligated to the 3’ end of CoA-RNA.

Despite the higher capacity for CoA-RNA capture, the ULIA beads had an
inherent problem with their structure. Capture of CoA-RNA is irrelevant if the
RNA cannot be released from the resin. Iodo-functionalized resin is
advantageous because the formation of a stable thioether bond with CoA is a
hard bond to break in comparison to disulfide bonds that can be reduced in the
presence of DTT solutions. Therefore the release of CoA-RNA from iodofunctionalized resin is dependent on enzyme activity such as the murine Nudt7
enzyme described in the previous chapter. This enzyme is quite capable of
hydrolyzing CoA and CoA thioesters with good efficiency, and was shown to be a
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suitable candidate for our RNA release protocol. When beads conjugated with
internally labeled CoA-RNA were incubated with 1X Nudix buffer and 16 μM
Nudt7, however, no RNA was observed to be released as indicated by a lack of
radioactivity in the reaction solution.
The ULIA beads only have a short distance between the reactive iodo
group and the polyacrylamide bead itself (Fig. 5.2B), which seemed to create
problems for the enzyme hydrolysis of CoA. Therefore a photocleavable linker
was added to the ULIA resin to act the primary releasing of CoA (Fig. 5.2C and
Scheme 5.3). Upon photocleavage, the CoA can then be hydrolyzed by Nudt7 in
solution to yield the 5’-pRNA required for the subsequent processing and
sequencing protocols (Scheme 5.1, Reactions 3B and 4).
5.2.3 CoA Capture by Photocleavable ULLI and ULPCIA
The ULIA resin with the added photocleavable group and a terminal iodo
group (ULLI) was tested for capacity by incubating 20 μL resin with 10 mM Tris
(pH 8) and 0.8 mM β-mercaptoethanol at room temperature while monitoring the
absorbance at 226 nm. Using the extinction coefficient for I- at 226 nm, the
capacity was determined to be around 2.5 mM. The observed 10-fold decrease in
estimated capacity of ULLI in comparison to the parent ULIA could have resulted
from the manual preparation. The capacity, while low, should still be enough to
capture the CoA-RNA given its small estimated concentrations by Kowtoniuk et
al. (2016), and the release of the iodide was noted to occur quickly within 10
minutes of incubation (Fig. 5.4C). Considering the release of the target molecule
is as important as the high capacity for capture, the beads needed to be tested
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for their photocleavage efficiency. Aliquots of 10 μL of different iterations of ULIA
derivatized with photocleavable linkers, ULLI and ULPCIA (Fig. 5.2C and D),
were conjugated with 1 mM CoA in the presence of 20 mM Tris (pH 8) at room
temperature, vortexing for 5 minutes by hand immediately upon addition of the
RNA/Tris solution and then another hour afterwards. After conjugation, the
absorbance at 260 nm was tested using the extinction coefficient of adenosine
15 mM-1 cm-1 to determine the amount of CoA not conjugated to the beads. Upon
washing, unconjugated CoA continued to be quantified in addition to released
iodide determined by the absorbance at 226 nm in order to quantify the capacity
of the beads. Capacity was calculated by adding the difference between the
initial CoA and CoA that was washed out added to the amount of iodide released
in solution. The ULLI beads were determined to have a 14 mM capacity with 12
mM CoA estimated to be conjugated, while the ULPCIA beads were determined
to have a capacity of 23 mM with 15 mM CoA estimated to be conjugated.
Each resin was split into two aliquots, where one would be treated with 16
μM Nudt7 in 1X Nudix buffer for 30 minutes at 37 °C, and the other exposed to a
365 nm UV lamp for 5 minutes on ice. The resulting solutions were tested for
their absorbance at 260 nm to detect released CoA, and the ULPCIA, but not the
ULLI beads, were noted to have released CoA upon exposure to UV light (Fig.
5.6A). The released fragments were analyzed by electrospray ionization mass
spectrometry (ESI-MS) where the expected photocleavage product of 824.14 Da
was observed as a peak with m/z of 823.09 representing the [M-H+] species, as
well as a peak with m/z of 411.16 representing the [M-2H+]/2 species (Fig. 5.6C).
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Photocleavage reactions were quantified by the absorbance of released CoA at
260 nm, and it was determined that approximately 1.5 mM CoA was released
after 5 minutes of UV exposure, and another 1.4 mM released after 10 minutes of
exposure. Based on the initial 1 mM CoA concentration in the reaction volume of
120 μL and the bead volume of 5 μL, the capture of 100% of the available CoA
would result in a 24 mM concentration on the beads. Given the estimated amount
of conjugated CoA to be 15 mM, and the combined 2.4 mM CoA observed to be
released upon photocleavage, the ULPCIA beads were determined to release
approximately 16% of the total possible CoA.
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Figure 5.6 CoA Release from ULLI and ULPCIA.
A, UV absorbance spectra of CoA released by photocleavage from ULLI beads (square boxes) and ULPCIA beads (x)
after 5 minutes (solid line) and 10 minutes (dashed line). B, UV absorbance spectra of 3’, 5’-ADP released by overnight
treatment of ULLI (box) and ULPCIA (x) by Nudt7. C, ESI-MS of photocleavage product from ULPCIA beads.

The method of photocleavage was apparently unsuccessful for the ULLI
beads altogether, for no observable CoA appeared in the reaction solution after
photocleavage (Fig. 5.6A). The reasoning for the low photocleavage could be
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due to the inability for the photons to penetrate the polyacrylamide resin
completely, and therefore only the plane exposed to the UV light was capable of
reacting. The aliquot of CoA-conjugated ULLI and ULPCIA beads that were
subjected to Nudt7 digestion were also analyzed by UV absorbance at 260 nm
for the 3’, 5’-ADP released, and it was determined that 3 mM ADP was released
from the ULLI beads, and no detectable ADP was released by Nudt7 hydrolysis
from the ULPCIA beads. The two resins were incubated overnight in the same
Nudt7 reaction conditions at 37 °C, and subsequently another 3.8 mM ADP was
seen to be released from the ULLI beads for a total of 6.8 mM, and 3.2 mM ADP
was released from the ULPCIA beads (Fig. 5.6B). Given the estimates for CoA
conjugated to each resin, Nudt7 was able to hydrolyze 56% of the CoA from the
ULLI beads in 16 hours at 37 °C, and 12.5% of the CoA from the ULPCIA beads
in the same amount of time (Table 5.1).

183

Scheme 5.3 ULLI Synthesis.
The UltraLink Iodoacetyl resin (1) was reacted with the PC-linker (2) with two nitrophenyl groups flanked by units of
4,7,10-Trioxa-1,13-tridecanediamine (TOTDDA), with one of the two TOTDDA groups conjugated to a succinate and
cystamine to leave a free thiol that can react with the iodo from (1) forming a thioether linkage. The resulting molecule (3)
was then combined with succinimidyl iodoacetate (SIA, 4) to leave a free iodoacetyl group at the terminus opposite the
resin (5).
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Table 5.1
CoA Released from Iodo-functionalized Resins
Resin

Release Method

Time

% Released

ULIA

Nudt7

30 min

-

ULLI

Nudt7

30 min

25%

Overnight

56%

30 min

-

Overnight

12.5%

ULPCIA

Nudt7

ULLI

UV

10 min

-

ULPCIA

UV

10 min

16%

The amount of CoA conjugated to each resin was determined to be less
than the capacity. The most efficient resin for capturing CoA was the ULLI resin,
in which approximately 86% of the available capacity was actually conjugated
with CoA. Unfortunately, the photocleavage from the ULLI resin failed, and Nudt7
could only hydrolyze 56% of the conjugated CoA when incubated for an
extended amount of time. The incubation period for Nudt7 based on previously
characterized enzyme kinetics infer that hydrolysis should be completed at these
concentrations in under 30 minutes (Gasmi and McLennan 2001). Therefore
based on the fact that 30 minutes and 16 hours incubation yielded the same
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amount of hydrolyzed CoA, it is likely that the enzyme cleaved the maximum
possible CoA in the first few minutes of the reaction with the beads, and the
remaining time spent in incubation yielded no results. During the incubation of
the enzyme with the beads, the substrate is not in solution but rather in
suspension where the beads themselves settle over time and can exclude the
enzyme from contact with its substrate. Continuous agitation of the resin should
be carried out in order to keep it in suspension and maximize the contact of the
enzyme with the beads, thereby increasing the yield of hydrolysis. The ULPCIA
beads, on the other hand, proved to be a poor resin for use with Nudt7
hydrolysis. Considering the design of the resin was not for Nudt7 treatment but
for photocleavage, this discrepancy is understandable. The lack of Nudt7
hydrolysis from this resin may come from the extended hydrophobic region of the
photocleavable linker, which may have interfered with enzyme binding of the
substrate, or caused non-covalent interaction with the enzyme preventing its
activity.
5.2.4 Ligation Optimization
The CoA-RNA processing protocol was prepared separately from the
capture protocol for optimization purposes. Because of the amount of steps
involved in the entire process, it was considered unfeasible to begin with bead
conjugation and analyze efficiency at the final step of PCR. The process of
optimizing CoA-RNA ligation would be undertaken first. The principle of adapter
ligation to CoA-RNA is to add priming sites that can later be amplified by PCR
after reverse transcription (Scheme 5.4). The priming sequences must be
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distinctly different from the sequence of the CoA-RNA or else the PCR will be
problematic. Considering that the sequences are wholly unknown, there is much
uncertainty in the design of adapters. The CoA-RNA would ideally be ligated on
its 3’ end by a phosphorylated adapter that contains a 5’-phosphate, and itself is
blocked from self-ligation by either sodium periodate oxidation of the diol
(Scheme 5.5) or by amine derivatization which can be arranged when ordering
synthetic RNA. After the 3’ adapter ligation, reverse transcription can be carried
out using a primer complementary to the 3’ adapter. The resulting cDNA could
then be further ligated to another 3’ adapter, considering the 3’ end of the cDNA
is the complement to the 5’ end of the CoA-RNA. Following the second ligation,
PCR would be used to amplify the cDNA library, and the resulting products can
be submitted for NGS library preparation.
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Scheme 5.4 Capture Protocol Using Double Ligation.
Capture protocol using double ligation. RNA captured by resin and released by Nudix hydrolysis (1) leaves a 5’-pRNA
capable of 5’ ligation (2) to a 5’HO-adapter. The subsequent ligation of the 3’ adapter (3) is problematic due to the
possible multimer formation by the 5’-pRNA adapter used without blocking its 3’ end. RT (4) after ligation can be used to
generate cDNA that can then be amplified by PCR (5) to generate the NGS library.

Adapter ligation is key when capturing and amplifying RNA of unknown
sequences. A typical mRNA identification protocol would involve RT using a
poly(dT) primer that would prime the poly(A) tail of mRNA. Considering the lack
of knowledge of these CoA-RNA sequences and the probability for their lack of a
poly(A) tail, adapters with high ligation efficiency should be used that will serve
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as priming sites for RT. Two RNAs were generated to test the efficiency of
periodate treatment of RNA that serves to block RNAs from multimerization via
intermolecular self-ligation (Scheme 5.5). A 40 nt RNA (40mP) was generated by
IVT in the presence of AMP in a 4 molar excess to ATP. The increase of AMP in
the reaction mixture should result in a 4:1 ratio of 5’pRNA to 5’pppRNA. Similarly,
an 80 nt RNA (80ppp) was generated using standard IVT conditions to produce a
homogeneous stock of 5’pppRNA. After purification of both by 8% denaturing
PAGE, 40mP was treated with 10 mM NaIO4 for 40 minutes on ice in the dark to
oxidize the cis-diol of the 3’ terminal ribose into a dialdehyde, and the reaction
was quenched by ethanol precipitation. The resulting RNA p40cho was combined
in equimolar amounts of 80ppp in a ligation reaction at 37 °C for 50 minutes and
the reaction was visualized by 8% denaturing PAGE (Fig. 5.7A). The success of
the periodate treatment is noted by the single band resulting from ligation that
represents the 120 nt RNA. In this model, the 80ppp RNA represents our CoARNA which is incapable of 5’ ligation, and the p40cho represents our adapter to
be ligated to the 3’ end of the CoA-RNA.
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Scheme 5.5 Capture Protocol Using RNA Oxidation and Double Ligation.
Capture protocol using RNA oxidation and double ligation. Similar to the previous schemes, where captured RNA is
released by Nudix digestion (1) followed by ligation of the 5’ adaptor (2). Here, the 3’ adaptor is subjected to oxidation by
periodate to generate a dialdehyde on the 3’end of the 3’-adaptor (3) to prevent self-ligation and multimerization upon 3’adapter ligation (4). Removing such multimers allows the cleaner success of RT (5) and PCR (6) to generate the NGS
library.
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Figure 5.7 Adaptor Ligation.
A, Ligation of periodate-treated 5’-monophosphate RNA (p40cho) and 5’-triphosphate RNA (80ppp). B, Ligation of
adenylated pDNA adapter Adp3 at increasing concentrations with in vitro transcribed adapter T7Ad.

The ligation of the 3’ adapter in some miRNA capturing protocols (rapid
amplification of cDNA ends, or RACE) involves the use of a DNA adapter, which
is still capable of ligation to a ssRNA molecule at a lower efficiency. The
differences in efficiency of reactions in solution and on solid surfaces such as
resin can be attributed to the diffusion barriers that prevent the interaction of the
substrates and enzyme. In the case of ligation, the ligase enzyme must come in
contact with the donor molecule (the adapter), the acceptor molecule (the CoARNA), and ATP in order for the reaction to be catalyzed. Using an adenylated
adapter is a way of increasing the efficiency by relieving the reaction’s need for
ATP. A short 20 nt 5’-pDNA oligo for this purpose (Adp3) was obtained from IDT
modified with a 3’-amino modification to block multimerization during ligation. The
DNA was incubated with 30 mM MgCl2 and 120 mM adenosine
phosphoimidazolide (ImpA) at 50 °C for 3 hours and purified by an Amicon 3K
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spin column followed by ethanol precipitation. The resulting product was resolved
on 10% denaturing PAGE from which it was purified and combined with an IVTproduced adapter (T7Ad) in a ligation reaction at 37 °C for 1 hour (Fig 5.7B).
Increasing amounts of the adenylated pDNA Adp3 increased the single
ligation product with T7Ad in the absence of ATP as shown in Figure 5.7B,
therefore indicating the adenylation of Adp3 had been successful. Despite the
success of ligation with the adenylated DNA oligo Adp3 with ligation, further
experiments were carried out to determine which of a group of different short
synthetic RNAs would give the best ligation efficiency. Ten different samples of
synthetic RNA were treated with T4PNK to add a 5’-phosphate group to become
ligation donors, and were subjected to ligation reactions to determine reaction
efficiency based on the degree of intramolecular ligation that occurred. Based on
the sequences of the RNA and the observed ligation efficiencies, the RNA GL1a
was determined to be the best suitable adaptor.
5.2.5 Reverse Transcription Optimization
The process of RT-PCR would require some optimization when
considering its success was coupled to the success of adapter ligation. To first
test the efficiency of RT, a known RNA sample that is an 800 bp fragment of
EGFP mRNA was generated via IVT in the presence of depCoA to generate
CoA-EGFP and purified from the reaction mixture using an M100 spin column.
The CoA-RNA was ligated with adenylated Adp3 and purified by an M100 spin
column, treated with 16 μM Nudt7 for 1 hour at 37 °C, and immediately ligated to
T7Ad for 30 minutes at 37 °C. A parallel reaction was carried out simultaneously
192

without Nudt7 reaction to be used as a negative control. Both RNA samples were
subjected to RT using primers complementary to the 3’ adapter Adp3, followed
by PCR on the resulting cDNA with primers complementary to both adapters.
The resulting agarose gel indicated that while PCR had been successful, the 800
bp target band was not amplified, but instead a smaller band below 150 bp had
appeared in both experimental samples and control samples where RT was not
carried out (Fig. 5.8A).
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Figure 5.8 RT-PCR of Adapter-Ligated RNA.
A, Results of PCR on CoA-EGFP-RNA sample after RT along with controls (-RT). B, Results of PCR on CoA-EGFP-RNA
sample with and without RT using primers specific for the sequence itself (Bap12/SP10) or primers requiring adapter
ligation for success (Bap12/Adp21). C, Results of PCR on CoA-EGFP-RNA sample after with or without RT treatment
after the removal of the dsDNA template for IVT by restriction digestion.

The PCR was repeated on obtained cDNA with different primers that were
complementary to the EGFP sequence (Bap12 as forward primer, SP10 as
reverse primer), as well as one primer complementary to the EGFP sequence
(Bap12 forward) and another complementary to the adapter (Adp21 reverse),
and the resulting agarose gel indicated a band at the expected size of
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approximately 900 bp (Fig. 5.8B). Given the appearance of the band in a
negative control that did not undergo RT and the additional lack of amplification
using the Adp21 primer, it seemed the RT did not succeed due to the failure of
the initial ligation reaction. The bands observed in Figure 5.8B likely resulted
from the presence of the dsDNA template for IVT that was never purified from the
reaction mixture for this testing. RNA generated by IVT is typically purified by 8%
denaturing PAGE that can resolve down to a single nucleotide, but the CoAEGFP RNA was so large that this method became unfeasible. Therefore the
M100 spin column used instead to purify the RNA from the buffer and enzyme
was not enough to discriminate against the dsDNA template that is larger due to
the incorporation of the promoter sequence.
The process was repeated excluding Nudt7 after the double digestion of
CoA-EGFP RNA with AluI and HaeIII restriction enzymes to remove the dsDNA
template from the RNA solution. After ligation of adenylated Adp3 and RT using
its complementary primer Adp21, PCR with a specific forward primer Bap12 with
the reverse primer Adp21 was carried out to produce the expected 800 bp EGFP
band (Fig. 5.8C). The lack of a band in with from control samples that did not
undergo RT in addition to the band produced using Adp21 as a reverse primer
indicated that the 3’ adapter ligation was successful, as was the subsequent RT
(Fig. 5.8C). While the 3’ adapter was shown to be ligated when the process was
repeated, the secondary ligation of the 5’ adapter remained problematic. This
could have been due to the requirement for Nudt7 digestion to be complete
before the ligation could occur. Nudt7 digestion in solution is a quick reaction with
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low concentrations of substrate (< 1 mM), and therefore should not be the issue.
The secondary ligation reaction did take place directly following Nudt7 digestion,
and both were carried out in the same buffer. Nudt7 activity was testing in the
ligation buffer and CoA hydrolysis was not observed to be impeded, and Nudt7
was also demonstrated to have no activity against ATP, thereby again the Nudt7
hydrolysis of CoA was not likely the problem. It seemed more feasible that the
problem was the ligation itself, as it has been known to occur at a low efficiency
depending on the sequences being used (Munafo and Robb 2010). Such
reasons warranted earlier studies to optimize ligation conditions to maximize the
efficiency before moving forward. However considering that the CoA-RNA
sequences are unknown, the 3’ adapter ligation can never truly be optimized due
because of the variable of the 3’ terminal nucleotide. On the other hand, the 5’
ligation should be easier to predict due to the fact that the donor will always be
adenosine. Unfortunately, previous studies have shown A to be a poor donor in
T4 RNA Ligase reactions, with only ~16% of the activity as cytosine (Romaniuk
et al. 1982).
The ligation of two adapters to the CoA-RNA following Nudt7 digestion
was determined to be a problematic approach to the capture protocol. Despite
Nudt7 maintaining activity in a variety of buffers, the ligation of the 5’ adapter to
the RNA was never successful based on the lack of results from RT-PCR using
primers complementary to both adapters. For this purpose, the template-switch
method of RT was employed (Scheme 5.6). As stated previously, known
sequences flanking the unknown CoA-RNA sequences are required for the
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success of PCR amplification of the cDNA resulting from RT. While these
sequences can be added to the target RNA through ligation, the template-switch
(TS-RT) mechanism of reverse transcriptase can be used to add a known
sequence to the 5’ end by itself. Once reverse transcription is primed and the
enzyme reaches the end of the RNA template, it extends the cDNA with 3
cytosine residues (Ko and Lee 2006). Carrying out the RT reaction in the
presence of an addition DNA oligo containing 3 guanosine residues at its 3’ end
allows this oligo to anneal to newly generated cDNA with terminal cytosines, and
therefore the enzyme continues to generate the single cDNA by switching
templates from the original RNA to the secondary adaptor known as the TS oligo
Adp26.

197

Scheme 5.6 Capture Protocol Using Template Switch-RT.
After the capture of CoA-RNA (1) and extensive washing of nonspecifically interacting RNA from the resin (2), the CoARNA is released from the beads by Nudix digestion (3). The following molecule is adenylated by poly(A) polymerase (4)
and subjected template-switch RT (5) to add the adapter sequences for PCR (7) and preparation of the NGS library.

In addition to the TS-RT protocol, a ligation-free protocol for the addition of
the 3’ adapter was adopted. Using the highly efficient enzyme poly(a)
polymerase, the captured RNA can be tailed with multiple adenosines, and then
a reverse primer to anneal to this tail can be used to initiate RT. Because this
does not satisfy the installment of a known priming sequence for downstream
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PCR amplification, a primer containing a poly(dT) region downstream of a known
sequence can be used so that the subsequent cDNA contains a priming region
followed by a patch of thymines for PCR amplification of the unknown CoA-RNA
sequence (Scheme 5.6). Due to the inherent problems with amplifying DNA
homopolymers with DNA polymerase, the poly(dT) region of the primer will be
limited to a lengths under 30 nt by design, and be followed by the sequence VN,
where V is any nucleotide besides T, and N is any nucleotide (known as Adp13).
The Adp13 primer structure is therefore a known priming sequence for later PCR
followed by 12 thymines and VN, allowing the annealing of the primer to the
interface of the original RNA sequence and the additional poly(A) tail and the
addition of an adapter sequence to the resulting cDNA. The exclusion of ligation
in the RNA processing protocol was therefore expected to increase its overall
success considering ligation is a problematic and inefficient process.
A 150 nt RNA was transcribed via IVT in the presence of depCoA and
purified by an M30 column to produce 150 nt CoA-RNA. After restriction enzyme
treatment to remove the DNA template, the CoA-RNA was subjected to
polyadenylation by poly(a) polymerase and RT using Superscript IV Reverse
Transcriptase (Thermo) in the presence a reverse poly(dT) primer Adp16 and the
TS-primer Adp26 followed by PCR amplification using primers PCF1 and PCF2
that are complementary to the adapter sequences present in Adp16 and Adp26,
respectively. Early experiments using the template switch RT protocol with
MMLV (Promega) yielded a mixture of bands, due to nonspecific interactions of
the TS-primer with the template as noted by other investigators (Matz et al.
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1999). The appearance of off-target products is a problem, considering that they
may amplify more efficiently than true captured cDNA, and there is no way of
distinguishing these artifacts from the captured CoA-RNA until after the samples
have been sequenced.
The temperature of RT needed to be increased in order to reduce the
nonspecific activity of the TS oligo, and for this the more thermostable enzyme
Superscript IV Reverse Transcriptase (SSIV) was obtained from Thermo.
General RT protocols dictate that denaturing of secondary structure and
annealing of primer to template need to occur outside of the presence of the RT
enzyme and the buffer which contains Zn2+ at a high pH. If these are put in the
presence of the captured RNA for the 10 minute denaturation step at 70 °C, the
RNA will likely be hydrolyzed. As such, after the denaturation, the samples are
generally put on ice to cool before the addition of the buffer and enzyme, and
afterwards RT proceeds. When the efficiency of the RT protocol was tested by
varying the extension temperature from 46 °C to 70 °C as well as the method of
enzyme addition, the ideal conditions that minimize off-target products while
maximizing target cDNA yield was determined to be direct addition of the enzyme
following RNA denaturation and annealing followed by incubation at 60 °C (Fig.
5.9). As temperature of incubation increases, the amount of off-target (noted as a
smear between 75 and 150 bp) decreases. The amount of off-target product
continues to decrease as the incubation temperature rises above 60 °C, however
the total yield of cDNA tends to decrease as well. The direct addition of enzyme
without cooling the reaction mixture on ice also clearly shows a better total yield
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in addition to a more favorable target to off-target product ratio. Therefore the TSRT protocol was determined to be optimal at 60 °C with the direct addition of the
enzyme.

Figure 5.9 Template Switch-RT Optimization.
Different parameters of template-switch RT (TS-RT) were tested in order to optimize the total target cDNA generated as
well as increase the ratio of target to off-target by-products. Samples were incubated at various temperatures during the
RT reaction and were composed by the addition of enzyme and buffer following denaturation either after cooling on ice or
by direct addition. The expected product of 300 bp and the off-target products between 75 and 150 bp were visualized
after 30 cycles of PCR following RT.

Based on the troubles noted in the specific capture protocol of Cahova et
al. (2009), the observed artifacts generated by the use of template-switch RT
were problematic. The issue of purity up to this point has been of paramount
importance when optimizing capture and release protocols. The purity during
RNA processing and generation of the NGS library is something that should not
be compromised, for these small sized off-target PCR products can quickly
overtake the actual targeted library during PCR, and the subsequent NGS results
can be tainted. While the NGS protocols do offer quite a depth of sequencing on
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the order of tens of millions of reads, the submission of high quality NGS libraries
will result in high quality sequencing results. This should be the overarching
purpose of the CoA-RNA protocol, and it should not be compromised by DNA
amplification techniques, of all things.
5.2.6 E. coli CoA-RNA Capture
Once all of the components of the CoA-capture and RNA processing
protocol were optimized individually, the template-switch RT protocol was
decided against. While convenient due to the exclusion of low-efficiency ligation
reactions, the additional artifacts resulting from PCR cannot be tolerated if it is
possible to avoid them. In light of the previously stated determination for the
utmost purity and quality of the CoA-RNA sample, the previously assessed resins
were decided against as well, for they could only at the highest estimate facilitate
56% release of the CoA-RNA with additional enzyme treatments. Instead, the
thiol sepharose 6B resin was decided upon for the CoA-RNA capture (Scheme
5.7). While incomparably simpler than any of the other resins tested, it has been
routinely used in the past to purify CoA-RNA from a heterogeneous pool of RNA
from IVT protocols for SELEX as well as other purposes (Coleman and Huang
2005, Coleman et al. 2005, Coleman and Huang 2002).
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Scheme 5.7 Capture Protocol Using Single Ligation and Thermostable RTase.
The CoA-RNA is captured by disulfide bond formation (1) to the resin, and the nonspecifically interacting RNA is washed
away (2). Upon the release of the RNA by the addition of reductant (3), the CoA-RNA is converted to 5’pRNA by Nudix
hydrolysis (4) so that the 5’ adaptor can be ligated (5). A poly(A) tail is added (5) to act as a seeding region for the RT
primer AdpR in order to add the reverse priming sequence (6) so that the resulting cDNA can be amplified by PCR (7) to
generate the NGS library.

Total RNA isolated from E. coli High-Control BL21(DE3) cells was purified
by thiol sepharose resin to capture the free thiol group with a disulfide bond
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(Scheme 5.8). The washing of the column with DTT after capturing to elute is a
characteristically simpler method of thiol purification, and has previously been
used to purify CoA-RNA from triphosphate RNA made through IVT (Huang
2003a). The isolated total RNA from E. coli was bound to thiol sepharose
(Column A) in the presence of 70 mM Tris (pH 8) while collecting the flowthrough. The column was washed extensively to remove nonspecifically bound
RNA with excess 3 M NaCl, 4 M sodium acetate (NaAc, pH 5.2), 4 M urea, and
water, followed by three rounds of excess 3 M NaCl and water, and then 3 M
NaCl, 4 M NaAc pH 5.2, 4 M Urea, and water. After draining the column, 0.5 mL
of 100 mM DTT in 100 mM Tris (pH 8) with 10 μg glycogen as a carrier was
added to the column to release the CoA-RNA. The column was washed with the
addition of 400 μL 0.4 M NaAc (pH 5.2) and 10 μg glycogen, and the collected
flow-through was precipitated by the addition of ethanol. The initial flow-through
collected was devoid of CoA-RNA, but still contained some thioester-CoA-RNA.
Therefore the initial flow-through was treated with 50 mM hydroxylamine and 20
mM DTT for 15 minutes at room temperature to react with the thioester and
release the free thiol.
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Scheme 5.8 E. coli CoA-RNA Capture.
Total RNA from E. coli was captured by thiol sepharose resin (1). Flow-through from column was collected for later (2).
Column was washed and CoA-RNA released by addition of DTT (3) as sample A. Flow-through (2) was treated with
hydroxylamine to release the free thiol (3) and subjected to another column (5). Flow-through was collected (6) for later.
Column was washed and CoA-RNA was released by addition of DTT (7) as thioester-CoA-RNA sample B. Flow-through
(6) was subjected to another column, washed, and released (7, 8) as background RNA sample C. Each product A, B, and
C was subjected to another column (9, 10, 11), and the final products A’, B’, and C’ denoted by hashed box were
processed for NGS library preparation.

The newly generated CoA-RNA, considered to be thioester-CoA-RNA
before treatment, was then ethanol precipitated to remove residual salts and DTT
before loading to a new thiol sepharose column (Column B), where it was
washed and eluted with 100 mM DTT and 100 mM Tris (pH 8) the same as
Column A. The initial flow-through of the Column B was retained in order to be
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loaded to a third thiol sepharose column (Column C) for similar washes and
purification, and would serve as a negative control for subsequent RT-PCR
experiments. The RNA purified from thiol Columns A, B, and C were each
subjected to a secondary thiol sepharose column to further enrich CoA-RNA from
nonspecifically purified RNA (Columns A’, B’, and C’, respectively). The eluted
CoA-RNA was ethanol precipitated and recovered in water.
Recovered CoA RNA samples were treated with 16 μM Nudt7 for 1 hour
at 37 °C and then ligated to the 5’ adapter GL1a. While previous tests with T7Ad
had shown promising results, GL1a was of a similar efficiency and a much higher
abundance considering it was synthetic and in a 0.2 M stock in contrast to T7Ad
being made in vitro and in a stock of 30 μM after purification. After RT of the
ligated RNA with the Adp16 RT primer using the optimized parameters for SSIV,
PCR was carried out using primers PcR1 and Adp2 that are complementary to
the 3’ adaptor installed by RT and the GL1a 5’ adaptor, respectively. The result
was a strong band in each sample around 150 bp (Fig 5.10A). This result was
peculiar given that only results from Columns A and B should have yielded a
PCR product, and the product observed is much higher intensity than expected
given previous estimates of CoA- and thioester-CoA-RNA abundance (Kowtoniuk
et al. 2009). Given the size of the adapter sequences, the range of RNA isolated
by this method was estimated to be 100 bp and below, which did not match
previously isolated NAD-RNA sequences of near 300 bp (Cahova et al. 2015).
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Figure 5.10 RT-PCR on CoA-RNA Capture from E. coli total RNA.
A, RT-PCR of CoA-RNA captured by thiol sepharose column. B, PAGE of captured RNA compared to tRNA.

The isolated RNA was run on 8% denaturing PAGE to visualize the RNA
before cDNA and determine if the bands observed from previous PCR were
artifacts or if there was in fact isolated CoA-RNA of specific sizes (Fig. 5.10B).
RNA from samples A’ and B’ was easily visualized, and both had similar patterns
of migration showing four distinct bands near the front as well as two bands near
the wells. There were 4 bands present in the A sample that were not in the B
sample that were of low intensity, indicating that the two treatments of the
samples did result in isolation of different RNA populations. The intensity of the
RNA bands, however, was quite confusing given the picomolar amount of RNA
estimated to be isolated. Upon further investigation, similarities of the isolated
RNA to tRNA samples were noticed (Fig. 5.10B), and it was concluded that the
CoA-RNA capture protocol by the thiol sepharose column had actually captured
207

thiol-modified tRNA such as 2- and 4-thiouridine (s2U, s4U) in addition to CoARNA (Fig. 5.11) (Leipuviene et al. 2004). From the gel it appeared that the thiolmodified tRNA was the majority of the RNA captured.

Figure 5.11 Thiol-modified RNA found in tRNA.

Despite the lack of homogeneity produced by the CoA-RNA capture,
Figure 5.11B illustrates that RNA of various sizes were isolated that cannot be
attributed to tRNA contamination. Previous investigations produced NAD-RNA of
around 300 nt in length, which was a consequence of the capture protocol that
employed a terminal transferase activity and annealing between few cytosines
and guanine for a splint adapter ligation (Kowtoniuk et al. 2009). Such a method
has the similar drawbacks to template-switching mechanism, as the annealing
hinges upon the terminal cytosines of the transcript and guanosines of the
adaptor for success and fidelity. As a result, the relatively short-length sRNA
were seen as enriched, and other RNAs that were not previously-annotated
sRNA were determined to be 5’ fragments of known mRNA related to
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metabolism. Considering that method employed selected for RNA of a certain
size, its unknown whether these shortened mRNA fragments occur in this form
within the cell or not. Based on Figure 10B, it seems there are larger RNA are
slightly larger than the 90 nt tRNA, and some that are significantly larger than
tRNA, including a portion that is barely able to enter the 8% polyacrylamide gel.
This indicates that CoA could be attached to whole mRNAs and not just 5’
terminal fragments. In addition, there is the possibility that CoA-RNA was
captured of the same size as tRNA but was masked on the gel due to the
intensity of the tRNA itself. Before pursuing the sequencing of these RNAs, it is
important to purify them to heterogeneity. Otherwise the sequence reads would
be overwhelmingly dominated by the tRNA impurities.
5.3 Conclusions
The CoA-capture protocol was proven effective, but there were still pieces
that required optimization. In order to exclude the enrichment of the relatively
high concentrations of tRNA in the capture method, the Nudt7 enzyme would be
a necessity. Rather than using the thiol sepharose column to discriminate thiolcontaining RNA from others, formation of more stable covalent bonds would be
required so that Nudt7 hydrolysis could occur and specifically release tRNA.
Considering the problems encountered with the capture efficiency of previous
iterations of the iodo-functionalized resins tested above, another type of
functional group with a more amenable linker would be required for both the
CoA-RNA capture and the Nudt7 hydrolysis to be effective.
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Due to the previous challenges with the capture of CoA-RNA by the highly
reactive iodo functional group affixed to solid state resin, a better system for CoA
capture could be designed to be carried out in solution. The use of a biotin(PEG)n-maleimide molecule would be advantageous for this purpose due to the
formation of a thioether bond upon the reaction of the maleimide with the free
thiol of CoA in pH ranges lower than allowed for iodo-sulfide conjugation (Fig.
5.12). The lower pH would offer increased stability for the RNA and allowed the
increased contact time with the resin to maximize conjugation efficiency. After
reaction, the RNA itself could be ethanol precipitated to remove any unreacted
linker, and the biotin group can be captured by streptavidin resin. The presence
of the linker group between the CoA-RNA and the streptavidin should give
enough space for Nudt7 hydrolysis to occur, therefore specifically releasing the
CoA-RNA as 5’-pRNA that is readily ligated to a 5’ adapter and ready to undergo
RT-PCR.
Previous attempts at Nudt7 hydrolysis of resin functionalized with PEG
linkers resulted in a low enzyme activity (TGSIA), and it was uncertain if PEG
was interacting with the enzyme itself. The use of other organic linkers to create
space between substrate and solid surface would create solubility problems, as
these RNA captures and enzyme hydrolyses need to occur in aqueous solutions.
Therefore PEG, or PEG-like linkers such as TOTDDA (4,7,10-trioxa-1,13tridecanediamine) used in the ULPCIA resin seem to be a good candidates for
this purpose, and the length of the PEG linker will be a crucial component to tune
in order for the CoA hydrolysis to be optimized. While the presence of PEG
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groups to a certain extent keeps the complex soluble, they greatly affect the
solubility of the Biotin-PEG-Maleimide-CoA-RNA complex during ethanol
precipitation. The principle of ethanol precipitation is that in high concentrations
of salt and in organic solvent such as ethanol, the ionic bonds between the ionic
compounds become strong enough that the RNA precipitates from solution. PEG
is known to enhance the solubility of organic compounds through the exclusion of
water molecules, and is also used in biochemical reactions as a concentrator to
increase the interactions of ionic compounds in a large space. The incorporation
of PEG linkers at increased unit size can prevent the conjugated RNA from
precipitating, therefore preventing the concentration of the captured CoA-RNA.
For these reasons, the PEG linker size will need to be optimized for the capture
protocols.
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Figure 5.12 CoA-Capture by Maleimide.

The capture of CoA-RNA for identification is a large task with many
pitfalls. Based on the number of components involved from beginning to end of
this protocol, it seems the lack of CoA-RNA sequence identification reported in
the 7 years since its discovery is for good reason. Despite the problems
encountered with each step of the way, this work presents multiple pathways for
which the CoA-RNA can be captured and identified. As a result, CoA-RNA was
successfully captured from E. coli total RNA, but purification to homogeneity was
not achieved. Although multiple avenues for specifically capturing and releasing
CoA-RNA were proven successful, their efficiencies are adequate, at best, and
still require some amount of optimization.
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CHAPTER VI – PERSPECTIVES
The identification of CoA-RNA is a goal that would uncover many
unknown aspects of bacterial metabolism. Despite the significance of the
identification of NAD-RNA sequences, so many more questions were realized
upon the analysis of the data (Cahova et al. 2015). In addition to the realization
that the sequences identified only represented those from one organism grown in
one condition, the question of the metabolism of these coenzyme-RNA
conjugates is in question.
In terms of CoA-RNA, the degradation can potentially be carried out by
NudC or NudL in vitro, but how it occurs in the cells is another matter (Bird et al.
2016). Based on kinetic data, both enzymes are not suited for high turnover rates
of CoA alone given its cellular concentrations. The Km of NudL for CoA of 0.5
mM, in particular, is high in comparison to the known concentrations of CoA up to
0.4 mM in the cell (Miller et al. 2007). Even in the event that cells are in nutrient
rich conditions and this number is at its peak, the turnover number of NudL is
substantially low in comparison to other Nudix CoAses (AbdelRaheim and
McLennan 2002). Therefore the existence of NudL as a CoAse within E. coli
must occur at a very tempered state, where the induction of its expression is
required to influence the rate of CoA hydrolysis.
The evolutionary aspect of such a poor enzyme as NudL comes into focus
when considering how it could have survived divergence to the γ-Proteobacteria.
Given that prokaryotes do not typically possess organelles to compartmentalize
cellular processes, the majority of biochemical components of metabolism are
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located in the bacterial cytoplasm, if not the cell wall. Considering that CoA
instrumental in growth and metabolism, the presence of a high-activity CoA
hydrolase in the cell would be detrimental to survival. The eukaryotic
counterparts of C. elegans NDX8 and M. musculus Nudt7 do have a much higher
activity, but they also enjoy the benefit of peroxisomal localization via signal
peptide targeting. With the main store of CoA existing in the mitochondria, these
eukaryotic enzymes are separated by multiple membranes from their substrate,
and thus are only capable of interacting with derivatives of CoA that would come
within proximity such as oxidized CoA or thioester-CoA. Therefore these
eukaryotic enzymes have no selective disadvantage for being highly active within
the cell.
NudC is a peculiar enzyme due to its wide-spread substrate ambiguity.
When tested in vitro, NudC was shown capable of hydrolyzing over 10 different
nucleotide-derived substrates with different activities, including 3 common
coenzymes in different oxidation states such as NAD (Frick and Bessman 1995).
For such an enzyme to exist within E. coli in the open world of the cytoplasm with
such unbridled targeting of metabolically integral compounds, one would think
NudC activity would be inversely proportional to cell survival. The turnover
number of NudC is less than the eukaryotic Nudix CoAses, but the ability to
cleave important redox molecules such as NAD and FAD, especially with the
high affinity for NADH, implies its activity to be dangerous to cell survival. Given
the importance of the build-up of reduced NADH to metabolism and ATP
production, it’s curious to think that such an enzyme is ready and waiting to
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waste all of its potential. The same could be said for CoA, of course, however
NADH is not capable of dimer formation via oxidation render it useless, and is
also not known for complex metabolism such as fatty acid metabolism that
requires an abundance of sequential biochemical reactions for its regeneration.
Both of these things are true of CoA and have been speculated as to the purpose
of certain Nudix CoAses (Cartwright et al. 2000, Reilly et al. 2008).
If these Nudix hydrolases NudC and NudL exist as a part of CoA-RNA
metabolism, this metabolism could not be carried out quickly. Given the amount
of CoA-RNA estimated in the cell of 8 fmol per μg RNA, these concentrations
would bring both NudC and NudL to extremely low activities. Increasing the
enzyme concentrations within the cell through some type of regulation event
would increase this activity, but this implies some regulation either on the level of
transcription or translation. The role of these Nudix enzymes in bacterial CoARNA metabolism needs to be probed by the generation of knockout mutants for
each, and the subsequent transformation of a plasmid that encodes each
enzyme. This plasmid should be under the control of a dose-dependent inducible
promoter such as the arabinose promoter, so that different levels of NudC and
NudL activity can be tuned while assessing the quantity of captured CoA-RNA.
The Nudix enzymes cloned were chosen for specific purposes. While the
determination of NudL as a specific Nudix CoAse in E. coli and the
characterization of CoA as a substrate for NudC were goals set out by this study,
the foremost reason for cloning these enzymes was to develop a CoA-RNA
capture protocol. As of now, the world is without any knowledge of these
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sequences. The sequences themselves represent a wealth of knowledge on a
topic unknown before 2009. As such, the retrieval and identification of such RNA
is vital to the understanding of its purpose.
There is much debate, albeit mostly between the two labs who have
published work on the topic and our own, about the generation of CoA-RNA and
its purpose within the cell. It is hard to imagine that CoA-RNA exists simply as a
cap to RNA as proposed for NAD-RNA. Firstly, the existence of redundant
capping structures serves no evolutionary purpose, especially considering that
there are other, more available adenosine derivatives that could fulfill this role
such as AppA without siphoning indispensable metabolic coenzymes. Second,
the installation of these coenzymes into RNA cannot be achieved by the current
model of transcription initiation (Bird et al. 2016). Transcription initiation by CoA
is out of the question, as is achieving levels of depCoA to out-compete ATP for
transcript initiation (Huang 2003a). Third, the existence of the thioester-CoA-RNA
implicates the comparably higher complexity of CoA-RNA than NAD-RNA
(Kowtoniuk et al. 2009).
Four versions of CoA-RNA were discovered in bacteria, indicating that the
CoA can continue to react as an acylation substrate when attached to RNA. The
reasoning for this is, again, that CoA cannot be used to initiate transcription, and
therefore thioester-CoA cannot either. Therefore the CoA must be installed
before thioesterification either as depCoA in some unforeseeable way given the
cellular environment, or through a mechanism similar to that of the depCoAsynthesizing ribozyme that utilizes ATP and PhP (Huang et al. 2000).
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Considering the data available, the latter mechanism seems more plausible. In
addition, the three separate CoA-thioesters found with RNA do not occur in the
same organism, meaning the RNA modification could be species specific.
Considering this, it is more likely that CoA is installed similar to the ribozyme
synthesized mechanism and then acylated based on the specific cellular
environment than the possibility that different organisms evolved specific
machinery that allow the installation of distinct CoA-thioesters as initiators.
Furthermore, if CoA-RNAs can be acylated based on a similar rationale to CoA
acylation, it’s possible that these modified RNAs are a product of the energy
state of the cell. Therefore the identification of CoA-RNA from cultures grown in
different conditions that influence the state of the cell and therefore the state of
CoA is important to discerning the reasoning behind this modification. In addition,
the idea of CoA-RNA in different acylation states is reminiscent of coenzymeRNA ribozymes hypothesized from the RNA World predating protein enzymes. It
is therefore intriguing to consider that sequences may exist in contemporary
bacteria that act as ribozymes and facilitate the acylation activity of CoA, and
possibly participate in specialized metabolism. Such sequences would never
have been discovered before based on limitations in CoA-RNA capturing and
sequencing, both of which can now be overcome with modern methods.
The use of any of the studied Nudix hydrolases could surely achieve
hydrolysis of CoA in a capture protocol. However, given the problems
encountered with both the release of captured CoA-RNA from solid resin and the
inherent contamination of non-CoA-RNA, NudC should be used with caution due
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to its substrate ambiguity in vitro. The specific CoAse Nudt7 is the most viable
option at this moment for release due to its ability to hydrolyze CoA-thioesters
(Reilly et al. 2008). Capture resins, therefore can be modeled to mimic lauroylCoA after capture, as this was the molecule that showed the highest activity with
Nudt7. Given the assumptions of the solid resins in suspension with the CoARNA inhibiting enzyme degradation, the focus may need to move to a system
where hydrolysis can occur in solution after capture and purification on the
beads.
The capture of thiol-modified tRNA presents a large problem with the
overall capture protocol. These tRNA can participate in every purification step
along with CoA-RNA, including the capture by thiol cross-linking chemistries. The
cellular abundance of these tRNAs can cause them overtake the true CoA-RNA
in amplification for NGS library preparation. Therefore the discriminatory step
must be Nudix CoAse release of CoA-RNA from solid resin, as this offers the
most accessible method of physically separating molecules that have reacted
from those that have not. Ideally, the resin of a high capacity would react with
both CoA-RNA and thiol-tRNA, and Nudt7 digestion would allow the CoA-RNA to
elute while the thiol-tRNA remains. This requires the development of a resin that
is capable of facilitating enzyme hydrolysis at efficiencies greater than the 50%
observed in this study.
The enzyme hydrolysis of CoA-RNA could also be increased by a more
active CoAse such as C. elegans NDX8. However due to the struggles of
obtaining a soluble protein from recombinant expression in E. coli, other avenues
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of generating this enzyme should be investigated. The original investigator who
characterized this enzyme did it with a TrxA fusion from a T7 promoter similar to
the pET32b system used in this study, however their yields went unreported and
were apparently very poor when observing their gels (AbdelRaheim and
McLennan 2002). If this enzyme is capable of hydrolyzing CoA-RNA, which is
likely considering that Nudt7 had no problem and they are structurally related, it
could be used for a more efficient hydrolysis of CoA from resin in a capture
protocol. Mammalian expression systems may be an avenue worth pursuing for
this endeavor if bacterial expression cannot be achieved.
Considering the entirety of this study, the identities of CoA-RNA remain
unknown. The capture of CoA-RNA has been demonstrated, however its lack of
purity taints the result that would come from NGS. CoA-RNA metabolism is still
largely unknown, however with the data provided here the case for extended
regulation of the CoA-RNA pathway can be made. Identification of multiple Nudix
enzymes capable of CoA hydrolysis in E. coli offer new targets for probing their
roles in the CoA-RNA pathway, or the CoA pathway alone considering that CoA
degradation has never itself been characterized in E. coli (Leonardi et al. 2005).
This study presents many viable options for many steps of a protocol to capture
and identify of CoA-RNA, and even demonstrates its success. The future
directions of this area should continue to be those that strive for stringency and
purity of results. The focus should not be towards a specific size range of RNA,
but towards all possible sizes of CoA-RNAs to get the true picture of what these
RNAs are and how they function within the cell. Only by focusing on the entire
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picture and not excluding certain areas can we hope to grasp the understanding
of such a process as CoA-RNA function.
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